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Abstract 
 
Modular proteins serve assembly platforms and often actively regulate cellular 
signaling events. An intrinsic diversity of interaction modules, typical for scaffolding 
proteins, facilitates the organization of numerous protein partners into signaling cascades, 
contributing to the spatial precision, efficiency and fidelity of signal transduction. 
The role of complex molecular dynamics of postsynaptic density (PSD) proteins 
in synaptic plasticity is relatively new and yet to be fully understood. AIDA-1 is one of 
the most abundant members of the PSD protein family. Growing research evidence of 
multiple protein partnerships suggests that AIDA-1 functions as an essential PSD 
molecular scaffold, NMDA receptor functional mediator, and a synapse-to-nucleus 
messenger. The NMR structure of AIDA-1 carboxy-terminal phosphotyrosine binding 
domain (PTB), presented in this study, provided the structural basis for comparative 
analysis with the other PTB domain-containing proteins, Fe65 and X11/Mint1, that also 
participate in amyloid beta precursor protein (AβPP) processing and amyloid beta peptide 
(Aβ) secretion. A combination of peptide arrays, mutagenesis and fluorescence based 
assays was employed to characterize the affinity and specificity of the AIDA-1 PTB 
domain and AβPP intracellular domain (AICD) interaction.  
iii 
Another modular protein of these studies is a pre-synaptic scaffolding protein, 
Caskin2. Presently, its function within the synapse is less clear compared to its more 
widely studied homolog, Caskin1. However, the structural differences between the two 
identified by our research suggest the possibility of distinct functional outcomes in the 
neuron. We demonstrated that Caskin2 Sterile Alpha Motif (SAM) assembles into an 
oligomeric architecture different from Caskin1, with the minimal repeating unit being a 
dimer, rather than a monomer. In invertebrates, Caskin has been functionally linked to 
LAR receptor tyrosine phosphatase functional pathways, implicated in axonogenesis and 
synaptogenesis. Using a combination of biophysical and biochemical methods, the 
partnership between Caskin2 and LAR Homo sapiens homologs was confirmed and 
characterized. These integrated structural and functional studies provide a platform for 
further elucidation of AIDA-1 and Caskin cellular functions.   
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1.  CHAPTER 1: 
GENERAL INTRODUCTION 
_______________________________________________________________________ 
 
 
1.1.   Cell Signaling and Signal Transduction 
Cell signaling is a complex process regulating virtually every aspect of cellular 
function and essentially cell survival itself. It allows cells to detect and process sensory 
information from external stimuli and communicate with each other via distinct signaling 
pathways producing a coherent response. Intercellular signaling controls cell division and 
proliferation, differentiation and development as well as metabolic fluxes in different 
tissues. It works in synchrony with intracellular signaling which coordinates individual 
cell metabolism, protein expression, cell motility, and morphology.  A human nervous 
system is incredibly complex with billions of neurons communicating every second via 
axons with their targets and their proteins, including cell surface receptors, downstream 
effectors, scaffolding and adaptor proteins. These proteins are the workhorses controlling 
the integrity of such complex processes as neurotransmission, synaptic plasticity, and 
synaptogenesis.   
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The complete sequencing of several eukaryotic genomes, including the human 
genome, provided a foundation for a whole new paradigm of proteomic studies with the 
ultimate goal of identifying and characterizing all protein networks and their connections 
with particular cellular mechanisms or functional pathways.  Such knowledge ultimately 
drives a better understanding of malfunctions within organisms and opens up new 
possibilities for human disease therapeutics. 
1.2.   Modular Proteins in Cell Signaling and Signal Transduction 
 A comparison of the proteomes across different species and development of 
sequence alignment tools and protein databases led to the realization that eukaryotes share 
a number of recognizable protein families with the same type and number of protein 
domains (also called peptide recognition modules or PRMs).  Evidently, the higher 
eukaryotes gained an evolutionary advantage by assembling these modules in numerous 
combinations; consequently, the human genome comprises almost twice of the 
multidomain combinations compared to worm or fly (Lander et al., 2001).  
The protein domain is traditionally defined as an evolutionarily conserved, 
independently folded globular structure, with an assigned or unknown biological function 
(Cesareni et al., 2005).  The primary functional outcomes of modular domains include 
colocalization of enzymes with their substrates resulting in signaling cascades and 
recognition of specific post-translational modifications (PTMs) and finally, cross-talk 
signaling modules that link different pathways. The modular signaling proteins such as 
kinases and phosphatases, although they harbor catalytic functions, are distinct from other 
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enzymes that are designed to process a large amount of substrate promptly (fast substrate 
turnover). Their catalytic center is often separated from their substrate binding motifs that 
specialize in recruiting specific protein targets (Cohen et al., 1995). In addition, they 
possess other protein binding and extracellular communication modules. Kinases and 
phosphatases assemble into dynamic signal transduction cascades in conjunction with a 
non-catalytic adaptor and scaffolding proteins.  This exceptional complexity allows them 
to link to downstream and upstream proteins and concentrate the signaling event at 
particular subcellular regions, therefore providing fine control of signal transduction.    
In addition to polypeptide binding domains, there are a number of specialized lipid 
and carbohydrate binding modules.  Overall, although employing diverse interaction 
models, modular domain binding is characterized by specific sequence recognition. For 
instance, PTB domains recognize NPxY in both a phosphorylation-dependent and -
independent fashion; Sarc homology-2 (SH2) are phospho-tyrosine binding modules; a 
large group of polyproline sequence recognition domains includes the SH3, WW, GYE, 
UEV and EVH1 domains, PDZ domains which recognize the binding motifs at their C-
terminal ends of their ligands; PH and PX domains bind phospholipids; and the SAM 
domain is known for its ability to assemble SAM-containing protein into homo- and/or 
hetero-oligomeric structures.   
Although protein domains vary in size from as small as ~30 amino acids to as big 
as several hundred residues, the majority of modular domains are composed of ~50-150 
residues (Petsko & Ringe, 2004). The modest interaction surface is energetically 
compensated by the extensive hydrogen bonding network and electrostatic interactions. 
4 
At the same time, the affinity of an enzyme for its binding epitope should not be too strong, 
in fact, it is typically found within the range from 10-3 M to 10-9 M (Petsko & Ringe, 2004), 
to assure fast dissociation rates required for dynamic signaling systems (Cesareni et al., 
2005). Another consequence of the small size is that the binding groove is often 
accompanied by various supporting sequences especially common in the unstructured 
loops. For example, the LAR receptor-like tyrosine phosphatase catalytic cleft formed by 
a motif named the PTP loop and two other substrate recognition regions: WPD and p-Tyr-
binding loop (Nam et al., 1999). Another reason for the small size is that the protein-
interaction modules are often found in clusters, so called supramodules that ensure binding 
selectivity, such as phospholipase C-gamma (PLC) consisting of two PH, an SH2 and an 
SH3 domains which together engage in lipase recognition (Cesareni et al., 2005). The 
small size of the minimal binding epitope is also often compensated by the adjacent 
residues that support binding specificity. For instance, a typical PTB ligand recognition 
spreads to the amino acids N-terminal from pY, while in the case of SH2 domains residues 
carboxy-terminal from phospho-tyrosine define their ligand specificity (Uhlik et al., 
2002). 
Since the number of modular domains in any given organism is quite limited, most 
of them serve multiple functions. A certain degree of molecular cross-talk and redundancy 
is a natural evolutionary outcome and an essential instrument of cell survival. The 
observation that increasing complexity of the organism correlates with growing 
complexity of modular domain architecture supports the hypothesis that requirement for 
new signaling networks supporting more complex cellular functions prompted a new 
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domain evolution from preexisting domains as well as multi-modular assemblies (Ernst et 
al., 2009; Jin et al., 2009). For instance, certain non-catalytic domains of adaptor and 
scaffolding proteins could have originally diverged from enzymatic domains. An example 
of such domain evolution could be found in the MAGUK (membrane associated guanylate 
kinase) adaptor protein family that plays a critical role at neuronal synapses supporting a 
number of protein-protein scaffolds. The C-terminal domain of MAGUKs are strikingly 
similar to a guanylate kinase domain, but lacks its catalytic function.  Studies indicate that 
its pSer/pThr-binding pocket most likely had evolved from the catalytic GMP domain of 
guanylate kinases (Jin & Pawson, 2012; Zhu et al., 2011). 
In the following sections, I will discuss in greater detail the structural and 
functional aspects of SAM and PTB domains as the key elements of AIDA-1 and Caskin2 
structural and functional studies. 
1.3.   The Sterile Alpha Motif (SAM) Domain 
 Over two decades ago, Ponting first identified SAM domains based on the 
predicted high-level alpha-helical content and significant sequence similarity among 14 
eukaryotic proteins (Ponting, 1995). The conservation of helical structure and the fact that 
four of these proteins were linked to yeast sexual differentiation prompted the name sterile 
alpha motif (SAM) domain (Kim, 2003). Later, in 1997, Shultz et al. united a number of 
previously recognized modules named SPM (Scm, Ph, lethal-3 malignant brain tumor), 
SEP (yeast sterility, Ets-related, PcG proteins), PNT (pointed), NCR (N-terminal 
conserved region) and HLH (helix – loop – helix) under this name (Schultz et al., 1997).  
6 
 Currently, the SMART (Simple Modular Architecture Research Tool) database 
(Schultz et al., 1998) identifies over 6000 SAM domain-containing proteins in 
mammalian genomes alone, and over 14000 in all genomes. SAM domain representation 
in the human genome (>200 by homology) comparable to the most common protein-
protein interaction domains such as SH2 and SH3. SAM domains play diverse roles 
facilitating an array of protein-ligand interactions, and they generally exist as single units. 
However, tandem and even triplet (Taru & Jin, 2011) modules have been found in higher 
eukaryotes which suggests that they offer more complexity to the signaling interaction 
platform. SAM domains are often present in multidomain proteins of a remarkably 
versatile range of functions, including scaffolding and adaptor proteins, transcription and 
translational regulators, tyrosine kinases and serine/threonine kinases, and even nucleic 
acid and lipid binding proteins (Kim, 2003; Qiao, 2005).  
1.3.1.  Oligomerization States of SAM Domains Associate with Their Physiological 
Functions 
 The most common and well-characterized protein partnerships of SAM domains 
are other SAM domains. Although the SAM domain structures determined to date 
typically form conserved alpha helical bundles, the surface complementarity leads to a 
great variety of homotypic and heterotypic SAM-SAM interactions, especially in 
transcription factors (C. A. Kim, Gingery, Pilpa, & Bowie, 2002; C. A. Kim et al., 2001) 
and neuronal signaling protein assemblies (Baron et al., 2006; Bourgeron, 2009; Harada 
et al., 2008). The ability to polymerize appears to be a fundamental property of tandem 
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and multiple SAM domain proteins and has been connected to their regulatory and 
structural roles in building cellular complexes. Knight et al. (2011) first used the term 
‘polymerizome’ for SAM domain-mediated protein assemblies. This section aims to 
review a number of reported cases where the SAM domain oligomerization state was 
central to the activity of the protein within the biological system, whether it was 
transcriptional regulation or pre/post-synaptic scaffolding.   
 A transcriptional tumor suppressor, TEL (translocation Ets leukemia), was shown 
to self-assemble into a polymeric helix in a head-to-tail orientation with six SAM domains 
per turn (C. A. Kim et al., 2001). Mutations specifically targeting polymerization contacts, 
specifically Lys99, increased nuclear retention and hindered TEL repression in vitro (Tran 
et al., 2002; Wood et al., 2003). Remarkably, two other transcriptional repression proteins 
from the polycomb group (PcG), polyhomeotic (Ph) and Sex-comb-on-midleg (Scm) form 
oligomers analogous to TEL although the intermolecular interface is supported by 
different residues (Kim et al., 2002; Kim & Kim, 2005). Despite very modest sequence 
similarity, these all exhibit a left-handed head to tail helical type of polymeric architecture 
that is linked to their biological function. The loss of PcG repression Drosophila 
phenotypes were observed in vivo for mutations disrupting Scm SAM domain self-
association. Moreover, negative phenotypes resulted from an overexpression of isolated 
Scm-SAM domain as a consequence of its competition with functional full-length Scm 
protein for its binding partners (Peterson et al., 2004). The cooperativity of functions 
between Ph and Scm was suggested since both proteins colocalize with polytene 
chromosomes in fly and, in addition to self-oligomerization, can interact with each other 
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in a heterotypic manner via C-terminal SAM domains (Kyba & Brock, 1998; Peterson et 
al., 1997).  Altogether, accumulated experimental evidence suggests the existence of a 
mechanism in which PcG family of proteins provides a platform for chromatin modulation 
and long-term repression mediated by their polymerization states (Kim et al., 2002; 
Peterson et al., 2004). 
 Perhaps the most studied heterodimeric SAM domain interactions are scaffolding 
proteins Ste4 and Byr2 (Schizosaccharomyces pombe) that are involved in MAP kinase 
controlled yeast sexual differentiation and their orthologs in Saccharomyces cerevisiae, 
Ste11 and Ste50. Similar to the common polymerization mode described above, Byr2-
SAM / Ste4-SAM (Ramachander & Bowie, 2004; Ramachander et al., 2002) as well as 
Ste11 / Ste50 (Grimshaw et al., 2004; Kwan et al., 2004) utilize their EH/ML (end-
helix/mid-loop) interface to form a heterodimer with nanomolar affinities. Amongst them 
only Ste11 demonstrated weak (~0.5mM) homodimerization potential (Grimshaw et al., 
2004). Three SAM domain containing proteins Mae, Yan and Pnt-P2 regulate 
transcription in Drosophila eye development controlled by receptor tyrosine kinase (RTK) 
pathways (Qiao et al., 2006). Mae-SAM and Yan-SAM can form closed hetero-oligomers 
(Qiao et al., 2004) resulting in Yan depolymerization and exposing MAPK 
phosphorylation site. Following the phosphorylation event, Mae is displaced by CRM1 
permitting Yan nuclear export (Song et al., 2005; Tootle et al., 2003). The interaction 
between Mae-SAM ML surface and EH surface of Pnt-P2-SAM prevents MAPK 
phosphorylation by blocking its target surface and prevents transcriptional activation 
activity of Pnt-P2 as part of the MAPK signaling pathway regulation (Qiao et al., 2006). 
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 The scaffolding protein Shank organizes multiple proteins assemblies at the 
postsynaptic density (PSD). Shank family proteins (Shank1, Shank2, Shank3) have been 
associated with a number of neurodegenerative conditions termed idiopathic autism 
spectrum disorders (ASD) (Kim & Sheng, 2004; Sheng & Kim, 2000; reviewed in Jiang 
& Ehlers, 2013). Shank 3, in particular, defines the size and shape of dendritic protrusions, 
and deletion of various domains of Shank3 led to abnormal dendritic spine development 
in mice (Roussignol et al., 2005). All Shank family proteins have a conserved single SAM 
domain at the C-terminus. Shank3 self-associates (Naisbitt et al., 1999) into a helical 
polymer that is 70 Å in diameter, which in turn assembles into large sheets over 100nm 
wide (Baron et al., 2006).  The PDZ domain-mediated interactions with NMDA, AMPA 
and mGluRs receptors define the specific glutamatergic synaptic localization of Shanks 
(Jiang & Ehlers, 2013) and the SAM domain amplifies their presence by polymerization 
at the C-terminus (Hayashi et al., 2009; Naisbitt et al., 1999). It was established that in 
Shank3-SAM higher order assembly, Zn2+ plays an important role in stabilizing the 
formation of two-dimensional sheets of helical fibers (Gundelfinger et al., 2006). Zn2+ 
stabilized salt bridges exist at the site where intra- and inter- Shank3-SAM polymer 
interfaces meet. Therefore, it was proposed that Zn2+-mediated assembly and packing 
density of Shank oligomers contributes to mechanisms regulating synaptic formation, 
maturation and structural plasticity (Baron et al., 2006). Examples of SAM domains 
employing common structural interfaces for homo- and heterotypic interactions are 
presented in Figure 1.1. 
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Overall, these examples demonstrate that many SAM domain proteins use their 
surface complementarity to produce an array of oligomeric states (Ramachander & Bowie, 
2004) as well as a strong basis for heterotypic SAM-SAM domain associations.  The 
oligomeric state is often a driving force for a specific cellular function such as 
transcriptional repression or pre/post-synaptic scaffolding or playing part of a greater 
regulatory mechanism such as synaptic plasticity.  
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Figure 1. 1 – Structural diversity of SAM domains. Representative examples of SAM-
SAM homo- and heterotypic interactions. (a) AIDA-1 SAM1-SAM2 tandem (PDB: 
2KIV) intramolecular interactions; (b) heterotypic EphA2:SHIP2 SAM:SAM complex 
(PBD: 2KSO); (c) human Anks3-SAM/Anks6-SAM heterooligomeric packing (PBD: 
4NL9). The cartoon representations were generated using MacPyMOL program with 
color scheme from blue (N-terminus) to red (C-terminus).   
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1.3.2.  SAM Domain Interactions Beyond SAM-SAM Type  
 C-terminal SAM domains are also present in all Eph family receptor tyrosine 
kinases (RTKs) (Pawson & Nash, 2000). Eph family receptor tyrosine kinases mediate 
axonal pathfinding, neuronal cell migration, angiogenesis and capillary morphogenesis 
(Smalla et al., 1999; Stapleton et al., 1999). Although the biological significance of homo-
dimerization and oligomerization of Ephrin SAM domains remain unclear (Stapleton et 
al., 1999; Thanos, 1999) its potential impact on cell signaling via receptor clustering is 
anticipated (Qiao, 2005). EphA RTKs attenuate cell migration (Borthakur et al., 2014). 
Structural studies, supported by in vitro experiments, have reported the requirement for 
phosphorylation of two tyrosine residues in EphA2 SAM domain for it to be recruited by 
the adaptor protein Grb7 [also by both Grb7 and Grb10 in the case of EphB1 RTK (Han 
et al., 2002)]. A reverse signaling event, dephosphorylation of EphA2 at Tyr930 by 
receptor protein tyrosine phosphatase LAR, decouples it from another adaptor protein, 
Nck1, likewise involved in EphA-mediated cell migration (Hu et al., 2009; Lee & Bennett, 
2013). A number of recent studies elucidated the details of the heterotypic association of 
EphA2 and the lipid phosphatase Ship2 that leads to inhibition of receptor endocytosis as 
well as enhancement of Eph kinase activation (Lee et al., 2012; Leone, Cellitti, & 
Pellecchia, 2008; Zhuang et al., 2007).  
 Traditionally, SAM domains were viewed solely as protein-protein interaction 
modules until RNA binding SAM domains of Smaug and its ortholog Vts1 emerged in 
the literature (Aviv et al., 2006; 2003; Green et al., 2003). The primary function of Smaug 
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is morphogen gradient control by repression of Nanos mRNA translation in developing 
Drosophila embryos. The surface exposed positively charged cluster (Green et al., 2003) 
of the Smaug SAM domain directly targets non-stem-loop RNAs at hairpins termed the 
Smaug recognition element (SRE) (Johnson & Donaldson, 2006; Oberstrass et al., 2006). 
Essentially, Smaug fulfills the function of a translational switch that controls Nanos 
distribution and proper abdominal segmentation in the early embryogenesis stages in 
Drosophila (Dahanukar, Walker, & Wharton, 1999). 
1.3.3.  Phosphotyrosine Binding Domain (PTB) 
 The PTB domain along with the SH2 domain were originally classified as a 
phosphotyrosine interaction domains (PID) that play an active part in phosphotyrosine 
related cell signaling. In the human genome, there are approximately 60 proteins that have 
PTB domains (Uhlik et al., 2005), and while they are also present in Drosophila and C. 
elegans genomes, and none found in Arabidopsis thaliana or S. cerevisiae (Yaffe, 2002).  
 The SH2-domain-containing adaptor molecule (Shc) and the docking protein 
insulin receptor substrate-1 (IRS-1) were the first two proteins where PTB domains were 
independently identified (Yaffe, 2002) as NPXpY-motif binding modules. Successively 
two PTB-domain neuronal proteins, Fe65 and X11/Mint (Borg et al., 1996; Zambrano et 
al., 1997), well-known nowadays as amyloid precursor protein (APP) partners, have been 
shown to specifically target the non-phosphorylated NPTY sequence of the APP 
intracellular domain, suggesting that the PTB module has a separate set of functions aside 
from kinase signaling. Numerous examples of PTB domain substrate recognition through 
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non-canonical NPXY sequences have been identified and described (reviewed in Uhlik et 
al. 2005). Furthermore, examples of PTB-binding motifs that lack tyrosine residues 
entirely include:  the PTB domain of cell-fate-determinant protein Numb interaction with 
Numb-associated kinase Nak; Protein Kinase C3 (PKC3) and Numb-interacting protein 
(NIP); hSNT-1 and -2 PTB binding to fibroblast Growth Factor Receptor 1 (FGFR1); 
mammalian protein Disabled (Dab) and Protocadherin 18 (Pcdh 18) (Uhlik et al., 2005; 
Yaffe, 2002). The PTB domain of Shc (Ravichandran et al., 1997) and mDab (Howell et 
al., 1999a) have been reported to interact with phospholipids (Yan, Kuti, & Zhou, 2002a) 
which further contributes to the complexity and versatility of PTB supported functions.  
1.3.4.  Classification and Structural Features of PTB Domains 
 Traditionally, PTB domains were segmented into two groups based on structural 
organization and ligand binding specificity: two phosphotyrosine-dependent, Shc-like and 
IRS-like, more recently Dab-like phosphotyrosine-independent PTB was defined as a 
separate subgroup (Forman-Kay & Pawson, 1999; Uhlik et al., 2005; Yaffe, 2002).  
Unlike the SH2 domain family that is characterized by high sequence similarity, PTB 
domains exhibit a surprisingly low level of sequence conservation. Nonetheless, they 
adopt a similar structural fold (also referred as pleckstrin homology (PH) domain 
superfold (Uhlik et al., 2005) that consists of an orthogonal β-sandwich capped with a C-
terminal α-helix. The conserved glycine-based loop differentiates the Shc group from IRS 
and Dab. In addition, Shc and Dab1 PTB domains lack a β1’ strand, but contain two 
additional α-helices, one N-terminal from the β-sandwich and another between β1 and β2 
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(Uhlik et al., 2002).   Despite the structural differences all PTB domains have a distinct 
peptide binding pocket lined up by residues from the β5 strand and C-terminal α helix. 
The other common structural feature is a highly basic phospholipid-binding surface 
formed by the N-terminal loops (Uhlik et al., 2005). A representative example from each 
group is shown in Figure 1.2.  The structural foundations of PTB domains distinct ligand 
binding modes will be discussed in greater details in the following section.  
1.3.5.  Structural Foundation for Canonical NPX(Y/Py) Versus Non-Canonical 
Peptide Binding and Interactions with Phospholipids  
 As noted earlier, PTB domains engage multiple ligands highlighting their 
functional significance and evolution as a modular binding domain. A typical PTB ligand 
recognition site extends to the amino acids N-terminal from pY; while in the case of SH2 
domains residues carboxy-terminal to the phospho-tyrosine define ligand specificity 
(Uhlik et al., 2005; Yaffe, 2002). With the accumulation of substantial structural data on 
ligand-bound PTB domains, the general basis for the “classic” PTB NPX(p)Y motif 
recognition has emerged (Eck et al., 1996; Shi et al., 2002; Stolt et al., 2003; Z. Zhang, 
1997; Zhou et al., 1996; 1995; Zwahlen, Li, Kay, Pawson, & Forman-Kay, 2000) et 
cetera.   A consensus Asn-Pro-X-Tyr motif adopts a type-I β-turn conformation which 
ensures precise positioning of the Y residue in the L-shaped hydrophobic binding groove 
of PTB also called the “anchoring pocket”. The stretch of N-terminal residues forms a 
pseudo anti-parallel β-sheet through hydrogen bonding with the β-5 strand and the C-
terminal α-helix (Uhlik et al., 2005; Yaffe, 2002). One of the earliest solved pY-ligand 
bound structures, IRS-1 (Eck et al., 1996; Zhou et al., 1996) and Shc (Zhou et al., 1995), 
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demonstrates the phosphorylated tyrosine coordination by basic residues which explains 
the high-affinity binding observed for phospho-tyrosine ligands (Farooq et al., 1999; Wolf 
et al., 1995). In the case of non-phosphorylated ligands similarly tight binding is achieved 
through compensation by extended recognition of carboxy-terminal residues adjacent to 
tyrosine (or non-canonical phenylalanine) in addition to amino-terminal residues 
(Forman-Kay & Pawson, 1999; Yaffe, 2002).  
A closer look at Dab-like non-phosphorylated ligand binding specificity is 
essential as it is most relevant to my structural study of the APP interaction with the 
AIDA-1 PTB domain (described in Chapter 2). With the Dab-like PTB mode of binding, 
phosphorylation of tyrosine is not only unnecessary but in most cases specifically 
disfavored since it perturbs the binding (Howell et al., 1999; Yun et al., 2003; Z. Zhang, 
1997). The role of a hydrophobic anchoring pocket is less prominent and Tyr at position 
0 in X11-APP complex (Z. Zhang, 1997) or Phe in Numb-NAK complex (Yun et al., 
2003) does not play a central role in sharp contrast to Shc-like and IRS-like type of ligand 
recognition. Furthermore, the X11 PTB-APP interaction remains preserved even when 
Tyr0 was substituted by Ala (Borg et al., 1996). On the other hand, a large number of 
hydrophobic interactions and hydrogen bonds occur between β-5 strand and the peptide 
binding sequences in both N-terminal and C-terminal directions from position 0.  In the 
case of Fe65 interaction with the APP intracellular domain (AICD), the minimal AICD 
peptide binding motif extends to as much as 32 amino acids and aligns the entire PTB 
binding groove.  In fact, the Fe65 PTB2 domain demonstrated ~100-fold difference in 
affinity between an 11 aa. minimal sequence (Kd = 100 mM) and an amino-terminally 
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extended 32 aa. (Kd = 0.2 mM) (Mulvihill & Komives, 2011; Radzimanowski et al., 2008). 
Another unique aspect of the Fe65-APP interaction is that the phosphorylation on 
threonine preceding tyrosine acts as a conformational switch that forces proline (P669) to 
transition from trans to cis conformation thereby precluding APP ligand binding 
(Radzimanowski et al., 2008). To add another layer of complexity, the PTB domain of 
SNT1 (also referred as FRS2 -fibroblast growth factor receptor substrate 2) was shown to 
engage two completely different ligands: first, the TrkA (Tropomyosin receptor kinase A) 
receptor which is classified as IRS-type of binding and second, FGFR1 which not only 
lacks the NPTY motif but does not have any Asp, Tyr or Phe within the minimal binding 
sequence (Dhalluin et al., 2000; Yan et al., 2002). Another exception is Talin which 
interacts with the cytoplasmic tail of β3 integrin. Although the binding mode structurally 
resembles the IRS-type, it occurs in a phosphorylation-independent manner. Furthermore, 
the Tailin PTB binding pocket lacks both arginine residues typical for IRS mode of 
binding (García-Alvarez et al., 2003). 
Another characteristic feature of PTB as an interaction hub is its phospholipid 
binding capability. It is achieved through a surface-exposed highly basic cluster distinct 
from the peptide binding pocket described earlier (Figure 1.2). The numerous examples 
of direct binding to liposome-associated or free phospholipid head groups (Uhlik et al., 
2005) reported to date, including Dab1, Dab2, X11, Numb, ARH, IRS-1, Shc, and Talin 
PTB domains (Dho et al., 1999; Martel et al., 2001; Mishra et al., 2002; Okamoto & 
Sudhof, 1997; Ravichandran et al., 1997; Takeuchi et al., 1998; Yun et al., 2003) suggest 
the evolutionary conservation of lipid-binding function in PTB domains.  
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Figure 1.2 – The representative PTB structures of IRS-like, Shc-like and Dab-like 
families. Top panel: Structures of IRS-1 PTB in complex with the IL-4R peptide (PDB: 
1IRS), Shc PTB in complex with the TrkA receptor peptide (PDB:1SHC), and Dab1 PTB 
in complex with ApoER2 receptor and PI-4,5P2 (PDB: 1NU2). The residues contributing 
to PTB binding cleft are shown in purple; the basic surface exposed side chains forming 
phospholipid-binding clusters highlighted in orange (in both stick and molecular surface 
formats); and the ligand peptides (in yellow, cartoon representation). Bottom panel: close-
up view of the tyrosine- or phospho-tyrosine-coordinating residues of each PTB domain. 
Dashed lines represent electrostatic interactions anchoring pTyr/Tyr in the binding 
pockets of IRS-1, Shc and amino acids at corresponding positions in Dab-1. Figure revised 
from (Uhlik et al., 2005). 
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1.3.6.  PTB Domains in Signal Transduction  
 Remarkably, while the majority of the PTB domains exist along with multiple 
interaction domains within a protein, close to a third of PTB domain containing proteins 
do not have any other defined modules (Figure 1.3).  This, combined with the absence of 
catalytic activity, solidifies them as ultimate adaptor and scaffolding proteins (Uhlik et 
al., 2005). In line with the classification outlined in the previous section, distinct groups 
of PTB domain proteins fulfill different cellular functions. They are involved in tyrosine 
kinase, cytokine receptor signaling; APP regulation; integrin related cell adhesion; 
asymmetric cell division and low-density lipoprotein (LDL) controlled endocytosis 
(Cesareni et al., 2005; Uhlik et al., 2005; K. S. Yan, Kuti, & Zhou, 2002a). One of the 
most well-studied adaptor proteins contains an SH2 domain in addition to a PTB domain.  
The Shc PTB connected to activated growth factor receptors undergoes phosphorylation 
which in turn permits Gb2 adapter recruitment followed by Ras (nucleotide exchange 
factor) mediated MAPK pathway activation (Ravichandran, 2001).  Shc has been reported 
to bind as many as 15 different phospho-tyrosine activated growth factor and cytokine 
receptors (Uhlik et al., 2005). IRS and Dock family proteins are notably involved in 
various signal transmission assemblies, including insulin receptor, B-cell receptor, CD2 
and Eph family receptors mediated signaling (Cesareni et al., 2005; Yaffe, 2002).   
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Figure 1.3 – Modular architecture of PTB-domain-containing proteins. Top panel 
depicts Shc-like PTB domain family representatives (colored terracotta), including 
(p)Tyr-independent Dab-like subfamily, whereas bottom panel illustrates IRS-1-like PTB 
domain family representatives (colored violet).  
Domain annotations: ANK, ankyrin repeats, SAM, sterile alpha motif; IRS-1/2, insulin-receptor 
substrate-1/2; JIP, c-Jun amino-terminal kinase-interacting protein; PDZ, domain present in PSD-
95, discs large and ZO-1; PH, Pleckstrin homology domain; PTB, phosphotyrosine binding; 
PTPase, protein tyrosine phosphatase; RBD, Raf-like Ras-binding domain; RGS, regulator of G-
protein-signalling domain; SHC, Src-homology-2-containing transforming protein; SNT, suc1-
associated neurotrophic-factor target; SH2, Src-homology-2; SH3, Src-homology-3; WW, domain 
with two conserved tryptophan (W) residues. Figure adapted from (Yaffe, 2002) with the addition 
of AIDA-1 schematic diagram.   
SAM SAMANK ANK ANK ANK ANK ANKAIDA(1
Shc(like
IRS(1(like
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The numerous PTB adapters, including Shc, JIP, CED-6, ARH, Fe65, X11, 
CAPON, ICAP [reviewed in (Uhlik et al., 2005)] have been found to bind low-density 
lipoprotein receptor family proteins and are believed to directly affect the regulation of 
LDL receptor (LDLR) endocytosis. Furthermore, two of these proteins, Fe65 and X11, 
are also involved in amyloid precursor protein (APP) processing (Cesareni et al., 2005; 
King & Scott Turner, 2004). Fe65 employs two of its PTB domains for simultaneous 
recruitment of both APP and lipoprotein receptor LRP intracellular tails and is linked to 
upregulation of APP processing and generation of amylogenic fragments that are known 
determinants of Alzheimer's disease pathogenesis (McLoughlin & Miller, 2008). 
Conversely, X11 is believed to have a positive regulatory function in APP exocytosis and 
an inhibitory role in its endocytosis (Cesareni et al., 2005; King & Turner, 2004; Sakuma 
et al., 2009). It is not surprising that many PTB domain proteins are involved in integrin-
cytoskeleton signaling pathways that regulate focal adhesion development (Calderwood 
et al., 2003) since β-integrin tails offer double NPxY motifs for their recognition.  Finally, 
Numb is a cell-fate determinant proposed to function downstream of transmembrane 
receptor Notch, which activates transcription of many cell-fate mediating genes. The 
Numb “recycling inhibition” model of Notch signaling through regulation of Notch-
Sanpodo oligomers trafficking has been most recently proposed (Couturier, Mazouni, & 
Schweisguth, 2013). 
  Thus, the versatility of PTB domain functions has been proven repeatedly with 
numerous example that highlight evolutionary complexity of cell signaling and the critical 
role of protein-protein interaction modules in maintaining specificity and selectivity in 
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signaling cascades.  
1.4.    Multidomain Scaffolding Proteins  
Scaffold, adaptor, anchoring proteins support complexity and specificity required 
for signal transduction pathways. Scaffolding proteins do not typically possess an 
enzymatic function, yet their role as molecular hubs is particularly important in organizing 
numerous protein complexes of signaling machinery.  The presence of multiple modular 
domains, such as in Fe65, Mint, AIDA-1, Numb, MAGUK family, Caskins, Shank, Mint, 
SARM, Liprin-α scaffolding proteins, permits a panoply of protein partner recognition.  
Therefore, modular proteins serve as an assembly platform for protein signaling networks 
(Pawson & Nash, 2000; Pawson & Scott, 1997).  In addition to the distinct protein 
interaction domains, intrinsically unstructured segments of scaffolding proteins are known 
to contribute to their functional specificity by carrying various post translational 
modifications, recruiting ligands and contributing to structural versatility (Van der Lee et 
al., 2014).  Scaffolding proteins do not only passively serve as molecular docking sites, 
organizing multiple protein partners; they often carry regulatory modifications and 
actively mediating signaling cascades (Burack & Shaw, 2000; Smith & Scott, 2013).  
Mitogen-activated protein kinase (MAPK) cascades are perhaps the most 
extensively studied signal transduction scaffolds. MAPK signaling pathways regulate 
many cellular processes, including cell differentiation, trafficking, division and apoptosis 
(Garrington & Johnson, 1999; Schaeffer & Weber, 1999).  Growth factor receptor-bound 
protein 2 (Grb2), Ste5 (in yeast), mammalian kinase suppressor of Ras (KSR), guanine 
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exchange factor (GEF) and JNK-interacting protein (JIP) are scaffolding organizers of 
multi-MAP kinase assemblies crucial for initiation of MAPK phosphorylation cascades 
(Meister et al., 2013; Smith & Scott, 2013).   
Adaptor and scaffolding proteins maintain signal specificity, subcellular co-
localization of signaling scaffold components and amplify signal transduction. More 
complex regulatory roles of scaffolds such as Ste5p. Ferrell et al. (2000) extend their 
function to the regulation of the strength of signaling response in either a graded or switch-
like manner, in which case overexpression of the scaffolding protein could lead to a lower 
signaling output.  For instance, the KSR-1 scaffold mediates Ras signaling response 
favorably at low and negatively at high expression levels (Burack & Shaw, 2000; Ferrell, 
2000). Smith and Scott, (2013) reviewed the number of studies that demonstrated the 
phosphorylation-dependent recruitment of signaling components by scaffolding proteins, 
where modification of scaffolding proteins themselves defined the outcomes of the 
signaling process they regulate.  For example, the Wnt-β-catenin signaling pathway 
regulated gene expression relies on the Axin scaffold. Phosphorylation of Axin promotes 
destruction complex formation in β-catenin degradation, as part of the “destruction” 
pathway; and dephosphorylated Axin complex facilitates the stabilization pathway and 
destabilization of the destruction complex, leading to β-catenin nuclear accumulation 
where it serves as a transcription co-activator of Wnt responsive genes. This phospho-
dependent switch is regulated by glycogen synthase kinase 3β (GSK3β), PP1c𝛾 protein 
phosphatase and its inhibitor (Kim et al., 2013; Smith & Scott, 2013). 
It is not surprising that oligomerization is an intrinsic property and one of the 
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regulatory mechanisms of scaffolding proteins. In the context of cellular signaling, 
repeated rounds of a quick scaffold assembly, dissociation and reinitiating is required. 
Therefore, scaffolding proteins often present themselves as multimeric complexes (Pan et 
al., 2012). Sterile alpha motif, as discussed earlier, is one of the most common homo- and 
hetero- oligomerization modules of scaffolding proteins.  
A family of neuronal scaffolding proteins, including Homer/Velis, PSD95, Shank, 
CASK and Caskin are indispensable for proper synaptic function. Homer/Velis link 
neurotransmitter receptors to intracellular effectors and postsynaptic density (PSD) 
scaffolds; Shank and PSD95 are implicated in receptor trafficking, receptor organization 
at the surface plasma membrane and activity-dependent PSD remodeling (Iasevoli, 
Tomasetti & de Bartolomeis, 2013).  Signal transduction utilizing multiple protein 
domains could be exemplified by the MAGUK family of neuronal scaffolding protein 
CASK (Ca2+/calmodulin-associated Ser/Thr kinase). SH3 and guanylate kinase domain 
(GK) compose a structural supramodule (Zhu et al., 2011) with GK providing the binding 
pocket specific for either pSer-­‐ or pThr-­‐containing targets, while PDZ domain is 
responsible for CASK multimeric assembly via complementary surfaces (Rademacher et 
al., 2013).  
Evidence from genetic, biochemical and clinical studies promote PSD-associated 
scaffolding proteins as important determinants of synaptic plasticity associated with 
learning and memory formation (Iasevoli et al., 2013). In this respect, the mechanistic 
understanding of neuronal scaffolding protein functions is necessary for development of 
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therapeutic strategies treating/controlling neurodegenerative disorders such as 
schizophrenia, dementia, and autism.  Structure-directed studies of neuronal scaffolding 
proteins AIDA-1 and Caskin2 are therefore the foci of this dissertation. The following 
sections aim to introduce the structural attributes of the two proteins and the context of 
their plausible neuronal functions. 
1.5.   Amyloid Beta Precursor Intracellular Domain-Associated 
Protein-1 (AIDA-1) a Major Synaptic Scaffolding Protein with 
Multiple Functions 
 The AIDA-1 protein was originally discovered in a yeast-two hybrid screen as a 
new interacting partner of the C-terminal cytoplasmic fragment of a membrane-associated 
amyloid precursor protein (AβPP) (Ghersi et al., 2004). This fragment, termed AβPP 
intracellular domain (AID, or AICD), is produced by the subsequent proteolytic 
processing of AβPP that also generates a short polypeptide fragment β-amyloid (or Aβ).  
Aβ aggregation in the brain leads to plaque formation and is one of the determinants of 
Alzheimer's disease (AD), a neurodegenerative disorder characterized by loss of synapses 
and neuronal cell death (Awasthi et al., 2009). AIDA-1 is encoded by a single gene, 
ANKS1, on human chromosome 12. Five different isoforms of AIDA-1 depicted in Figure 
1.4 as a result of alternative splicing have been identified (Ghersi et al., 2004).  
In addition to the protein-protein interaction domain module composed of two 
SAM domains and a single PTB domain that is present in all isoforms, the longest isoform 
AIDA-1b also includes six N-terminal ankyrin repeats. A similar supramodular layout of 
multiple protein-protein interacting domains was also found in two neuronal proteins, 
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Mint1/X11 and Fe65, that regulate AβPP processing and intracellular trafficking 
(Dumanis et al., 2012; Han et al., 2016b etc.; Saito et al., 2011; Sakuma et al., 2009; X. 
Xie et al., 2012). In addition to a regulatory role in APP processing originally proposed 
by Ghersi et al. (2004), AIDA-1 has since been implicated in Cajal body regulation, 
nucleolar formation and stability, nuclei-to-synapse signaling and PSD structural 
remodeling long term memory formation and synaptic plasticity (Xu & Hebert, 2005; 
Dosemeci et al. 2015, Jordan et al. 2009, Tindi et al., 2015). Recognized AIDA-1 protein 
partnerships in conjunction with associated pathways and proposed functions will be 
discussed in the following subsections.  
1.5.1.  AIDA-1 Associates with APP Intracellular Domain 
 Similar to Mint/11 and Fe65, AIDA-1 interacts with APP through its PTB domain 
in a phosphorylation-independent manner characteristic of the Dab-like PTB domain 
family. In our study, we employed a combination of biochemical methods to characterize 
the interaction between AIDA-1 PTB and APP and reported the AIDA-1 PTB NMR 
structure that permitted AIDA-1-APP ligand-binding by molecular modeling. This study 
resulted in the following publication: Smirnova E., Shanbhag R., Kurabi A., Mobli M., 
Kwan J.J., Donaldson L.W. (2013) Solution Structure and Peptide Binding of the PTB 
Domain from the AIDA-1 Postsynaptic Signaling Scaffolding Protein. PLoS ONE 8(6) 
which will be described in Chapter 2.  
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Figure 1.4 – AIDA-1 domain organization.  (a) Five splice variants of AIDA-1. All 
isoforms contain double sterile alpha motif and phosphotyrosine binding domain. The 
longest isoform differs by presence of stretch of N-terminal ankyrin repeats and putative 
self-inhibition region encoded by exon 14. (b) Ribbon presentations of NMR solution 
structures of SAM1 (PDB: 2KE7), SAM1-SAM2 (PDB: 2KIV) and PTB (2M38) 
domains. 
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AICD is a 6kDa intracellular fragment that has held a research spotlight for over 
two decades, as part of effort to elucidate APP pathogenic and nonpathogenic pathways 
and to develop AD therapeutic strategies. Since the foundation of the amyloid cascade 
hypothesis [the chain of events neurotoxic effects leading to the cell death and neuronal 
degeneration in AD (Selkoe, 1991; Selkoe & Hardy, 2016)] more than twenty protein 
partners, including AIDA-1, have been observed to associate with AICD, reviewed in 
(Raychaudhuri & Mukhopadhyay, 2007) thereby (Multhaup et al., 2015), linking it to 
diverse cellular processes including APP processing and trafficking (Lorenzo et al., 2000; 
Marks & Berg, 2010), transcriptional regulation, (Cao & Sudhof, 2004), apoptosis (Passer 
et al., 2000), calcium homeostasis (Hamid et al., 2007) and AD pathogenesis, 
physiological and behavioral hallmarks (Beckett et al., 2012; Galvan et al., 2006). 
Many scaffolding and protein adaptors employ PTB or SH2 domains to recognize 
a YENPTY motif of AICD. In contrast to AIDA-1, the roles of X11/Mint1 and Fe65 in 
APP metabolism are more characterized. Fe65 facilitates non-phosphorylated AICD 
transport to the nucleus (Bórquez & González-Billault, 2012; Cao & Sudhof, 2001) where 
in conjunction with Fe65, MED12 and transcription factors Tip60 or CP2/LSF/LBP1 
AICD regulates gene expression acting as transcription co-factor (Beckett et al., 2012; 
Minopoli et al., 2001; Cao & Sudhof, 2001) [refer to Figure 1.5].   
In contrast, the X11 protein family (X11s) is believed to have a positive regulatory 
function in APP exocytosis and an inhibitory role in its endocytosis (Cesareni et al., 2005; 
King & Turner, 2004; Sakuma et al., 2009). X11s regulate APP by at least two distinct 
events. Firstly, by suppression of APP maturation and direction of immature APP 
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(imAPP) to the early secretory pathway (Han et al., 2016b; Saito et al., 2011). Second, as 
observed in the late protein secretory pathway, by direct binding to AICD via its PTB 
domain X11 prevents γ-secretase cleavage (Saito et al., 2008; Sakurai et al., 2008), 
illustrated in Figure 1.5. Therefore, expression of X11 favors an overall metabolic 
stabilization of APP, promotes imAPP intracellular accumulation, and consequently 
reduces Aβ secretion (Saito et al., 2011). The phosphorylation-dependent conformational 
switch mechanism has been proposed (illustrated in Figure 1.6) in which the 
phosphorylation on a threonine residue (Thr668), located 14 aa. N-terminally from the 
NPTY-motif anchoring tyrosine, forces proline (Pro669) to transition from trans to cis 
conformation thereby preventing Fe-65-APP binding (Ando et al., 2001; Radzimanowski 
et al., 2008; Suzuki & Nakaya, 2008). At the same time this conformational change does 
not prevent X11s from binding to the GYENPTY motif (Suzuki & Nakaya, 2008). 
 Noticeably, AIDA-1 isoforms have different subcellular localizations: while the 
longest AIDA-1b is normally found in the cytoplasm, AIDA-1 a/c/d/e have a 
predominantly nucleolar distribution. The short AIDA-1a isoform demonstrates 
preferential binding to AICD AβPP (cytoplasmic domain of APP) and reduces amylogenic 
fragment secretion by preventing γ-secretase cleavage, while isoform b was found to be 
AβPP-inactive (Ghersi et al., 2004a). Moreover, later studies by our group supported 
observations by Ghersi et al. that the short region (~24 aa.) encoded by exon 14 prevented 
AIDA-1 from associating with AβPP which suggests the possibility of an AIDA-1 
intrinsic self-inhibitory mechanism that directly impacts any AβPP related functions.    
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Figure 1.5 – The schematic diagram of APP alternative processing pathways. APP is 
subjected to α- or β-secretase cleavage resulting in soluble N-terminal fragments sAPPα or 
sAPPβ. The successive cleavage of remaining membrane-bound C-terminal fragments by γ-
secretases to release a non-toxic p3 peptide and AICD (non-amyloidogenic) or Aβ and AICD 
(amyloidogenic pathway involves endocytosis). An alternative non-amylogenic pathway 
involves AICD degradation by the insulin-degrading enzyme (IDE) and cathepsin B or 
caspase-3. Fe65 facilitates AICD transport to the nucleus where in conjunction with Fe65, 
MED12 and Tip60 AICD regulates gene expression. X11 and AIDA-1 competitive binding 
to AICD suppress the γ-secretase cleavage. X11 also facilitates retention of imAPP in the 
cytoplasm, although the exact mechanism is unknown and may involve additional protein 
effectors. imAPP = immature APP. Revised from (Beckett et al., 2012) with the addition of 
AIDA-1 and X11 APP-interacting proteins in line with the context of this thesis.   
AIDA-1
X11
?
X11
imAPP
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Figure 1.6 – A schematic representation of the APP cytoplasmic region 
conformational switch mechanism. Amino acid sequence of the APP cytoplasmic region 
presented on top of the panel (residue numbering based on APP695 isoform). Two motifs 
involved in the conformational switch mechanism, 667-VTPEER-672 and 681-
GYENPTY-687 are highlighted and used in the panels below to indicate these regions in 
the schematic molecule models. Panel (i) The 681-GYENPTY-687 is a recognition motif 
for APP binding partners X11L, FE65, and JIP1b. Panel (ii), phosphorylation at Thr668 
acts as a conformational switch and results in FE65 release from the 681-GYENPTY-687 
motif (Ando et al., 2001; Ramelot & Nicholson, 2001). Panel (iii), binding of X11L to the 
681GYENPTY687 motif may facilitate the conformational change that leads to the 
upstream Thr668 exposure and susceptibility for phosphorylation by protein kinases such 
as JNK (Taru & Suzuki, 2004). TM, transmembrane domain. Figure adapted from (Suzuki 
& Nakaya, 2008).  
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Autoinhibition and ligand-induced competitive modes are common regulatory 
features of scaffolding proteins. For example, a Mint1(X11α) structural study revealed 
Mint1 phosphorylation regulated self-inhibition where the C-terminal linker adopts an α-
helical structure and blocks the PTB binding cleft, hence, preventing APP from binding 
(Matos et al., 2012). Interestingly, Mint2(X11β) was reported to have a different self-
regulatory mechanism through an open to close conformational switch (Xie et al., 2012). 
Other examples include integrin regulating Talin autoinhibition (Goksoy et al., 2008), 
scaffolding protein GRIP1 (Long et al., 2008) and PTP-BL tyrosine phosphatase (Van den 
Berk et al., 2007) allosteric inhibition.  
1.5.2.  AIDA-1 Structural Role at PSD  
AIDA-1 is recognized as a prominent protein of postsynaptic densities (PSDs) 
(Jacob et al., 2010; Jordan, 2004) which are cellular protein-rich substructures that 
coordinate postsynaptic signal transduction that have been associated with mechanisms 
sustaining synaptic plasticity (Dosemeci et al., 2015; Jacob et al., 2010; Sheng & 
Hoogenraad, 2007). Recently, a quantitative mass spectrometry study reported the 
stoichiometric distribution of AIDA-1 at the PSD as 1:1:2 relative to total GKAP 
guanylate kinase-associated proteins and PSD-95 respectively (Lowenthal, Markey & 
Dosemeci, 2015). The fact that both GKAP (guanylate kinase-associated protein) and 
AIDA-1 directly interact with PSD-95 (Jordan et al., 2007) and all three are found in the 
same electron-dense PSD layer (Jacob et al., 2010) suggests that AIDA-1 serves an 
important structural function at the PSD core. Activity-induced PSD reorganization is 
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believed to be part of a complex mechanism regulating synaptic plasticity via fluctuations 
in synaptic strength. It also involves NMDA receptor reorganization, active protein 
trafficking, and activity-induced synaptic protein degradation.  A recent research reports 
the reversible translocation of AIDA-1 outside of the deep PSD core under excitatory 
conditions, similar to another PSD member, SynGAP (Dosemeci et al., 2015). While 
PSD-95 and GKAP proteins maintain the same positions at PSD layers, other proteins, 
such as CaMKII, Shank and CYLD, tend to cluster in the denser PSD zone. Since AIDA-
1 directly associates with PSD-95, it has been suggested that its temporary shuffling out 
of the PSD core opens up a large number of PSD-95 binding sites and, consequently, 
allows for NMDAR reorganization during synaptic excitatory state (Dosemeci et al., 
2015). 
1.5.3.  AIDA-1 as Novel Synapse-to-Nucleolus Messenger and its Role in NMDAR 
Regulated LTP and Other Emerging Cellular Functions  
 In 2007, Jordan at al. reported N-methyl-D-Aspartate (NMDAR) dependent 
nuclear transport of the AIDA-1d isoform upon neuronal stimulation. NMDAR activation 
triggers the proteolytic cleavage and subsequent translocation of the AIDA-1d fragment 
to the nucleus where it associates with Cajal bodies and stabilizes its interaction with 
nucleoli (Jordan et al., 2007). Another isoform, AIDA-1c, lacks exon 19 and was shown 
to interact with coilin, a major Cajal body protein marker (Xu & Hebert, 2005). Cajal 
bodies are nuclear suborganelles enriched with small nuclear ribonucleoproteins 
(snRNPs) and basal transcription factors specializing in pre-mRNA, pre-rRNA, siRNA 
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and miRNA processing (Pontes et al., 2008) and telomerase formation (Jády et al., 2006; 
Xu & Hebert, 2005). Silencing AIDA-1 through siRNA knockdown resulted in disruption 
of Cajal bodies and increased cell death rate (Xu & Hebert, 2005).  
 Among other “shuffling” proteins, identified by proteomics studies, AIDA-1 was 
suggested to serve in NMDAR-regulated neuronal signaling and protein trafficking 
(Dudek, 2007; Jordan & Kreutz, 2009). NMDA receptor stimulation leads to a chain of 
nuclear signaling events, characterized by increased nuclear transfer of several synaptic 
proteins, including AIDA-1, that were originally suggested by Jordan et al. (2009) as 
novel synapse-to-nucleus messengers. A growing body of evidence strongly suggests that 
NMDAR signaling controls complex processes regulating long term memory formation, 
thus, neuronal plasticity. The facilitated nuclear transport of AIDA-1 was supported by 
the presence of a nuclear localization sequence, 124-HRKR-127, within the SAM1-SAM2 
domain interface (Kurabi et al., 2009). Most recently, the breakthrough study by Bryen 
A. Jordan’s group (2015) reported forebrain-specific conditional AIDA-1 knock-out 
(cKO) results in mouse models that redefine AIDA-1 function as a subunit-specific 
NMDAR transport facilitator. NMDAR channels are composed of 4 subunits, two GluN1 
and two subunits primarily responsible for forebrain signal transmission: GluN2A and 
GluN2B (Tindi et al., 2015). Selective loss of AIDA-1 in the forebrain manifested as a 
change in NMDAR subunit composition thereby decreasing the abundance of GluN2B-
NMDARs and significantly increasing GluN2A-mediated synaptic transmission. 
Likewise, accumulation of GluN2B in the ER was confirmed as well as the direct 
association of AIDA-1 with the CASK signaling complex (Tindi et al., 2015). Although 
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the molecular basis for preferential GluN2B binding has yet to be revealed, Tindi et al. 
(2015) suggested that other signaling molecules could be involved, especially APP and 
CASK that interact with AIDA-1 and NMDARs (Jeyifous et al., 2009; Tindi et al., 2015). 
Another study has shown that the CASK/MALS1/Mint1 tripartite signaling complex 
facilitates transport of NMDARs from endoplasmic reticulum (ER) to the nucleus and 
elimination of SAP97 and CASK expression causes accumulation of GluN2B in ER 
(Jeyifous et al., 2009; Tindi et al., 2015). 
AIDA-1 PTB was also shown to recognize a non-NPTY sequence in the 
juxtamembrane region of ephrin A8 (EphA8) receptor tyrosine kinase (Shin et al., 2007). 
Another study reported that ubiquitinated EphA8 associated with AIDA-1b via SAM 
domains (Kim et al., 2010).  The heterotypic interaction between SAM domain of EphA2 
receptor and SAM1 domain of scaffolding protein Odin has been characterized at the 
structural level (Mercurio et al., 2012). Encoded by the ANKS1A gene, Odin is 
ubiquitously expressed in most tissues including brain (Park et al., 2015) and has a 
strikingly similar domain organization as AIDA-1 and high sequence similarity (i.e. Odin 
PTB to AIDA-1 PTB - 81% identity). Odin has been implicated in the of EphA receptor 
signaling (Zhong, et al., 2011; Mercurio et al., 2012) and regulation of epidermal growth 
factor receptor (EGFR) (Park et al., 2015). Experimental evidence suggests that Odin, in 
conjunction with 14-3-3 protein complexes, downregulates growth factor signaling via 
regulation of receptor tyrosine kinase endocytosis (Zhong, et al., 2011). In contrast to 
Odin that expressed in nearly all mammalian cell lines, AIDA-1 could perform a brain-
specific function in receptor tyrosine kinase signaling regulation. However, to date, the 
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biological significance of AIDA-1–EphA8 interaction remains unknown, and no 
functional relation to Odin has been established.  
1.5.4.  Connection of ANKS1b to the Human Diseases 
A number of genetic studies have linked the AIDA-1 gene ANKS1B to 
schizophrenia (Purcell et al., 2014; Snyder & Gao, 2013) and autism spectrum disorders 
(ASDs) (Pinto et al., 2014; M. Uddin et al., 2014). A systematic exome sequencing study 
in patients with schizophrenia revealed de novo mutations in ANKS1B (Fromer et al., 
2014; Purcell et al., 2014).  Single nucleotide polymorphisms (SNP) in ANKS1B and rare 
copy number variations had been observed in ASD affected patients (Pinto et al., 2014).  
Furthermore, ANKS1B comprises exons critical for brain development: de novo mutations 
in these exons are enriched in autism (Uddin et al., 2014). ASDs have been strongly 
associated with NMDAR dysfunctional synapses and GluN2B-containing NMDARs in 
particular (Tindi et al., 2015). Moreover, GluN2B-containing NMDARs have been linked 
to AβPP processing regulation and Alzheimer’s disease pathogenesis (Mota, Ferreira, & 
Rego, 2014). Tindi et al. (2015) hypothesize that mutations in the AIDA-1 gene may 
contribute to neuropsychiatric disorders through alternations in the GluN2B-NMDARs 
functions. The alternative splicing leading to domination of GluN2B-inactive AIDA-1 
isoform is another possible cause yet to be investigated.  
Continuous attenuation of synaptic activity involves extensive protein 
transcription and degradation regulation, and, therefore, requires complex nuclear 
signaling. Although the precise molecular mechanisms are not fully understood, AIDA-1 
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multiple protein partnerships including AD associated protein APP, Cajal body protein 
Coilin, EphA8 receptor, PSD95 and NMDA receptor, proteins of CASK scaffold, and, 
quite possibly, other unrevealed ligands, indicate the wide range of AIDA-1 orchestrated 
functions in the brain and, perhaps, therapeutic possibilities for human neurodegenerative 
disorders yet to be uncovered. 
1.6.   Scaffolding Proteins Caskins and Their Emerging Neuronal 
Functions 
 Multidomain protein Caskin is a relatively recent addition to the scaffolding group 
of proteins; it was originally discovered as a brain-specific protein found both in 
vertebrates and invertebrates (Tabuchi et al., 2002). Two mammalian homologs, 
CASKIN1 and CASKIN2, encoded on chromosome 16 and 17 respectively, are classic 
members of multidomain scaffolding proteins. Both have a similar domain organization: 
The amino-terminal part is composed of a series of ankyrin repeats followed by an SH3 
and two SAM domains in close juxtaposition, the carboxy-terminal half consists of low 
complexity, proline-rich sequences (Balázs et al., 2009) ending with a conserved 25 aa. 
segment of unknown function. All of these modules are recognized in the literature as 
protein-protein interaction domains (Krauss, 2008) and with the exception of the proline-
rich segment, demonstrate substantial (~70%) sequence conservation (Tabuchi et al., 
2002) in Caskins. Furthermore, tandem SAM domains are well-known for their 
oligomerization potential based on their surface complementarity.  
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1.6.1.  Caskin-Specific Scaffold as Part of Ca2+/Calmodulin-Associated Ser/Thr 
Kinase (CASK) Pathway 
 Originally, Caskin1 and 2 were named by homology, for the ability to interact with 
the Membrane Associated Guanylate Kinase (MAGUK) protein CASK 
(Ca2+/calmodulin-associated Ser/Thr kinase), a plasma membrane scaffolding protein 
and transcriptional co-regulator (Ojeh et al., 2008; LaConte & Mukherjee, 2013). 
However, only Caskin1, but not Caskin2, is capable of binding CASK.  The CASK/Mint1 
and Velis tripartite complex is functionally linked to calcium-mediated signaling, actin 
microfilament assembly, and communication through the neurexin-neuroligin synaptic 
adhesion junctions (Borg et al., 1999; LaConte & Mukherjee, 2013; Tabuchi et al., 2002).  
The structure of CASK is composed of an N-terminal Ca2+/calmodulin-dependent protein 
kinase II (CaMKII) domain and PDZ domain, a central SH3 domain and finally a 
guanylate kinase homology domain at the C-terminus (Ojeh et al., 2008; LaConte & 
Mukherjee, 2013; Tabuchi et al., 2002). A consensus sequence, ExIWVxR, located 
between the SH3 domain and SAM1 of Caskin1 was identified as minimal binding motif 
recognized by CaMKII of CASK (Stafford et al., 2011a; 2011b; Tabuchi et al., 2002). 
This consensus peptide sequence, termed CID (CASK interaction domain), is conserved 
in both Mint1 and Caskin1, but not in Caskin2 (Stafford et al., 2011a) (Figure 1.7).   
 Shortly after, the crystal structure of another scaffolding protein called Liprin-α2, 
recognized to be involved in synaptogenesis, cell adhesion and cell migration, was 
reported in complex with CASK (Wei et al., 2011). In the Liprin-α2-CASK-CaMKII 
complex the C-lobe of CaMK is involved in an extensive interaction network with both 
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SAM1 and SAM2. An insertion helix is located between the SAMs (namely αL helix) 
(Wei et al., 2011) where Trp981 serves as a hydrophobic anchor within the determined 
minimal binding sequence, GNVWVTHE. Therefore, it is clear that although Liprin-α2 
employs a different minimal binding motif, all three proteins (Mint1, Caskin1 and Liprin-
α2) target the same hydrophobic pocket on CASK and all three use tryptophan as a key 
docking residue (Stafford et al., 2011a; Wei et al., 2011). The fact that both mammalian 
CASK/Caskin1 and CASK/Liprin-α2 are not observed in the other CASK orthologues 
(LaConte & Mukherjee, 2013), and the mammalian Liprin-α2 binding motif is not 
conserved in C-elegans, Drosophila and Liprin-α1 isoform, could be a manifestation of 
evolutionary development in CASK regulated pathways of higher order organisms. In 
addition to the CaMK domain of CASK, Caskin1 interacts with the intracellular tails of 
cell surface proteins such as neuronal cell adhesion protein neurexin 1 and Ca2+-regulated 
vesicle fusion-mediator protein synaptotagmin (Stafford et al., 2011b). A functional 
connection of the Caskin competitor Mint1 to synaptic vesicle fusion has been also 
reported (Okamoto & Sudhof, 1997; Olsen et al., 2005). Therefore, the putative model of 
Caskin1-modulated architecture at presynaptic sites has been proposed, whereby 
neurexin1-CASK-Caskin1 associations link the CASK/Caskin1/Velis complex to the 
presynaptic membrane and oligomeric-Caskin1 recruited synaptotagmin docks and guides 
synaptic vesicles to the synaptic cleft.   
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Figure 1.7 – An array of CASK-mediated protein-protein interactions. Cask is recruited 
to the plasma membrane via its PDZ domain interactions with cytoplasmic regions of cell 
surface proteins (neurexins, syndecans). The scaffolding proteins Caskin1 Mint1 compete for 
the same binding sequence within the N-terminal CaMKII domain (Wei et al., 2011), whereas 
Mint1 and Liprin-α could form a complex with CASK bound to neurexin1 (LaConte et al., 
2016). Velis recognizes the sequence between CaMKII and PDZ domain. In addition, protein 
4.1 interaction with the C-terminal SH3 and guanylate kinase domains is required for actin 
filaments assembly. This interaction may also link actin microfilaments to the cytoplasmic 
tails of cell-surface receptors. CASK C-terminal sequences may support additional intra- and 
intermolecular interactions. Bottom panel depicts Caskin1/2 domain organization. Domain 
annotations: CaMKII, Ca2+/calmodulin-dependent protein kinase II; PDZ, domain present in 
PSD-95; SH3, Src-homology-3, GK, guanylate kinase; SAM, sterile alpha motif; CID, CASK 
interaction domain; CTD, C-terminal domain.  
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A global database search revealed that T-cell lymphoma invasion and metastasis 1 
(TIAM1) was the only other protein containing this conserved sequence within 
EEVIWVRRE peptide that, not unexpectedly, also was able to bind CASK in vitro 
(Stafford et al., 2011a). The TIAM1 protein is responsible for tumor propagation and 
metastasis (Minard et al., 2004) and a certain overlap in CASK/TIAM1 cellular functions 
have been recognized (Caruana, 2002; Mertens, Pegtel, & Collard, 2006; Stafford et al., 
2011b). A follow-up investigation of Caskin1/Mint1/TIAM1 interaction in vivo and its 
downstream effects is a logical next step.  
More recent studies have reported Caskin to have a distinct role in retinal synapses 
(Anjum et al., 2014) in addition to specializations in brain neuronal synapses (Tabuchi et 
al., 2002).  Punctate co-localization of Caskin1 and CASK was found in a distinct subset 
of retinal synapses at pre-synaptic sites, which once again supports Caskin in a highly 
specialized role in organizing scaffolds around particular cell surface receptors (Anjum et 
al., 2014). This functional outcome is further reinforced by reported Caskin interactions 
with cytoskeletal adaptor proteins Abi2 (Balázs et al., 2009) and Nck/Dock (Weng et al., 
2011) which link actin-based cytoskeleton to cell surface receptors (Anjum et al., 2014; 
Weng et al., 2011). The SH3 domain of Caskin1 has been shown to be recruited by EphB1 
and Nck (Pesti et al., 2012) and subsequently phosphorylated, resulting in a structural 
change though the biological significance of this is still under investigation. Members of 
our research group recently contributed with an NMR structure of Caskin2 SH3 domain 
(Donaldson & Kwan, 2016) and proposed that upon phosphorylation of Y336, the SH3 
domain could serve as a suitable ligand for the Crk/Grb2 family of SH2 domains, as 
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supported by molecular modeling. However, the possibility of the SH3 domain as a non-
functional remnant is also anticipated. New studies detected decreased levels of Caskin1 
mRNA as a result of intestinal ethanol stress in rats (Middleton et al., 2009) and the study 
reveals a possible connection of Caskin1 to infantile myoclonic epilepsy through analysis 
of disease-related co-expression profiles conserved in human and mouse (Ala et al., 2008). 
These data are opening intriguing possibilities of Caskins’ connection to a number of 
cellular pathways.  
1.6.2.     Caskin2 Functionally Connected to Leukocyte Common Antigen-Related 
(LAR) Tyrosine Phosphatase Regulated Pathways  
 Phosphorylation and dephosphorylation on protein tyrosine residues is the 
fundamental cell-signaling mechanism maintained by protein-tyrosine kinases (PTKs) 
and protein-tyrosine phosphatases (PTPs).  The Leukocyte common Antigen Related 
(LAR) family of proteins is a subclass of receptor-like PTPases (RPTPs) in vertebrates 
represented by three homologs: LAR, PTPσ and PTPδ (Chagnon et al., 2004). 
LAR has been implicated in regulation of neurite outgrowth, axonal extension and 
guidance (in Drosophila), disassembly of cell focal adhesions, maintenance of 
neuromuscular junctions, nerve regeneration, murine mammary gland development and 
function and has even been connected to cancer metabolic regulation (Chagnon et al., 
2004; Serra-Pagès et al., 1998). The fact that both Liprin-α2 and Caskin2 were shown to 
interact with LAR may link them to the CASK signaling pathway, on the other hand, some 
experimental evidence suggests a possibility of a distinct set of functions. The initial 
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results by Weng et al. (2011) regarding the interaction between Drosophila orthologs Dlar 
and Csk2 provided the background for our investigation of human LAR and Caskin2 
partnerships. Therefore, it is essential to provide an overview on LAR PTPases from both 
structural and functional perspectives. 
1.6.3.  Structure and Regulation via Alternative Splicing and Proteolysis 
 The extracellular domain of LAR PTPase greatly resembles the domain structure 
of cell adhesion molecules (CAM) and contains a variable number of Immunoglobulin-
like (Ig-like) and fibronectin type III-like (FNIII) repeats followed by a hydrophobic 
transmembrane region and ending with two cytoplasmic domains, D1 and D2 (Chagnon 
et al., 2004).  Unlike the variable extracellular region, the intracellular domains are 
remarkably conserved among receptor-like PTPases demonstrating ~84% identity in both 
vertebrates and invertebrates (Chagnon et al., 2004; Pulido et al., 1995).  The membrane 
proximal domain (D1) is responsible for PTPase enzymatic function and contains a 
conserved (I/V)HCXAGXGR(S/T)G  motif that forms an active site cleft (Tonks, 2003). 
The central cysteine is directly involved in the nucleophilic attack on the phosphoryl group 
of the substrate, forming a covalent phosphoenzyme intermediate followed by 
dephosphorylation (Pot & Dixon, 1992; Serra-Pagès et al., 1998; Zhang, Wang, & Dixon, 
1994).  Although both domains, D1 and D2, show significant conservation of primary 
sequence and very similar tertiary structures (Nam et al., 1999) two key amino acid 
differences (Y/L and D/E) in the substrate coordinating loops change the catalytic site 
conformation, which renders the D2 domain catalytically inactive and thereby suggests a 
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regulatory nature (Tsujikawa et al., 2008). The tandem domain crystal structure was 
solved as a monomer (Nam et al., 1999) at the same time studies demonstrated the 
inhibitory effect of cis-dimerization (or oligomerization) on LAR-RPTP catalytic activity 
suggesting the structure-directed regulatory role of D2 domain in this catalytic 
suppression mechanism (Coles, Jones, & Aricescu, 2015; Coles et al., 2014; Wallace et 
al., 1998). In addition to dimerization, proteolytic cleavage, alternative splicing and 
glycosylation have been implied to regulate the catalytic activity of LAR RPTPs at distinct 
synaptic sites and in different tissues (Chagnon et al., 2004; Pulido et al., 1995; Wallace 
et al., 1998; Zhang & Longo, 1995) 
1.6.4.  Synaptic Functions of LAR PTPase family 
 LAR family receptors have been strongly associated with axonal pathfinding, 
regeneration, synaptogenesis, based largely on genetic and biochemical studies in 
Drosophila and C. elegans (Desai et al., 1996; Krueger et al., 1996; Weng et al., 2011b; 
Xie et al., 2012; Yang et al., 2003; Yeo et al., 1997). It has been proposed that LAR 
receptor-like protein tyrosine phosphatases link the extracellular matrix (ECM) to 
developing focal adhesions and promote actin cytoskeleton reorganization (Baker & 
Macagno, 2010). Remarkably, the axon guidance function of LAR RPTP appears to be 
preserved across different types of neurons, including motor (Desai et al., 1996; Krueger 
et al., 1996; Weng et al., 2011), retinal neurons (Clandinin et al., 2001; Hofmeyer & 
Treisman, 2009; Maurel-Zaffran et al., 2001) and more recently reported somatosensory 
neurons in a zebrafish study (Wang et al., 2012). The latest intriguing study revealed the 
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details of LAR regulatory function in circadian pacemaker neuron development. The Lar 
RNAi knockdown phenotype in Drosophila resulted in the elimination of axonal 
processes from clock neurons and ultimately disruption of activity rhythms (Agrawal & 
Hardin, 2016).  
While precise mechanisms involving the LAR RPTP family proteins remain to be 
fully characterized, the studies in mammalian systems are especially complicated due to 
a certain level of cooperation and/or redundancy of functions between LAR, PTPσ and 
PTPδ (Um & Ko, 2013). Nonetheless, two major synaptic processes mediated by 
mammalian LAR RPTPs have been highlighted: synaptic assembly and synaptic 
plasticity. In contrast to studies in invertebrates where LAR was predominantly implicated 
in presynaptic processes (Xu & Fisher, 2012), mammalian LAR was found to be enriched 
at excitatory synapses (Dunah et al., 2005) serving at postsynaptic sites. RNA interference 
(RNAi) knockdowns resulted in a dramatic decrease of excitatory synapses and dendritic 
spines (Dunah et al., 2005); likewise, disruption of the intracellular protein-binding 
function of LAR manifested as inhibition of the β-catenin–cadherin complex recruitment 
at synaptic sites (Brigidi & Bamji, 2011; Um & Ko, 2013). The β-catenin–cadherin 
complex is involved in axonal development and dendrite arborization (Um & Ko, 2013) 
and by association with G-protein-coupled receptor kinase-interacting protein 1 (GIT1) 
linked to AMPA glutamate receptor-mediated synaptic transmission (Brigidi & Bamji, 
2011; Ko et al., 2003). Therefore, the role of LAR PTPase AMPA signaling and regulation 
of synaptic transmission was implied. The growing number of extracellular ligands 
interacting with Ig domains of LAR, including syndecan, dallylike protein, and laminin-
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nidogen complex (Fox & Zinn, 2005; Johnson et al., 2006) endorse LAR as a membrane 
signal transmitter and synaptic active zone morphogenesis regulator (Stryker & Johnson, 
2007).  
All three mammalian LAR RPTPs have been reported to interact through their D2 
domains with SAM domains of the alpha-liprin family (Serra-Pagès et al., 1998; 1995; 
Stryker & Johnson, 2007) one of the established determinants of synaptic organization 
and maturation in C. elegans and Drosophila (Dai et al., 2006; Spangler & Hoogenraad, 
2007). The Liprin-α-LAR complexes specifically localize at focal adhesions (Serra-Pagès 
et al., 1995). The recruitment of Liprin-α into the Velis/CASK/X11 scaffold (Olsen et al., 
2005; Wei et al., 2011), as discussed earlier, and other Liprin-α partnerships with known 
active zone modulators such as RIM1-α, ERC2 and GIT1 (Ko et al., 2003; Schoch et al., 
2002; Stryker & Johnson, 2007) suggest the presence of a Liprin-α-LAR-specific 
assembly mechanism localizing signaling components at synaptic sites.  
Compared to the liprin family, Caskin2 (ckn2) is a more recently identified protein 
partner of LAR and so far their interaction and its functional requirement for motor axon 
guidance have been confirmed in Drosophila (Weng et al., 2011). The fact that Liprin-α 
and Caskin2 cannot bind LAR simultaneously suggests the possibility of the distinct 
signaling outcomes of these complexes (Weng et al., 2011). Moreover, since both proteins 
are linked to the CASK signaling pathway and are genetically preserved in both 
invertebrates and vertebrates, it is reasonable to hypothesize that the mammalian Caskin-
LAR specific assembly adds signaling complexity and specificity but its functional 
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significance remains to be revealed.  
The diversity of LAR-RPTPs synaptic protein partnerships including major 
synaptic scaffolding molecules and transmembrane signaling proteins promote LAR-
RPTPs as bona fide synaptic adhesion molecules (Han, 2016a; Um & Ko, 2013). In other 
words, their primary function in neurons as synaptic organizers function has gained 
substantial support in the literature.  
To add to the complexity, besides the functions outlined above, studies had shown 
that LAR PTPase deficient mice exhibit reduced glucose and insulin levels and impaired 
mammary gland development (Schaapveld et al., 1997; Yeo et al., 1997).  Several studies 
have revealed the LARσ specific requirement for efficient neuronal regeneration (Fry et 
al., 2010; Van der Zee et al., 2003; Xie et al., 2001). 
1.6.5.  Oligomerization Through Tandem SAM Domains 
 The intrinsic ability of multiple SAM domain proteins to oligomerize is an 
important requirement often strongly connected to biological function. The tightly bound 
Caskin1 SAM1-SAM2 unit oligomerizes into long fibrils via contacts between the 
exposed head and tail surfaces. Electron micrograph images of both Caskin1 and Caskin2 
oligomers (Figure 1.8.) have a regular shape of rod-like structures although they appear 
morphologically different.  
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As this mode of oligomerization has also been observed in vivo, Caskin1 may be 
serving as a railway that links presynaptic vesicles together through an association with 
synaptotagmin (Stafford et al., 2011b). Oligomerization potential is clearly strategically 
advantageous for molecular scaffolds in the assembly of signaling complexes at specific 
cellular sites and signal output amplification. The localized CASK CaMK domain 
assembly on Caskin1 SAM SAM fibrils resemble “beads on the string,” and furthermore, 
in vitro experiments support that the polymer interface indeed facilitates this assembly 
(Stafford et al., 2011a). The novel oligomerization mode of Caskin2, distinct from 
Caskin1, is presented in detail in Chapter 3 of my thesis. 
 
 
 
Figure 1.8 – Electron micrographs of Caskin 1 and 2 tandem SAM oligomers expressed 
as negGFP-hSAM fusions and visualized by negative stain Electron Microscopy (EM) 
method demonstrate rod-like polymeric structures. Adapted from (Knight et al., 2011). 
 
 
Shank is the closest protein family with an analogous domain organization. It has 
the same structural elements as Caskins: ankyrin repeats, SH3 domain, polyproline region, 
with tandem SAM in Caskins and a single C-terminal SAM domain in Shank. The fact 
that sequence similarity between Caskin and Shank is not significant indicates that there 
is no evolutionary conservation between them, but rather the possibility of similar 
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scaffolding functions. At the postsynaptic sites Shanks are involved in regulation of actin-
dependent cytoskeletal remodeling, endocytosis of AMPA receptors, synaptogenesis, 
synaptic plasticity and signal transmission (Jiang & Ehlers, 2013). Mutations in Shank 
family genes are connected to neurodevelopmental disorders such as schizophrenia 
(Gauthier et al., 2010) and autism (Jiang & Ehlers, 2013). The single SAM domain of 
Shank forms long alpha-helical fibrils cross-linked with zinc ions into a tightly packed 
highly ordered array (Baron et al., 2006). The most recent study by Arons at al., (2016) 
proposed the Zn2+ sensitive signaling mechanism at excitatory synapses regulated by 
Shank3 oligomerization state.  They demonstrated that high Zn2+ levels facilitate an 
assembly of Shank3-based scaffolds that bring Homer, neuroligin, and AMPA receptors 
into the activated signaling complex, whereas low Zn2+ levels lead to an opposite effect 
resulting in retention of oligomerized Shank3 aggregates within dendritic spines, and 
therefore, a weaker synaptic response (Arons et al., 2016). An overall domain organization 
similarity and polymerization potential suggest that Shank and Caskins serve as signaling 
protein assembly platforms in the post- and pre-synapse respectively. If oligomerization 
of Shank3 into fibrils yields dense/static network ultimately reducing the synaptic 
strength, Caskin2 may alternatively function as a more dynamic net that can be 
assembled/disassembled rapidly to facilitate release of neurotransmitters at the 
presynapse. 
While the biological significance of a number of other Caskin protein partnerships 
identified using a yeast two-hybrid screen (Balázs et al., 2009) have yet to be uncovered, 
one of them is worth mentioning in context of this section: the ubiquitin ligase Siah1. Its 
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presence among other Caskin ligands could be significant in line with the outcome from 
a recent global mass spectrometry survey that identified a ubiquitinated lysine residue 
(K522) in Caskin1 (Wagner et al., 2012) (K535 in Caskin2) located exactly at the 
oligomerization interface of the SAM-SAM tandem (described in details in Chapter 3 of 
this thesis). The presence of the ubiquitination site may suggest the possibility of another 
regulatory mechanism, orchestrated by ubiquitin, specifically targeting Caskin 
oligomerization. 
 
1.7.   Thesis Overview 
An increasing complexity of signaling pathways and cellular networks through 
vertebrate evolution was a significant driver in protein functional diversity and 
multiplicity.  Molecular modules such as PTB and SAM domains are essential tools used 
by scaffolding proteins for multiple protein partner recruitment, and hence, regulation of 
cellular signaling. In addition to serving as protein-protein interaction platforms, SAM 
domains have a propensity for oligomerization which in itself is a powerful intramolecular 
signaling regulatory mechanism. The AIDA-1 and Caskin2 structure-function studies 
described in this dissertation contribute to both a general understanding of protein 
interaction/oligomerization module properties as well as new insights into their particular 
functional contributions at level of the neuron.  
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 Over a decade ago AIDA-1 was linked to amyloid-β precursor protein processing 
essentially earning its name for the ability to bind its cytosol-projected domain. Recent 
genetic studies connect the AIDA-1 gene ANKS1b with a number of neuropsychiatric 
disorders including Alzheimer’s disease (Mota et al., 2014), schizophrenia (Fromer et al., 
2014; Purcell et al., 2014) and autism spectrum disorders (ASDs) (Pinto et al., 2014; 
Uddin et al., 2015; Uddin et al., 2014). With respect to its role in the amylogenic pathway 
leading to Alzheimer’s disease, the consequences of AIDA-1 interaction with APP-AICD 
in ABPP processing remain largely unknown. At a minimum, this interaction may serve 
as a cytoplasmic anchor defining the subcellular localization of AIDA-1 as a result of 
specific signaling events. This work characterizes the affinity and specificity of the AIDA-
1 PTB domain and APP-AICD interaction to provide a comparative analysis at the 
structural level to the other PTB domain-containing proteins, Fe65 and X11/Mint1, 
particularly known as AβPP processing and Aβ secretion mediators.  
     The following section of the dissertation begins with a structural investigation of 
the Caskin2 protein SAM tandem module. The variety of Caskin2 oligomeric states, 
monomeric/dimeric at low and oligomeric at high concentrations, were identified and 
characterized by a combination of structural and biochemical approaches. Such structural 
diversity could serve as a concentration-dependent mechanism to suppress or amplify low-
affinity protein interactions common in signaling pathways. Growing evidence of the 
mammalian LAR receptor tyrosine phosphatase regulatory functions in complex 
processes such as axonogenesis, synaptic assembly, and neuronal plasticity, dictates a 
need for elucidation of the components of LAR-specific signaling pathways.  The 
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confirmation and structural dissection of Caskin2/LAR Homo sapiens homologs 
partnership were the additional objectives of my studies.  
 The remarkable abundance of AIDA-1 in various brain compartments; highly 
specific neuronal localization; multiple protein partnerships of AIDA-1; the self-
oligomerization property of Caskin2 collectively indicate that these scaffolding proteins 
have a potential to orchestrate a range of neuronal processes yet to be fully understood or 
uncovered.  These integrated structural and functional studies hopefully will serve as a 
platform for further elucidation of their cellular functions. 
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_______________________________________________________________________ 
2.  CHAPTER 2: 
SOLUTION STRUCTURE AND PEPTIDE BINDING OF 
THE PTB DOMAIN FROM THE AIDA-1 POSTSYNAPTIC 
SIGNALING SCAFFOLDING PROTEIN 
_______________________________________________________________________ 
 
The content reported within this chapter has been published in the article listed below: 
 
v   Smirnova E., Shanbhag R., Kurabi A., Mobli M., Kwan J.J., Donaldson W.L. 
(2013) Solution Structure and Peptide Binding of the PTB Domain from the 
AIDA-1 Postsynaptic Signaling Scaffolding Protein. PLoS ONE 8(6): e65605.  
 
Information of the authors’ contributions is provided in the corresponding section.  
 
2.1.   Introduction 
Neurons receive chemical signals through a collection of over four hundred 
proteins that are organized into a network termed the postsynaptic density (PSD) (Jordan 
et al., 2004). AIDA-1, a prominent member of the PSD, is edited into at least five 
isoforms, all of which contain two sterile alpha motif (SAM) domains and a PTB domain 
(Ghersi et al., 2004). Together, these domains suggest a role for AIDA-1 as a scaffolding 
molecule that collates proteins at the synapse through multiple protein-protein 
interactions. Mutations in AIDA-1, consequently impair long term potentiation (LTP), a 
basic molecular requirement for learning and memory (Jordan et al., 2007). Owing to its 
54 
role in many signaling processes, AIDA-1 (located at chromosome 12q23.1) is also known 
as ANKS1B, ANKS2, cajalin-2 and EB-1. 
AIDA-1 derives its name from the ability to bind the carboxy terminal cytoplasmic 
region of amyloid precursor protein (APP), widely implicated in the development of 
Alzheimer’s disease. AIDA-1 isoforms demonstrate differences in subcellular 
localization, affinity for APP and effect on the processing of APP to the Aβ40 
nonpathologic fragment (Ghersi et al., 2004). While AIDA-1 is predominantly expressed 
in brain, a related protein, Odin (ANKS1A), with the same domain organization, is more 
ubiquitously expressed and serves as an adaptor modulating the signaling outcomes of 
epidermal derived growth factor receptor (EGFR), platelet derived growth factor receptor 
(PDGFR) and Ephrin A8 receptor tyrosine kinase (Emaduddin et al., 2008).   
Previously, the members of our group determined the NMR structure of the AIDA-
1 SAM domain tandem and demonstrated that a nuclear localization signal was 
sequestered at the interface of the two domains (Kurabi et al., 2009). In this study, we 
have continued a reductionist investigation of a potential AIDA-1 SAM-SAM-PTB 
domain supramodule by determining the NMR structure of the PTB domain. The structure 
of the AIDA-1 PTB domain and its ability to bind an NPxY motif in the amyloid precursor 
protein (APP) cytoplasmic region are similar to the postsynaptic signaling proteins 
APPL (Mao et al., 2006) and X11/Mint (Matos et al., 2012) and to a lesser extent, 
Fe65 (Mulvihill et al., 2011). Thus, the nature of signals arising from APP is likely 
dependent on the context specified by AIDA-1 and the relative affinity of its competitors. 
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Our initial attempt to perform NMR structural studies on the AIDA-1 PTB domain 
were hindered by poor solubility regardless of solution conditions chosen. Expression of 
the PTB domain from Odin (81% identity), presented an even worse case, as this protein 
fragment could not be refolded from inclusion bodies. A strategy that we pursued to 
improve the solubility of the AIDA-1 PTB domain involved the progressive substitution 
of aromatic amino acids that were predicted to be solvent exposed. 
2.2.   Methods 
2.2.1.  Cloning, Expression and Protein Purification 
A gene fragment encoding the PTB domain (aa. 1043–1195) of human AIDA-1b was PCR 
amplified with NdeI and EcoRI restriction sites and was subsequently inserted into 
pET28a (Novagen). The expressed protein contained an amino terminal 6xHis tag and 
intervening thrombin site. Other PTB domain fragments that lacked either the N-terminal 
6xHis tag or the entire affinity tag along with 16 additional unstructured residues were 
also as insoluble as the fragment chosen for this study. To align the PTB domain described 
in this study with numerous AIDA-1 isoforms, S1 in the PTB domain structure 
corresponds to S1045 in AIDA-1b, the longest isoform. A one-liter fermentation in a 
minimal medium containing 1 g of 15NH4Cl and 4 g of 13C-glucose was sufficient to 
produce 5–10 mg of purified protein. Purification was achieved by Nickel-NTA affinity 
chromatography (Qiagen) and gel filtration chromatography on a S-100 HR 16/60 size 
exclusion column (GE Biosciences). Final buffer conditions were 20 mM Na-phosphate, 
pH 7.8, 0.15 M NaCl, 0.05% (w/v) NaN3. Five single aromatic-alanine substitutions 
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(Y6A, F16A, F24A, Y70A and Y131A) were produced from pET28-AIDA-1-PTB using 
a service provided by Genscript (Piscataway, NJ). A 6xHis tagged PTB domain variant 
containing all five substitutions (PTB5M) was produced by DNA2.0 (Menlo Park, CA) 
by direct gene synthesis in the expression vector, pJExpress401 (T5 promoter plus 
kanamycin resistance). A 6xHis-tagged, APP-peptide (GYENPTYKFFE) fused to the 
amino terminus of the AIDA-1 PTB5M mutant with an intervening thrombin site was also 
synthesized by DNA2.0 in pJExpress401. 
2.2.2.  Protein Solubility Assessment 
Since the objective of the aromatic-alanine substitutions was to improve solubility for a 
structure determination, 15N-HSQC spectra were used qualitatively. From experience, the 
wild type AIDA-1 PTB domain was soluble for a least one day at room temperate at a 
concentration of 0.15 mM thereby permitting experiments to be performed but not to the 
extent of a structure determination. Each aromatic-alanine substitution mutant was 
concentrated to 0.15 mM, assessed by NMR and then concentrated until increased 
resonance line broadening was observed or there was apparent turbidity. 
2.2.3.  CD Spectroscopy 
Far UV circular dichroism (CD) spectra were acquired with a Jasco J-810 instrument at a 
protein concentration of 50 µM using a rectangular cell with a 0.1 cm path length. Spectra 
were recorded from 260–200 nm with a scan rate of 50 nm/min and a 1.0 nm bandwidth. 
A midpoint denaturation temperature (Tm) was determined by heating samples from 20–
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90 ºC at 2 ºC/min and monitoring ellipticity at 222 nm. 
2.2.4.  Protein Binding Studies 
Fluorescein isothiocyanate (FITC) labeled peptides spanning portions of APP were 
produced and purified by CanPeptide (Montreal, QC) for fluorescence anisotropy based 
binding studies at 25°C using an Agilent Eclipse spectrophotometer equipped with a 
manual polarizer accessory. Buffer conditions were similar to those used for NMR 
spectroscopy. Measurements were made under identical conditions and averaged. 
Anisotropy was calculated from the relationship (Iparallel–GIperp)/(Iparallel/2GIperp) and 
normalized with the blank experiment. The equilibrium dissociation constant (Kd) was 
calculated by direct fitting the titration curves with a standard two-state relationship using 
proFit 6.2 (Quantsoft). 
2.2.5.  Peptide Array 
A set of 12-mer peptides on a 150×100 mm cellulose membrane in a 10×30 array was 
synthesized using the SPOTS method (Frank, 2002) with an Intavis MultiPep instrument. 
A crude estimate of the peptide content in each spot was made by staining the array with 
Fast Green FCF. The array was probed with 1 µM of the solubility enhanced 6xHis-
PTB5M mutant in PBST (3.2 mM sodium phosphate, 0.5 mM potassium phosphate, 1.3 
mM KCl, 135 mM NaCl, 0.1% Tween-20, pH 7.4). Following blocking and washing with 
5% skimmed milk and 2.5% bovine serum albumin (Bioshop Canada) in PBST, bound 
AIDA-1 PTB was identified by incubating the array in a 1∶5000 dilution of horseradish 
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peroxidase (HRP)-conjugated 6xHis monoclonal antibodies in PBST and developing with 
a chemiluminescent reagent (Santa Cruz Biotechnology). A complete table of peptides is 
provided in Table 2.5. 
2.2.6.  NMR Spectroscopy 
15N-edited HSQC spectra of the wild type PTB domain, mutants and protein-peptide 
complexes were acquired at 30 ºC on a Varian 600 MHz NMR spectrometer equipped 
with a salt tolerant cold probe. The use of a low protein concentration (0.10–0.15 mM) 
permitted assessment of all protein fragments regardless of intrinsic solubility. Chemical 
shift assignments on a uniformly15N, 13C labeled sample of PTB5M at 0.8 mM were 
obtained using a conventional heteronuclear, triple-resonance strategy that incorporated 
non-uniform sampling for improved resolution and sensitivity. Backbone directed 
experiments: HNCACB, CBCA(CO)NH, HNCO, HNCACO, side chain directed 
experiments: H(C)(CO)NH, C(CO)NH, and 13C/15N-edited NOESY spectra were 
acquired on a Bruker Avance 900 MHz spectrometer equipped with a cold probe. Side 
chain HCCH-TOCSY, and aromatic HB(CBCG)CD, HB(CBCGCD)CE were acquired at 
600 MHz. Protein solutions contained 10% D2O with the exception of the 13C-edited 
NOESY dataset in which the PTB5M sample was buffer exchanged into >95% D2O before 
data acquisition. Datasets were processed with NMRPipe (Delaglio et al., 1995) or the 
Rowland Toolkit (Hoch and Stern, 1996) as required and interpreted with CCpNMR 
Analysis 2 (Fogh et al., 2006). Chemical shift assignments of PTB5M were deposited in 
the BMRB with the accession code 17934. 
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Structure Determination: From an initial set of 500 structures calculated with CYANA 3, 
the top 20 structures were selected with no NOE violations >0.3 Å and no torsion angle 
violations <5°. This ensemble was then subjected to additional refinement in explicit 
solvent with a Python script (wrefine.py) supplied with XPLOR-NIH 2.30. The top 15 
structures according to lowest refinement energy was deposited as an ensemble in the 
Protein Data Bank with the accession code 2M38. The ensemble was aligned using 
MOLMOL 2K1 (Koradi et al., 1996). Structure Comparisons: Cα RMSDs and alignments 
between the AIDA-1 PTB domain and related proteins were performed with 
PDBeFold (Krissinel and Henrick, 2004). 
Peptide Docking Simulations: Starting from the AIDA-1 PTB5M structure and APP 
peptide ligand placed in analogous position to that observed in the X11 PTB domain 
crystal structure (Matos et al., 2012), a two-stage docking simulation, at low resolution 
(200 structures) and then all-atoms high resolution (100 structures) was performed with 
FlexPepDock, part of the Rosetta 3.4 software package (Raveh et al., 2011). A low energy 
structure was selected for analysis. 
2.3.   Results 
Prior to the structure determination, a molecular model of the AIDA-1 PTB domain 
was made with HOMA (Bhattacharya et al., 2007) using the crystal structure of the X11 
PTB domain as the template (Zhang, 1997). Final refinement was performed with 
FOLDX (Guerois et al., 2002). The surface of the PTB model was scanned for exposed 
aromatics and compared to a sequence alignment consisting of the PTB domains from 
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X11, Numb (S.-C. Li et al., 1998) and Fe65 (Radzimanowski et al., 2008). Of the sixteen 
aromatics in the AIDA-1 PTB domain, Y6, F16, F24, Y70, and Y131 were selected as 
candidates that were most likely to be surface-exposed (Figure 1a). Thus, by selecting 
aromatic amino acids (Phe/Tyr/Trp considered equally), we were effectively sampling 
mutations under sparse conditions that still cover a wide range of surfaces. 
Table 2. 1 – Solubilities and thermal denaturation midpoints of the AIDA PTB 
domain and alanine substitution mutants.  
 
 
As shown in Table 2.1, the calculated Tm of the mutants was comparable to the wild type 
PTB domain suggesting that the alanine substitutions did not destabilize the fold. Like the 
wild type PTB domain, the Y6A and Y131A single mutants could only be concentrated 
to 0.1 mM before precipitation was observed. The remaining single mutants – F16A, F24A 
and Y70A – could be concentrated up to 0.5 mM; however, HSQC spectra at these 
concentrations suffered from line broadening and missing resonances. In contrast, the 
PTB5M mutant was very soluble at 0.8 mM, with line widths that were comparable to the 
single mutants acquired at low concentration. Thus, we observed a synergistic effect when 
multiple aromatic amino acids were substituted with alanine.  
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Figure 2. 1 – A comparison of 15N-edited HSQC spectra from the (a) AIDA-1 PTB5M 
protein and the (b) AIDA-1 PTB5M protein with an APP binding sequence 
(GYENPTYKFFE) appended to the N-terminus along with a linker sequence 
(TLRPPNEATALQ) derived from the native AIDA-1 protein. Both protein 
concentrations are 0.8 mM. 
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Supplementary Figure S1: A comparison of 15N-edited HSQC spectra from the (a) AIDA1 
PTB5M protein and the (b) AIDA1 PTB5M protein with an APP binding sequence (GYENPTY-
KFFE) appended to the N-terminus along with a linker sequence (TLRPPNEATALQ) derived from 
the native AIDA1 protein. Both protein concentrations are 0.8 mM.
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Figure 2. 2 – (a) Sequence alignment of the AIDA-1 PTB domain against the APP binding 
proteins, Dab1(Yun et al., 2003), X11 (Zhang, 1997) and Fe65 (Radzimanowski et al., 
2008). Five aromatic amino acids selected for alanine substitution in AIDA-1 PTB domain 
are boxed. (b) Backbone atom superposition of top15 structures according to lowest 
refinement energy. (c) Strip plots of a 13C-edited NOESY spectrum at the Cβ chemical 
shift of each alanine substituted in the PTB5M mutant. An asterisk denotes a resonance 
not associated with that strip. (d) A ribbon representation of the PTB5M model 
highlighting the positions of the alanine substitutions. Y6A is not shown in the figure as 
the first 14 amino acids are unstructured and were excluded from the structure calculation.  
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The impact of the APP ligand on solubility was also investigated. The APP ligand 
was added exogenously, as a 17-mer peptide and endogenously, by appending the 
sequence to the amino terminus of the wild type PTB domain. Tethering a peptide ligand 
to a protein is a useful approach to shift binding kinetics from biomolecular to 
unimolecular and ensure stoichiometric binding. In either case, addition of the APP ligand 
enhanced thermostability by 8°C but did not affect solubility. A structural determination 
of the APP-bound AIDA-1 PTB domain was not pursued because there were fewer HN 
resonances a 15N-edited HSQC spectrum of the bound PTB domain (∼120) versus the free 
PTB domain (∼131) suggesting that ligand and binding cleft were severely line broadened 
beyond detection (Figure 2.1). 
While the HSQC spectra of the Y6A, F16A, F24A, Y70A and Y131A PTB 
domains were all qualitatively similar in terms of chemical shifts and line widths, the 
F24A mutant spectrum was least similar to the other four mutant spectra under closer 
inspection suggesting that A24 could be making more structural contributions than the 
other alanine substitutions. Before the structure was determined (an ensemble of structures 
is shown in Figure 2.2b), we assessed the surface exposure of each aromatic-alanine 
substitution by examining the NOEs observed from the side chain methyl group. As shown 
in Figure 2.2c, only intramolecular and short range intermolecular NOEs were observed 
at A6, A16 and A70, suggesting that these methyl groups were significantly solvent-
exposed. This was certainly the case for A6 as the chemical shift assignments indicated 
that the first 15 amino acids of the PTB domain were unstructured. Long-range NOEs 
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were observed between the methyl group of A24 in β1 and the side chains of the adjacent 
β-strand (β7), specifically, the aromatic ring of F125 and the side chain of T123. The 
portion of the β-sheet in which substitution A24 resides was deemed to be resistant to 
hydrogen exchange as an NOE was observed between the methyl group of A24 and its 
own backbone amide despite the protein being dissolved in D2O. Taken together, these 
observations suggested that A24 was the least surface exposed of the five mutants chosen 
for the study. Once the structure determination was completed (a cartoon representation 
is shown in Figure 2.2d), these observations were confirmed and the F24A substitution 
appeared to be accommodated well. A PTB domain variant lacking the F24A substitution 
was not pursued because APP binding activity was unaffected. 
The structure of the AIDA-1 PTB5M mutant was aided substantially from data 
acquired at high field. A statistical summary is provided in Table 2.2. Overall, and as 
somewhat anticipated, the structure compares favorably to the other PTB domains that 
bind APP (Table 2.3). The PTB domain family can be divided into three major classes, 
namely Shc-like, IRS1-like and Dab-like (Margolis et al., 1999; Uhlik et al., 2005): The 
AIDA-1 PTB domain is a representative of the Dab-like class that binds non-
phosphorylated-tyrosine peptides. While essentially complete chemical shift assignments 
were made, the α1-β2 loop spanning Q51-P62 remains unstructured and consequently 
dynamic due to a lack of long range NOEs observed throughout the region. The β6-β7 
loop spanning K110-H116 also samples more conformations on average, supported by the 
observation that no resonance assignments could be attributed to N115. 
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Structural and biochemical investigations of the Fe65 PTB2 domain demonstrated 
>100-fold difference in affinity between an 11 aa. minimal sequence (Kd = 100 µM) and 
an amino terminally extended 32 aa. (Kd = 0.2 µM) (Mulvihill et al., 2011; Radzimanowski 
et al., 2008). One threonine (T668) in APP located in this extended region is susceptible 
to phosphorylation and acts as a switch that repartitions the cis and trans states of the 
adjacent proline (P669) that, in turn, affects the ability of Fe65 to engage its ligand (Ando 
et al., 2001; Ramelot & Nicholson, 2001). Titrations of long (APP32) and short (APP17) 
peptides showed no differences in binding affinity to the AIDA-1 PTB domain suggesting 
that AIDA-1, like many other PTB domains, binds an NPxY motif with a Kd of ∼10 µM 
(Figure 2.3 and Table 2.4). As predicted from the NMR structure, a semi-solubilizing 
Y70A single variant or the fully-solubilizing PTB5M variant had no effect on the affinity 
of the AIDA-1 PTB domain to APP. An APP peptide bearing a phosphorylated Y687 did 
not bind the AIDA-1 PTB domain providing further evidence for its inclusion in the Dab-
like family. The Kd of the X11 PTB domain with a short APP peptide (14 aa., which is 
comparable to APP17 used in this study) is 0.3 µM, or over 100× stronger than the AIDA-
1 PTB domain (Zhang, 1997). From the perspective of the AIDA-1 PTB domain, though, 
a lower affinity may not necessarily decrease its occupancy on APP relative to X11 and 
others, as the effective concentration of AIDA-1 within the PSD is extremely high. 
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Table 2. 2 – Restraints and statistics for the ensemble of 20 Structures. 
 
 
Table 2. 3 – Structural similarity of the AIDA-1 PTB domain to related PTB domains 
that also bind APP. 
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Figure 2. 3 – Titration of FITC-labeled APP peptides with a solubility enhanced 
mutant (Y70A) of the AIDA-1 PTB domain. Binding was monitored by fluorescence 
anisotropy. Legend: APP17, a short X11-like binding site; APP32, a longer Fe65-like 
binding site; APP17{pY}, a short X11-like phosphopeptide. The peptide sequences are 
listed in Table 2.4. 
 
 
 
 
 
Table 2. 4 – Affinities of APP-derived peptides for two solubility enhanced mutants 
of the AIDA-1 PTB domain.  
  
ND: not done. 
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A comparison of the binding clefts of the AIDA-1, X11 and Fe65 PTB domains is 
shown in Figure 2.4. The cleft of each PTB domain draws contributions from several 
secondary structures including a short, conserved 310 helix, strands β5/β6 and helix α2. 
Surveying down the cleft, the first tyrosine of the APP GYENPTYKFFEQ peptide is 
positioned such that it is predominantly making contacts with G138 and F141 in α2 
Analysis of the ensemble of peptides bound to the cleft from the Rosetta based docking 
simulation identifies an almost equal population of rotamers that place the tyrosine in an 
analogous position to what is depicted in the X11-PTB/APP complex. The alternative 
rotamer would contact I134 and L135 in α2 of the AIDA-1 PTB domain. The second 
tyrosine of the APP GYENPTYKFFEQ peptide is contacted by a different set of amino 
acids among AIDA-1, X11 and Fe65. In AIDA-1, these residues are N91 in 310 helix and 
K110 in β6. In X11 and Fe65, there is at least one supporting hydrophobic residue. The 
first of two consecutive phenylalanines in the APP GYENPTYKFFEQ peptide is 
supported by a tyrosine in all three PTB domain compared (Y145 in AIDA-1). 
A 12-mer SPOT peptide array (Figures 2.5a and 2.5b) was used to survey the 
amino acid preference of the AIDA-1 PTB domain for APP and APP-like peptides. From 
an initial window scan of the APP carboxy terminal cytosolic region (Figure 2.5c), a 
minimal binding sequence of YENPTYKFFE was observed that is consistent with 
previously described peptide titrations and docking simulations. The minimal binding 
sequence was then used to exhaustively survey each position in the form of an ‘alphabet 
array’ (exhaustive amino acid substitutions at each position in the peptide). The results, 
summarized in Figure 2.5d, present a consensus sequence of YxNxΦYxΨFE where Φ is 
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a hydrophobic amino acid and Ψ is an aromatic amino acid. Since the requirement for 
proline in the NPxY motif is not absolute, AIDA-1 has the potential to sample NxxY 
motifs in receptors such as Ret that guides the development of neurons in the enteric 
nervous system (L. Li et al., 2006). If this is the case, a higher Kd, and consequently a 
higher off-rate, would permit more ‘handshaking’ or sampling of potential protein partners 
to occur. 
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Figure 2. 4 – Interaction of a APP derived peptide (GYENPTYKFFE, shared among 
all) with the X11, Fe65 and AIDA-1 PTB domains. (a) Sequence alignment of amino acids 
that contribute to the binding cleft; identity in red, homology in blue. The Fe65 PTB 
domain recognized a longer APP sequence, amino acids that extend its cleft are shown in 
green. (b) APP (yellow, in stick format, N-C direction follows the arrow) interacting with 
the X11/Fe65 as determined from their respective X-ray structures and with AIDA-1 
determined from a molecular docking simulation. (c) Backbone alignment of the AIDA-
1 (grey), X11 (cyan) and Fe65 (green) PTB domain in the same orientation as (b) with the 
binding cleft facing forward. 
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Figure 2. 5 – Amino acid preferences of the AIDA-1 PTB domain for APP 
determined from a peptide array. A list of peptides on the array are provided in Table 
2.5. (a) The array probed with anti 6xHis mAb only. Positive control 6xHis peptides are 
identified by a (+). (b) The array probed with 6xHis-AIDA-1 PTB domain. (c) Sliding 
window peptide scan of 12-mers spanning aa. 672–697 of APP. Peptides are duplicated 
on the array; for example, at A3 and A18. Since peptide content per spot can vary, if a 
signal was observed at the exposure presented it was deemed to be interaction. (d) Results 
of a window scan across the APP C-terminal sequence and an exhaustive positional scan. 
Grey boxes indicate binding was observed, regardless of signal intensity.  
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2.4.   Discussion 
Our initial attempts at biochemical and structural studies of the AIDA-1 PTB 
domain were precluded by poor solubility. As a result, we made five aromatic-alanine 
substitutions. While individual substitutions were helpful, it was the combination of all 
five substitutions that increased solubility to extent that an NMR structure determination 
was possible. In addition to the solution structure of the AIDA-1 PTB domain, we have 
determined that its affinity for unphosphorylated APP is moderate relative to similar APP 
binding proteins such as X11/Fe65 for which dissociation constants of <1 µM have been 
observed. This difference in affinity may be advantageous for AIDA-1 to participate in 
signaling contexts beyond APP. From a peptide array study, we determined that the 
consensus sequence is less stringent (NxxY versus NPxY) for others in the same Dab-like 
class of PTB domains. Thus, at the neuronal synapse, AIDA-1 could serve as a versatile 
collator and convenor of signaling events arising from the NMDA receptor, and possibly 
others. 
The structural studies have revealed how the PTB domains of X11 (Matos et al., 
2012) and Talin (Goksoy et al., 2008) are autoinhibited by flanking sequences. The AIDA-
1-APP interaction is antagonized by a short 26 aa. sequence specified by exon14 in some 
isoforms through an unknown mechanism (Ghersi et al., 2004). The sequence itself, rich 
in hydrophobic amino acids, does not resemble the NPxY motif suggesting that regulation 
of the AIDA-1 PTB domain may be occurring by non-competitive binding. Further 
structural and biochemical studies of AIDA-1 may lead to the discovery of the selective 
modification of some neuronal signaling pathways while sparing others. Fine control of 
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signaling pathways may be one strategy to improve preventive and anti-progression 
therapies of Alzheimer’s disease. 
Table 2. 5 – A complete list of 12-mer peptide sequences on the APP peptide array 
presented in Figure 2.4. 
601 A 1       H-H-H-H-H-H-H-H-H-H-H-H 
603 A 3       R-H-L-S-K-M-Q-Q-N-G-Y-E 
604 A 4       H-L-S-K-M-Q-Q-N-G-Y-E-N 
605 A 5       L-S-K-M-Q-Q-N-G-Y-E-N-P 
606 A 6       S-K-M-Q-Q-N-G-Y-E-N-P-T 
607 A 7       K-M-Q-Q-N-G-Y-E-N-P-T-Y 
608 A 8       M-Q-Q-N-G-Y-E-N-P-T-Y-K 
609 A 9       Q-Q-N-G-Y-E-N-P-T-Y-K-F 
610 A10       Q-N-G-Y-E-N-P-T-Y-K-F-F 
611 A11       N-G-Y-E-N-P-T-Y-K-F-F-E 
612 A12       G-Y-E-N-P-T-Y-K-F-F-E-Q 
613 A13       Y-E-N-P-T-Y-K-F-F-E-Q-M 
614 A14       E-N-P-T-Y-K-F-F-E-Q-M-Q 
615 A15       N-P-T-Y-K-F-F-E-Q-M-Q-N 
616 A16       P-T-Y-K-F-F-E-Q-M-Q-N-G 
617 A17       T-Y-K-F-F-E-Q-M-Q-N-G-G 
618 A18       R-H-L-S-K-M-Q-Q-N-G-Y-E 
619 A19       H-L-S-K-M-Q-Q-N-G-Y-E-N 
620 A20       L-S-K-M-Q-Q-N-G-Y-E-N-P 
621 A21       S-K-M-Q-Q-N-G-Y-E-N-P-T 
622 A22       K-M-Q-Q-N-G-Y-E-N-P-T-Y 
623 A23       M-Q-Q-N-G-Y-E-N-P-T-Y-K 
624 A24       Q-Q-N-G-Y-E-N-P-T-Y-K-F 
625 A25       Q-N-G-Y-E-N-P-T-Y-K-F-F 
626 A26       N-G-Y-E-N-P-T-Y-K-F-F-E 
627 A27       G-Y-E-N-P-T-Y-K-F-F-E-Q 
628 A28       Y-E-N-P-T-Y-K-F-F-E-Q-M 
629 A29       E-N-P-T-Y-K-F-F-E-Q-M-Q 
630 A30       N-P-T-Y-K-F-F-E-Q-M-Q-N 
631 B 1       P-T-Y-K-F-F-E-Q-M-Q-N-G 
632 B 2       T-Y-K-F-F-E-Q-M-Q-N-G-G 
633 B 3       A-A-Y-E-N-P-T-Y-K-F-F-E 
634 B 4       N-A-A-E-N-P-T-Y-K-F-F-E 
635 B 5       N-G-A-A-N-P-T-Y-K-F-F-E 
636 B 6       N-G-Y-A-A-P-T-Y-K-F-F-E 
637 B 7       N-G-Y-E-A-A-T-Y-K-F-F-E 
638 B 8       N-G-Y-E-N-A-A-Y-K-F-F-E 
639 B 9       N-G-Y-E-N-P-A-A-K-F-F-E 
640 B10       N-G-Y-E-N-P-T-A-A-F-F-E 
641 B11       N-G-Y-E-N-P-T-Y-A-A-F-E 
642 B12       N-G-Y-E-N-P-T-Y-K-A-A-E 
643 B13       N-G-Y-E-N-P-T-Y-K-F-A-A 
644 B14       Q-G-Y-E-N-P-T-Y-K-F-F-E 
645 B15       N-Q-Y-E-N-P-T-Y-K-F-F-E 
646 B16       N-G-Q-E-N-P-T-Y-K-F-F-E 
647 B17       N-G-Y-Q-N-P-T-Y-K-F-F-E 
648 B18       N-G-Y-E-Q-P-T-Y-K-F-F-E 
649 B19       N-G-Y-E-N-Q-T-Y-K-F-F-E 
650 B20       N-G-Y-E-N-P-Q-Y-K-F-F-E 
651 B21       N-G-Y-E-N-P-T-Q-K-F-F-E 
652 B22       N-G-Y-E-N-P-T-Y-Q-F-F-E 
653 B23       N-G-Y-E-N-P-T-Y-K-Q-F-E 
654 B24       N-G-Y-E-N-P-T-Y-K-F-Q-E 
655 B25       N-G-Y-E-N-P-T-Y-K-F-F-Q 
656 B26       A-G-Y-E-N-P-T-Y-K-F-F-E 
657 B27       C-G-Y-E-N-P-T-Y-K-F-F-E 
658 B28       A-A-A-A-A-A-A-A-A-A-A-A 
659 B29       H-H-H-H-H-H-H-H-H-H-H-H 
660 B30       A-A-A-H-H-H-H-H-H-A-A-A 
661 C 1       D-G-Y-E-N-P-T-Y-K-F-F-E 
662 C 2       E-G-Y-E-N-P-T-Y-K-F-F-E 
663 C 3       F-G-Y-E-N-P-T-Y-K-F-F-E 
664 C 4       G-G-Y-E-N-P-T-Y-K-F-F-E 
665 C 5       H-G-Y-E-N-P-T-Y-K-F-F-E 
666 C 6       I-G-Y-E-N-P-T-Y-K-F-F-E 
667 C 7       K-G-Y-E-N-P-T-Y-K-F-F-E 
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668 C 8       L-G-Y-E-N-P-T-Y-K-F-F-E 
669 C 9       M-G-Y-E-N-P-T-Y-K-F-F-E 
670 C10       N-G-Y-E-N-P-T-Y-K-F-F-E 
671 C11       P-G-Y-E-N-P-T-Y-K-F-F-E 
672 C12       Q-G-Y-E-N-P-T-Y-K-F-F-E 
673 C13       R-G-Y-E-N-P-T-Y-K-F-F-E 
674 C14       S-G-Y-E-N-P-T-Y-K-F-F-E 
675 C15       T-G-Y-E-N-P-T-Y-K-F-F-E 
676 C16       V-G-Y-E-N-P-T-Y-K-F-F-E 
677 C17       W-G-Y-E-N-P-T-Y-K-F-F-E 
678 C18       Y-G-Y-E-N-P-T-Y-K-F-F-E 
679 C19       W-G-Y-E-N-P-T-Y-K-F-F-E 
680 C20       Y-G-Y-E-N-P-T-Y-K-F-F-E 
681 C21       N-A-Y-E-N-P-T-Y-K-F-F-E 
682 C22       N-C-Y-E-N-P-T-Y-K-F-F-E 
683 C23       N-D-Y-E-N-P-T-Y-K-F-F-E 
684 C24       N-E-Y-E-N-P-T-Y-K-F-F-E 
685 C25       N-F-Y-E-N-P-T-Y-K-F-F-E 
686 C26       N-G-Y-E-N-P-T-Y-K-F-F-E 
687 C27       N-H-Y-E-N-P-T-Y-K-F-F-E 
688 C28       N-I-Y-E-N-P-T-Y-K-F-F-E 
689 C29       N-K-Y-E-N-P-T-Y-K-F-F-E 
690 C30       A-A-A-H-H-H-H-H-H-A-A-A 
691 D 1       N-L-Y-E-N-P-T-Y-K-F-F-E 
692 D 2       N-M-Y-E-N-P-T-Y-K-F-F-E 
693 D 3       N-N-Y-E-N-P-T-Y-K-F-F-E 
694 D 4       N-P-Y-E-N-P-T-Y-K-F-F-E 
695 D 5       N-Q-Y-E-N-P-T-Y-K-F-F-E 
696 D 6       N-R-Y-E-N-P-T-Y-K-F-F-E 
697 D 7       N-S-Y-E-N-P-T-Y-K-F-F-E 
698 D 8       N-T-Y-E-N-P-T-Y-K-F-F-E 
699 D 9       N-V-Y-E-N-P-T-Y-K-F-F-E 
700 D10       N-W-Y-E-N-P-T-Y-K-F-F-E 
701 D11       N-Y-Y-E-N-P-T-Y-K-F-F-E 
702 D12       N-G-A-E-N-P-T-Y-K-F-F-E 
703 D13       N-G-C-E-N-P-T-Y-K-F-F-E 
704 D14       N-G-D-E-N-P-T-Y-K-F-F-E 
705 D15       N-G-E-E-N-P-T-Y-K-F-F-E 
706 D16       N-G-F-E-N-P-T-Y-K-F-F-E 
707 D17       N-G-G-E-N-P-T-Y-K-F-F-E 
708 D18       N-G-H-E-N-P-T-Y-K-F-F-E 
709 D19       N-G-I-E-N-P-T-Y-K-F-F-E 
710 D20       N-G-K-E-N-P-T-Y-K-F-F-E 
711 D21       N-G-L-E-N-P-T-Y-K-F-F-E 
712 D22       N-G-M-E-N-P-T-Y-K-F-F-E 
713 D23       N-G-N-E-N-P-T-Y-K-F-F-E 
714 D24       N-G-P-E-N-P-T-Y-K-F-F-E 
715 D25       N-G-Q-E-N-P-T-Y-K-F-F-E 
716 D26       N-G-R-E-N-P-T-Y-K-F-F-E 
717 D27       N-G-S-E-N-P-T-Y-K-F-F-E 
718 D28       N-G-T-E-N-P-T-Y-K-F-F-E 
719 D29       N-G-V-E-N-P-T-Y-K-F-F-E 
720 D30       N-G-W-E-N-P-T-Y-K-F-F-E 
721 E 1       A-A-A-H-H-H-H-H-H-A-A-A 
722 E 2       A-A-A-A-A-A-A-A-A-A-A-A 
723 E 3       N-G-Y-E-N-P-T-Y-K-F-F-E 
724 E 4       N-G-Y-A-N-P-T-Y-K-F-F-E 
725 E 5       N-G-Y-C-N-P-T-Y-K-F-F-E 
726 E 6       N-G-Y-D-N-P-T-Y-K-F-F-E 
727 E 7       N-G-Y-E-N-P-T-Y-K-F-F-E 
728 E 8       N-G-Y-F-N-P-T-Y-K-F-F-E 
729 E 9       N-G-Y-G-N-P-T-Y-K-F-F-E 
730 E10       N-G-Y-H-N-P-T-Y-K-F-F-E 
731 E11       N-G-Y-I-N-P-T-Y-K-F-F-E 
732 E12       N-G-Y-K-N-P-T-Y-K-F-F-E 
733 E13       N-G-Y-L-N-P-T-Y-K-F-F-E 
734 E14       N-G-Y-M-N-P-T-Y-K-F-F-E 
735 E15       N-G-Y-N-N-P-T-Y-K-F-F-E 
736 E16       N-G-Y-P-N-P-T-Y-K-F-F-E 
737 E17       N-G-Y-Q-N-P-T-Y-K-F-F-E 
738 E18       N-G-Y-R-N-P-T-Y-K-F-F-E 
739 E19       N-G-Y-S-N-P-T-Y-K-F-F-E 
740 E20       N-G-Y-T-N-P-T-Y-K-F-F-E 
741 E21       N-G-Y-V-N-P-T-Y-K-F-F-E 
742 E22       N-G-Y-W-N-P-T-Y-K-F-F-E 
743 E23       N-G-Y-Y-N-P-T-Y-K-F-F-E 
744 E24       N-G-Y-E-A-P-T-Y-K-F-F-E 
745 E25       N-G-Y-E-C-P-T-Y-K-F-F-E 
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746 E26       N-G-Y-E-D-P-T-Y-K-F-F-E 
747 E27       N-G-Y-E-E-P-T-Y-K-F-F-E 
748 E28       N-G-Y-E-F-P-T-Y-K-F-F-E 
749 E29       N-G-Y-E-G-P-T-Y-K-F-F-E 
750 E30       N-G-Y-E-H-P-T-Y-K-F-F-E 
751 F 1       N-G-Y-E-I-P-T-Y-K-F-F-E 
752 F 2       N-G-Y-E-K-P-T-Y-K-F-F-E 
753 F 3       N-G-Y-E-L-P-T-Y-K-F-F-E 
754 F 4       N-G-Y-E-M-P-T-Y-K-F-F-E 
755 F 5       N-G-Y-E-N-P-T-Y-K-F-F-E 
756 F 6       N-G-Y-E-P-P-T-Y-K-F-F-E 
757 F 7       N-G-Y-E-Q-P-T-Y-K-F-F-E 
758 F 8       N-G-Y-E-R-P-T-Y-K-F-F-E 
759 F 9       N-G-Y-E-S-P-T-Y-K-F-F-E 
760 F10       N-G-Y-E-T-P-T-Y-K-F-F-E 
761 F11       N-G-Y-E-V-P-T-Y-K-F-F-E 
762 F12       N-G-Y-E-W-P-T-Y-K-F-F-E 
763 F13       N-G-Y-E-Y-P-T-Y-K-F-F-E 
764 F14       N-G-Y-E-N-A-T-Y-K-F-F-E 
765 F15       N-G-Y-E-N-C-T-Y-K-F-F-E 
766 F16       N-G-Y-E-N-D-T-Y-K-F-F-E 
767 F17       N-G-Y-E-N-E-T-Y-K-F-F-E 
768 F18       N-G-Y-E-N-F-T-Y-K-F-F-E 
769 F19       N-G-Y-E-N-G-T-Y-K-F-F-E 
770 F20       N-G-Y-E-N-H-T-Y-K-F-F-E 
771 F21       N-G-Y-E-N-I-T-Y-K-F-F-E 
772 F22       N-G-Y-E-N-K-T-Y-K-F-F-E 
773 F23       N-G-Y-E-N-L-T-Y-K-F-F-E 
774 F24       N-G-Y-E-N-M-T-Y-K-F-F-E 
775 F25       N-G-Y-E-N-N-T-Y-K-F-F-E 
776 F26       N-G-Y-E-N-P-T-Y-K-F-F-E 
777 F27       N-G-Y-E-N-Q-T-Y-K-F-F-E 
778 F28       N-G-Y-E-N-R-T-Y-K-F-F-E 
779 F29       N-G-Y-E-N-S-T-Y-K-F-F-E 
780 F30       N-G-Y-E-N-T-T-Y-K-F-F-E 
781 G 1       N-G-Y-E-N-V-T-Y-K-F-F-E 
782 G 2       N-G-Y-E-N-W-T-Y-K-F-F-E 
783 G 3       N-G-Y-E-N-Y-T-Y-K-F-F-E 
784 G 4       N-G-Y-E-N-P-A-Y-K-F-F-E 
785 G 5       N-G-Y-E-N-P-C-Y-K-F-F-E 
786 G 6       N-G-Y-E-N-P-D-Y-K-F-F-E 
787 G 7       N-G-Y-E-N-P-E-Y-K-F-F-E 
788 G 8       N-G-Y-E-N-P-F-Y-K-F-F-E 
789 G 9       N-G-Y-E-N-P-G-Y-K-F-F-E 
790 G10       N-G-Y-E-N-P-H-Y-K-F-F-E 
791 G11       N-G-Y-E-N-P-I-Y-K-F-F-E 
792 G12       N-G-Y-E-N-P-K-Y-K-F-F-E 
793 G13       N-G-Y-E-N-P-L-Y-K-F-F-E 
794 G14       N-G-Y-E-N-P-M-Y-K-F-F-E 
795 G15       N-G-Y-E-N-P-N-Y-K-F-F-E 
796 G16       N-G-Y-E-N-P-P-Y-K-F-F-E 
797 G17       N-G-Y-E-N-P-Q-Y-K-F-F-E 
798 G18       N-G-Y-E-N-P-R-Y-K-F-F-E 
799 G19       N-G-Y-E-N-P-S-Y-K-F-F-E 
800 G20       N-G-Y-E-N-P-T-Y-K-F-F-E 
801 G21       N-G-Y-E-N-P-V-Y-K-F-F-E 
802 G22       N-G-Y-E-N-P-W-Y-K-F-F-E 
803 G23       N-G-Y-E-N-P-Y-Y-K-F-F-E 
804 G24       N-G-Y-E-N-P-T-A-K-F-F-E 
805 G25       N-G-Y-E-N-P-T-C-K-F-F-E 
806 G26       N-G-Y-E-N-P-T-D-K-F-F-E 
807 G27       N-G-Y-E-N-P-T-E-K-F-F-E 
808 G28       N-G-Y-E-N-P-T-F-K-F-F-E 
809 G29       N-G-Y-E-N-P-T-G-K-F-F-E 
810 G30       N-G-Y-E-N-P-T-H-K-F-F-E 
811 H 1       N-G-Y-E-N-P-T-I-K-F-F-E 
812 H 2       N-G-Y-E-N-P-T-K-K-F-F-E 
813 H 3       N-G-Y-E-N-P-T-L-K-F-F-E 
814 H 4       N-G-Y-E-N-P-T-M-K-F-F-E 
815 H 5       N-G-Y-E-N-P-T-N-K-F-F-E 
816 H 6       N-G-Y-E-N-P-T-P-K-F-F-E 
817 H 7       N-G-Y-E-N-P-T-Q-K-F-F-E 
818 H 8       N-G-Y-E-N-P-T-R-K-F-F-E 
819 H 9       N-G-Y-E-N-P-T-S-K-F-F-E 
820 H10       N-G-Y-E-N-P-T-T-K-F-F-E 
821 H11       N-G-Y-E-N-P-T-V-K-F-F-E 
822 H12       N-G-Y-E-N-P-T-W-K-F-F-E 
823 H13       N-G-Y-E-N-P-T-Y-K-F-F-E 
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824 H14       N-G-Y-E-N-P-T-Y-A-F-F-E 
825 H15       N-G-Y-E-N-P-T-Y-C-F-F-E 
826 H16       N-G-Y-E-N-P-T-Y-D-F-F-E 
827 H17       N-G-Y-E-N-P-T-Y-E-F-F-E 
828 H18       A-A-A-H-H-H-H-H-H-A-A-A 
829 H19       G-S-H-H-H-H-H-H-G-S-S-A 
830 H20       A-A-A-A-A-A-A-A-A-A-A-A 
831 H21       N-G-Y-E-N-P-T-Y-F-F-F-E 
832 H22       N-G-Y-E-N-P-T-Y-G-F-F-E 
833 H23       N-G-Y-E-N-P-T-Y-H-F-F-E 
834 H24       N-G-Y-E-N-P-T-Y-I-F-F-E 
835 H25       N-G-Y-E-N-P-T-Y-K-F-F-E 
836 H26       N-G-Y-E-N-P-T-Y-L-F-F-E 
837 H27       N-G-Y-E-N-P-T-Y-M-F-F-E 
838 H28       N-G-Y-E-N-P-T-Y-N-F-F-E 
839 H29       N-G-Y-E-N-P-T-Y-P-F-F-E 
840 H30       N-G-Y-E-N-P-T-Y-Q-F-F-E 
841 I 1       N-G-Y-E-N-P-T-Y-R-F-F-E 
842 I 2       N-G-Y-E-N-P-T-Y-S-F-F-E 
843 I 3       N-G-Y-E-N-P-T-Y-T-F-F-E 
844 I 4       N-G-Y-E-N-P-T-Y-V-F-F-E 
845 I 5       N-G-Y-E-N-P-T-Y-W-F-F-E 
846 I 6       N-G-Y-E-N-P-T-Y-Y-F-F-E 
847 I 7       N-G-Y-E-N-P-T-Y-K-A-F-E 
848 I 8       N-G-Y-E-N-P-T-Y-K-C-F-E 
849 I 9       N-G-Y-E-N-P-T-Y-K-D-F-E 
850 I10       N-G-Y-E-N-P-T-Y-K-E-F-E 
851 I11       N-G-Y-E-N-P-T-Y-K-F-F-E 
852 I12       N-G-Y-E-N-P-T-Y-K-G-F-E 
853 I13       N-G-Y-E-N-P-T-Y-K-H-F-E 
854 I14       N-G-Y-E-N-P-T-Y-K-I-F-E 
855 I15       N-G-Y-E-N-P-T-Y-K-K-F-E 
856 I16       N-G-Y-E-N-P-T-Y-K-L-F-E 
857 I17       N-G-Y-E-N-P-T-Y-K-M-F-E 
858 I18       N-G-Y-E-N-P-T-Y-K-N-F-E 
859 I19       N-G-Y-E-N-P-T-Y-K-P-F-E 
860 I20       N-G-Y-E-N-P-T-Y-K-Q-F-E 
861 I21       N-G-Y-E-N-P-T-Y-K-R-F-E 
862 I22       N-G-Y-E-N-P-T-Y-K-S-F-E 
863 I23       N-G-Y-E-N-P-T-Y-K-T-F-E 
864 I24       N-G-Y-E-N-P-T-Y-K-V-F-E 
865 I25       N-G-Y-E-N-P-T-Y-K-W-F-E 
866 I26       N-G-Y-E-N-P-T-Y-K-Y-F-E 
867 I27       N-G-Y-E-N-P-T-Y-K-F-A-E 
868 I28       N-G-Y-E-N-P-T-Y-K-F-C-E 
869 I29       N-G-Y-E-N-P-T-Y-K-F-D-E 
870 I30       N-G-Y-E-N-P-T-Y-K-F-E-E 
871 J 1       N-G-Y-E-N-P-T-Y-K-F-F-E 
872 J 2       N-G-Y-E-N-P-T-Y-K-F-G-E 
873 J 3       N-G-Y-E-N-P-T-Y-K-F-H-E 
875 J 5       N-G-Y-E-N-P-T-Y-K-F-K-E 
876 J 6       N-G-Y-E-N-P-T-Y-K-F-L-E 
877 J 7       N-G-Y-E-N-P-T-Y-K-F-M-E 
878 J 8       N-G-Y-E-N-P-T-Y-K-F-N-E 
880 J10       N-G-Y-E-N-P-T-Y-K-F-Q-E 
881 J11       N-G-Y-E-N-P-T-Y-K-F-R-E 
882 J12       N-G-Y-E-N-P-T-Y-K-F-S-E 
883 J13       N-G-Y-E-N-P-T-Y-K-F-T-E 
885 J15       N-G-Y-E-N-P-T-Y-K-F-W-E 
887 J17       N-G-Y-E-N-P-T-Y-K-F-F-A 
888 J18       N-G-Y-E-N-P-T-Y-K-F-F-C 
889 J19       N-G-Y-E-N-P-T-Y-K-F-F-D 
890 J20       N-G-Y-E-N-P-T-Y-K-F-F-E 
891 J21       A-A-A-H-H-H-H-H-H-A-A-A 
892 J22       A-A-A-A-A-A-A-A-A-A-A-A 
893 J23       N-G-Y-E-N-P-T-Y-K-F-F-F 
894 J24       N-G-Y-E-N-P-T-Y-K-F-F-G 
895 J25       N-G-Y-E-N-P-T-Y-K-F-F-H 
896 J26       N-G-Y-E-N-P-T-Y-K-F-F-I 
897 J27       N-G-Y-E-N-P-T-Y-K-F-F-K 
898 J28       N-G-Y-E-N-P-T-Y-K-F-F-L 
899 J29       N-G-Y-E-N-P-T-Y-K-F-F-M 
900 J30       N-G-Y-E-N-P-T-Y-K-F-F-N 
901 K 1       N-G-Y-E-N-P-T-Y-K-F-F-P 
902 K 2       N-G-Y-E-N-P-T-Y-K-F-F-Q 
904 K 4       N-G-Y-E-N-P-T-Y-K-F-F-S 
905 K 5       N-G-Y-E-N-P-T-Y-K-F-F-T 
908 K 8       N-G-Y-E-N-P-T-Y-K-F-F-Y 
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_______________________________________________________________________ 
3.  CHAPTER 3: 
TANDEM SAM DOMAINS DRIVE THE DYNAMIC 
OLIGOMERIZATION OF THE CASKIN2 NEURONAL 
SCAFFOLDING PROTEIN 
_______________________________________________________________________ 
 
All of the content reported within this chapter has been published in the article listed below: 
 
v   Smirnova E., Kwan J.J., Siu R., Gao X., Zoidl G., Demeler B., Saridakis V., and 
Donaldson L.W. (2016) “A New Mode of SAM Domain Mediated Oligomerization 
Observed in the Caskin2 Neuronal Scaffolding Protein.” Cell Communication and 
Signaling, 1–14.  
 
Information of the authors’ contributions is provided in the corresponding section.  
3.1.   Introduction 
Caskin2 and its mammalian homolog Caskin1, are multidomain proteins that share 
the same overall organization (Tabuchi et al., 2002). The amino terminal half of both 
proteins consist of protein-protein interaction modules, namely six ankyrin repeats, an 
SH3 domain, and two SAM domains (Figure 3.1). The carboxy terminal half consists of 
low complexity, proline-rich sequences (Balázs et al., 2009) ending with a conserved 25 
aa. segment of unknown function. The Caskins are named for their ability to interact with 
CASK (calcium / calmodulin-dependent serine kinase), a MAGUK protein that is 
implicated in a number of neurological conditions including autism and X-linked mental 
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retardation (Hsueh, 2006; K. Chen and Featherstone, 2011; Corvin, 2010). Only one 
homolog, Ckn, is observed in the Drosophila genome (Weng et al., 2011) and no 
homologs are observed in C. elegans suggesting that from an evolutionary perspective, 
multiple mammalian Caskins may have arisen to promote a more comprehensive set of 
signaling circuits. In Caskin1, the CASK interaction domain (CID) is located between the 
SH3 and SAM1 domains and facilitates direct contact with the calmodulin kinase catalytic 
domain of CASK. The CID is also present in the scaffolding protein, X11/Mint (Stafford 
et al., 2011). The CID, however, is not present in Caskin2 rendering it unable to bind 
CASK (Tabuchi et al., 2002). Thus, despite their organizational similarity, Caskin1 and 
Caskin2 may have diverged with respect to their scaffolding functions in neurons, their 
structures and their protein partners.  
Sterile Alpha Motif (SAM) domains are well represented in the human genome 
reflecting the versatility of this compact, five-helix fold to facilitate protein-ligand 
interactions that include other proteins, nucleic acids and lipids (Qiao, 2005). The most 
prevalent partners of SAM domains are, in fact, other SAM domains leading to a variety 
of homotypic and heterotypic SAM-SAM interactions in transcription factors (Qiao et al., 
2004; Qiao et al., 2006) and neuronal signaling protein assemblies (Baron et al. 2006; 
Bourgeron, 2009; Harada et al., 2008). Because SAM domains generally employ two 
complementary surfaces, homotypic interactions may produce not only dimers, but also 
assemblies of SAM domains polymers to highlight the considerable molecular weight they 
can attain (Knight et al., 2011). 
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The Caskin1 and Caskin2 tandem SAM domains were first identified to self-
associate during an electron microscopy based survey which sought to identify new SAM 
domain mediated polymers (Knight et al., 2011). Later high resolution X-ray studies 
revealed that the Caskin1 SAM1-SAM2 tandem self-associated into helical fibrils 
(Stafford et al., 2011). Two roles have been proposed for this architecture at presynaptic 
sites. First, oligomers of Caskin1 could link and concentrate cell-adhesion proteins 
including Ephrin B1 and CASK-associated neurexin. Second, oligomers of Caskin1 could 
form a tether by which a stream of vesicles loaded with chemical transmitters could be 
guided via synaptogamin to the synaptic cleft (Stafford et al., 2011).  
A crystal structure demonstrating that the tandem SAM domains of Caskin2 form 
an oligomer that is distinct from Caskin1 is reported in this study. By analytical 
ultracentrifugation, a dissociation constant describing the monomer-dimer equilibrium of 
the SAM tandem was observed to be in the micromolar range, a favorable concentration 
in the cell for tuning oligomerization and opening up the possibility for additional 
regulation by post-translational modifications and protein partners. An EGFP-tagged 
Caskin2 SAM1-SAM2 protein expressed in neuroblastoma cells formed punctae 
consistent with high order oligomers while a structure-directed surface mutant was 
distributed diffusely. In support of the structural distinction between Caskin1 and Caskin2, 
the punctae were morphologically different. This study provides a foundation to begin 
exploring the effect of protein partnerships and post-translational modifications that direct 
the oligomeric state of Caskin2 and consequently, its function in neurons, possibly apart 
from the processes directed by Caskin1.  
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Figure 3. 1 – Conservation of the tandem SAM domains among three neuronal 
signaling scaffolding proteins, Drosophila Ckn, human Caskin1, and human Caskin2. The 
location of the binding site in Caskin1 for the scaffolding protein CASK is shown by an 
arrow. The Caskin2 SAM tandem described in this study is shaded grey. 
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3.2.   Materials and Methods 
3.2.1.  Cloning 
The human Caskin2 SAM1-SAM2 tandem (483-634; Uniprot Q8WXE0) and individual 
SAM1 (483-549) and SAM2 (550-634) domains were amplified by PCR from a human 
cDNA and inserted into the BamHI / XhoI restriction sites of pET28 (Novagen) followed 
by transformation into E. coli BL21:DE3 to produce a 6xHis tagged protein. Five Caskin2 
mutants, G537D, K540E, G537D/K540E, L589E, and G607D were made using the 
Quikchange method (Agilent). An EGFP fusion protein to the wild type Caskin2 SAM1-
SAM2 tandem and G537D/K540E mutant was prepared by inserting a suitable PCR 
product into the XhoI / KpnI restriction sites of pEGFP-N1 (Clontech). A similar approach 
was used to make EGPF-tagged Caskin1 SAM1-SAM2 (470-613; Uniprot Q8WXE9) and 
a G520D/K523E mutant using a synthetic Caskin1 gene fragment (GenScript). 
3.2.2.  Expression and Protein Purification 
Isotopic labeling of Caskin2 SAM1, SAM2, and SAM1-SAM2 for NMR spectroscopy 
was achieved by a 1.0 L fermentation in a minimal medium containing 1 g 15NH4Cl as the 
sole nitrogen source and/or 3 g of 13C-glucose as the sole carbon source. Proteins for X-
ray crystallographic studies were expressed in a minimal medium with the addition of 50 
mg/L of selenomethionine 15 min before induction. Cell pellets were dissolved in T300 
buffer (20 mM Tris-HCl, 300 mM NaCl, 0.05 % NaN3) and lysed by French press. Highly 
purified protein was obtained from a two-step purification involving Nickel-NTA affinity 
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chromatography (Qiagen), followed by gel filtration chromatography (Sephacryl-100, 
HiLoad 16/60; GE Life Sciences). The final buffer for NMR analyses was phosphate 
buffered saline (PBS; 20 mM sodium phosphate, pH 7.8, 0.15 M NaCl, 0.05% (w/v) NaN3. 
Crystallographic screening was performed with proteins in T300 buffer.  
3.2.3.  Cell Culture, Transient Transfection and Immunoblotting 
Neuroblastoma 2a (Neuro2a) cells (Olmsted et al., 1970) were maintained using standard 
growth conditions and used for expression and localization studies as described in 
(Prochnow et al., 2009). 30,000 cells were seeded onto 13 mm glass cover slips in 24 well 
plates and 200-400 ng plasmid DNA transfected using Effectene reagent as recommended 
by the manufacturer (Qiagen). Whole cell protein lysates from transfected Neuro2a cells 
collected 48 hours post-transfection were separated by 10% SDS-PAGE and transferred 
to 0.2 µm Hybond-ECL nitrocellulose membrane (GE Life Sciences) for 
immunodetection. Primary antibodies were diluted 1:1000 (rabbit anti-GFP; Santa Cruz) 
and 1:20000 (mouse anti-b-actin; Sigma-Aldrich). Secondary antibodies (LI-COR 
Biosciences) were diluted 1:20000 (donkey anti-rabbit IRDye680LT) or 1:20000 (goat 
anti-mouse IRDye800CW). Signals were detected using the Odyssey Infrared Imaging 
System (LI-COR Biosciences). 
3.2.4.  Confocal Microscopy 
Transfected cells were fixed with 4% paraformaldehyde for 20 min at room temperature, 
washed with PBS, counterstained with DAPI and mounted for imaging. Samples were 
83 
visualized using a Zeiss LSM 700 confocal microscope with a Plan-Apochromat 63x/1.4 
Oil DIC M27 objective and the ZEN 2010 program to control all hardware parameters. 
Images were collected by line averaging (4x) at high resolution (2048x2048 pixel) using 
single planes or z-stacks. Images were exported and further processed using ImageJ. For 
deconvolution, the point-spread function was calculated using the Gaussian PSF 3D and 
Iterative 3D Deconvolve software plugins in ImageJ. Images were combined in Adobe 
Photoshop for presentation. 
3.2.5.  Analytical Ultracentrifugation 
Sedimentation velocity (SV) experiments were performed with a Beckman Optima XL-I 
at the Center for Analytical Ultracentrifugation of Macromolecular Assemblies at the 
University of Texas Health Science Center at San Antonio. SV data were analyzed with 
UltraScan-III (Gorbet et al., 2015) All calculations were performed on the XSEDE 
UltraScan Science Gateway using high-performance computing resources at the Texas 
Advanced Computing Center, at the San Diego Supercomputing Center, and at the 
Bioinformatics Core Facility at the University of Texas Health Science Center at San 
Antonio. All measurements were made in 20 mM sodium phosphate buffer, pH 7.8, 
supplemented with 0.15 M or 0.3 mM NaCl. The experimental data were collected in 
intensity mode at 20˚C, and at 50,000 rpm, using standard epon-charcoal two-channel 
centerpieces. Hydrodynamic corrections for buffer density, viscosity and partial specific 
volume were made as implemented in UltraScan-III, except when equilibrium constants 
were fitted to whole boundary models. In those cases, the monomer molar mass, which is 
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known, was held constant, and the partial specific volume was floated to account for the 
variability in partial specific volume under different salt concentrations. The experimental 
data were first modeled with solutions of the Lamm equation (Cao and Demeler, 2005), 
which are fitted to experimental data by two-dimensional spectrum analysis (Brookes, 
Cao, and Demeler, 2009) using meniscus fitting and simultaneous time- and radially 
invariant noise removal (Demeler, 2001). Noise corrected data were further analyzed by 
the enhanced van Holde-Weischet method (Demeler and van Holde, 2004). This approach 
provides diffusion corrected sedimentation coefficient distributions, providing clear 
evidence for the presence of heterogeneity, and for identifying reversible mass action 
reactions. Quantitative equilibrium constants were obtained by fitting analytical 
ultracentrifugation sedimentation velocity (AUC-SV) experiments by genetic algorithm 
analysis of as described in (Demeler et al., 2010). 95% confidence intervals were 
determined by Monte Carlo analysis (Demeler and Brookes, 2007).  
3.2.6.  NMR Spectroscopy 
All experiments were performed with either uniformly 15N-labeled, or 13C,15N-labeled 
samples, as required. Assignment of the G537D/K540E mutant at 0.8 mM was achieved 
by a conventional triple resonance strategy (HNCACB, CBCACONH, HNCO, 
HNCACO) acquired at 310 K with non-linear sampling on a Bruker Avance 950 MHz 
NMR spectrometer at the Imaging and Characterization Core Laboratory (KAUST). 
Datasets were processed with a combination of NMRpipe (Delaglio et al., 1995) and 
istHMS (Hyberts et al., 2012) and interpreted with CCPN Analysis (Skinner et al., 2015). 
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Backbone 15N relaxation experiments at a protein concentration of 0.3 mM were acquired 
on a Bruker Avance 700 MHz NMR spectrometer at the York University Life Sciences 
Building Central Facility. A longitudinal 15N T1 relaxation rate was determined by 
acquiring 2D spectra with delays of 200, 400, 600, 800, 1000, and 1200 ms. A transverse 
15N T2 relaxation rate was determined by acquiring 2D spectra with delays of 17, 34, 51, 
68, 85, 102, 136, and 170 ms. In both cases, spectra were processed and peaks integrated 
with NMRPipe and then fit to a single exponential function with LMquick (Farrow et al., 
1994). A rotational correlation time (τc) was calculated from the average T1/T2 ratio (Kay, 
Torchia, and Bax, 1989). From the correlation time, a molecular weight was estimated 
according to the linear relationship τc = MW * 0.433 + 0.775 published at the University 
of San Diego NMR Center (http://sopnmr.ucsd.edu/biomol-tools.htm).  
3.2.7.  X-Ray Crystallography 
Crystals of selenomethionine labeled Caskin2 SAM1-SAM2 were obtained by hanging 
drop vapor diffusion at 4 ˚C with equal parts of a 0.6 mM protein solution in T300 buffer 
and reservoir solution containing 0.1 M Tris pH 7.5, 2.4 M sodium formate, 5 mM DTT. 
After 24 hours, mature crystals were cryoprotected with the same crystallization solution 
containing 15% glycerol and flash frozen in liquid nitrogen prior to diffraction 
experiments. A diffraction dataset using the single anomalous dispersion method at the 
peak wavelength was acquired at the Canadian Light Source beam line 08B1-1 with a 
Rayonix MH300HE area detector (Grochulski et al., 2012). All data were processed using 
XDS (Kabsch, Kabsch, and IUCr, 2010). The calculated Matthews coefficient 
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(Kantardjieff and Rupp, 2003) of 4.43 Å3/Da suggested the presence of one molecule in 
the asymmetric unit leading to a solvent content of 72%. Phasing, density improvement, 
solvent flattening and refinement was performed with Phenix (Adams et al., 2010). Six 
selenium sites were identified and an initial model was produced with AutoSol. From it, 
a partial model containing 113 of 166 amino acids was achieved with AutoBuild. This 
model was completed by successive cycles of refinement using Phenix-Refine and manual 
rebuilding in Coot (Emsley and Cowtan, 2004). Rigid body refinement and secondary 
structure restraints were applied throughout the refinement process. In the final refinement 
stages, target weight optimization was performed. No water molecules were added. 
Structural analysis was performed with MolProbity (V. B. Chen et al., 2009) and 
PROCHECK (Laskowski et al., 1993). Backbone RMSD was calculated with SSM 
(Krissinel and Henrick, 2004).  
3.3.   Results 
3.3.1.  The SAM Domains of Caskin2 
Prior to the structural studies, sequence alignments and secondary structure 
predictions were performed to define the boundaries of each five-helix SAM domain. 
These boundaries were experimentally established through the production of pure, 15N-
labeled SAM1, SAM2 and SAM1-SAM2 proteins for NMR spectroscopy. At room 
temperature, SAM2 appeared to be folded due to the excellent dispersion and uniform 
resonance intensities observed in 1H,15N-HSQC spectra (Figure 3.2). SAM1, however, 
demonstrated the spectral characteristics of a partially unfolded protein with fewer than 
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expected resonances and limited chemical shift dispersion. Upon cooling the SAM1 
protein to 5 ˚C and reacquiring spectra, a greater number of upfield and downfield 
resonances were observed suggesting that SAM1 was stabilized at low temperature. The 
1H,15N-HSQC spectrum of SAM1-SAM2 was not the straightforward addition of the 
SAM1 and SAM2 spectra suggesting the two domains were coupled. Throughout the 
course of these studies, we noted that SAM1-SAM2 had a strong tendency to oligomerize 
as evidenced by increased spectral line widths at concentrations greater than 50 µM and 
was affected by temperature and ionic strength. 
3.3.2.  Crystal Structure of The SAM1-SAM2 Tandem 
Serendipitously, we observed microcrystal formation during the concentration of 
the Caskin2 SAM1-SAM2 tandem preparations for NMR spectroscopy at high salt 
concentration (0.5 M NaCl). The salt dependence on crystallization was explored by a 
sparse matrix screen of crystallization conditions. The structure was subsequently solved 
at 2.75 Å resolution from a SAD dataset acquired at the Canadian Light Source 
Synchrotron (Table 3.1). A single SAM domain tandem was observed in the asymmetric 
unit. From a survey of the crystal contacts, the minimal biological unit was assigned to a 
dimer, which then repeated as a large oligomer.  
Despite having ~60% sequence identity to the Caskin1 SAM tandem, we observed 
a different oligomeric architecture in the crystal structure of the Caskin2 SAM tandem 
(Stafford et al., 2011). Since each SAM domain bears a complementary head and tail 
surface, a tandem can interact with itself, as in the case of Caskin1, to form a tight unit 
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which we will call a compact monomer. The unoccupied head and tail surfaces, in turned, 
can link compact monomers in both directions to produce long fibrils (Figure 3.3). In 
contrast, the Caskin2 SAM tandem presented here forms a domain swapped dimer where 
SAM1 interacts with SAM2 of a second molecule and vice versa. Since each SAM domain 
in the dimer has an available interaction surface, the Caskin2 SAM domain oligomer has 
the potential to form a branched oligomer in contrast to the linear assembly observed for 
Caskin1 (Figure 3.3). 
The intra-SAM domain contacts within one dimer and inter-SAM domain contacts 
between dimers follow a head-to-tail type interaction that has been observed in many 
homo- and heterotypic SAM-SAM structures including, but not limited to AIDA-1   
(Kurabi et al., 2009), ANKS3/ANK6 (Leettola et al., 2014), Ste11/Ste50 (Kwan et al., 
2006), LEAFY (Sayou et al., 2016), Liprin-α/Liprin-β (Wei et al., 2011), Ph/Scm (Kim 
and Kim, 2005), Shank3 (Baron et al., 2006), Ship2/EphA2 (Lee et al., 2012; Leone, 
Cellitti, and Pellecchia, 2008), TEL (Kim et al., 2001), and Yan/Mae (Qiao et al., 2004).  
The head interaction surface of SAM2, located on the opposite side of this small 
globular domain, draws contributions from helices 2, 3, and 4. The tail interaction surface 
of SAM1 draws contributions nearly exclusively from helix 5.  A detailed view of the 
head and tail surfaces of Caskin2 SAM1 and SAM2 are presented in Figure 3.4 and follow 
the same coloring scheme as Figure 3.3, for clarity. 
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Figure 3. 2 – In isolation, Caskin2 SAM1 and SAM2 demonstrate different 
thermostabilities. 1H-15N HSQC spectra acquired at 700 MHz at a protein concentration 
of 100 µM in PBS buffer supplemented with 10 % D2O. At 25 °C, SAM1 appears to be 
partially unfolded as the spectrum shows poor amide resonance dispersion as well as fewer 
resonances than expected. When the SAM1 sample is reacquired at 5 °C, more resonances 
are apparent. In contrast, the spectrum of SAM2 suggests that it is folded at 25 °C. The 
spectrum of the SAM1-SAM2 tandem is not an addition of the individual SAM1 and 
SAM2 spectra suggesting an interaction between the two domains. 
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Table 3. 1 – Data collection and refinement statistics. 
 
Values in parentheses correspond to the highest resolution shell (2.85-2.75 Å) 
 
While the SAM-SAM head-to-tail interaction is predominantly hydrophobic, ionic 
contacts serve an important role at the intramolecular SAM-SAM interface of the dimer 
and the intermolecular SAM-SAM interface between dimers. Specifically, ionic contacts 
were observed between D527 / K610 and D516 / K611 at the intramolecular SAM1-
SAM2 interface and between H538 / D585 and K540 / D592 at the intermolecular SAM1-
SAM2 interface. A more extensive ionic contact network was observed in the AIDA-1 
 
Data collection   
 
Space group P6522 
Cell dimensions (Å) 96.4, 96.4, 119.2 
Wavelength (Å) 0.97912 
Reflections 377 578 (38 328) 
Unique reflections 9004 (881) 
Multiplicity 41.9 (43.5) 
R-merge (%) 7.7 (0.86) 
< I / σ(I )> 56.8 (4.68) 
Completeness (%)  100.0 
  
Refinement  
Resolution 48.51-2.75 
Reflections  9004 
Rwork 0.2449 
Rfree  0.2649 
Protein atoms 1100 
Protein residues 140 
Water molecules 0 
RMSD bond lengths (Å) 0.012 
RMSD angles (˚) 1.269 
  
Ramachandran statistics  
Most favored (%) 92.14 
Additional allowed (%) 7.86 
Disallowed (%)   0.0 
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neuronal scaffolding protein SAM tandem; a consequence of a highly basic nuclear 
localization signal being buried at the SAM-SAM interface. Ionic contacts also help the 
SHIP2 SAM domain discern its bona fide EphA1 and EphA2 SAM protein partners from 
other closely related SAM domains such as EphB2 (Lee et al., 2012).  
A hydrophobic network with contributions from W554 and Y558 and peripheral 
support from L555, together serve to restrain the linker in one conformation in the crystal 
structure (Figure 3.5). These contacts, in turn, may limit the freedom that the two pairs of 
SAM domain have in solution. Near the linker, an ionic contact (E565 / R618) from the 
SAM domains across the dimer interface further add to the compactness of the assembly. 
It is worth noting that in Caskin1, Y558 is replaced by H542 and E565 is replaced by 
V549. Thus, both the hydrophobic and ionic contacts are not preserved in the linker and 
may contribute to the different types of oligomers observed. Finally, in this assessment of 
the linker region, we wish to emphasize that the sole conformation of the linker in the 
crystal structure should be interpreted with the caveats that it exhibited the highest B-
factors in the refined model along with diminished electron density quality from an 
examination of an omit map that provides an unbiased assessment of the experimental 
data (Figure 3.6).  
To test if the two Caskin2 SAM domains could bind each other independently, a 
1H-15N HSQC reference spectrum of uniformly 15N-labeled SAM2 at 100 µM was initially 
acquired, followed by the addition of unlabeled (14N) SAM1 at a 1:1 stoichiometric ratio 
and reacquisition of the spectrum. From an examination of the overlaid spectra, only a 
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few minor peak changes were observed in stark contrast to the spectrum of the tethered 
SAM1-SAM2 protein presented in Figure 3.4. Thus, this experiment suggests that the two 
SAM domains must be tethered to interact with each other, with the linker potentially 
playing an active role in their association.  
3.3.3.  Mutational Analysis of The SAM Domain Interfaces 
Consistent with the majority of SAM domain protein NMR and crystal structures 
solved to date, a head-to-tail type interaction facilitates SAM-SAM contacts within the 
dimer and throughout the oligomer. As a result, mutants on this surface can be designed 
that break one type of contact, intra- or intermolecular, while preserving the other. The 
substitution mutants described in this section are highlighted in Figure 3.5. 
The tail surface is comprised of residues from the beginning of helix 5. Within 
helix 5, a glycine plays a critical role because the absence of a side chain at this position 
permits the close approach of the helix backbone to the head surface of the opposing SAM 
domain. In Caskin2 SAM1 and SAM2, these glycines are G537 and G607, respectively. 
According to the crystal structure, a substitution at G537 is predicted to preserve the dimer 
interface and inhibit oligomerization. Likewise, a substitution at G607 is predicted to 
decouple the SAM domains within the dimer leading to an open monomer similar to what 
was observed in the asymmetric unit of the crystal structure. Consistent with these 
predictions, an isotopically 15N-labeled G537D mutant was more soluble than the wild 
type SAM tandem and demonstrated an 1H-15N HSQC spectrum with excellent dispersion 
while an isotopically labeled G607D mutant demonstrated poor solubility and was only 
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partially folded by a qualitative comparison of 1H-15N spectra with the wild type protein. 
Using the same NMR survey employed for the G537D mutant, a modest increase 
in solubility was also observed for a K540E mutant. This substitution is located one helical 
turn down from the previously described G537D mutant. The combination of the two tail 
substitutions, expressed as a G537D/K540E double mutant, produced synergistic increase 
in solubility. This double mutant permitted solution NMR studies to be performed at a 
high protein concentration (0.8 mM, ~15 mg/mL) and temperature (37 ˚C). Furthermore, 
the favorable solution characteristics of the G537D/K540E double mutant made an 
interesting counterpoint to the wild type protein for additional in vitro and in vivo studies. 
Given our success at breaking intermolecular contacts between dimers at the tail 
surface of SAM1, we also investigated an L589E mutant that was predicted to break 
contacts between dimers at the head surface of SAM2. 1H-15N HSQC spectra of 
isotopically labeled preparations of the L589E mutant presented the characteristic spectral 
dispersion of a folded and coupled SAM tandem but suffered from limited solubility 
similar to what we observed for the individual G537D and K540E mutants. 
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Figure 3. 3 – A comparison of the Caskin1 (PDB: 3SEI) and Caskin2 SAM domain 
tandem oligomers. Each SAM1-SAM2 tandem is colored individually, with SAM1 
represented by a darker shade. The repeating unit is boxed. All of the intra- and 
intermolecular SAM domain interactions shown follow a head-to-tail type interaction. The 
head surface is derived from helices 2, 3 and 4 while the tail surface is predominantly 
derived from helix 5. To the right of each structure is a schematic illustrating the 
interactions between head and tail surfaces. An asterisk denotes available head and tail 
surfaces. Note that the Caskin1 oligomer can only grow as a fibril in both directions while 
the Caskin2 oligomer can form a branched structure. 
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Figure 3. 4 – Detailed view of the complementary surfaces of the Caskin2 SAM 
tandem, following the same color scheme as Figure 3.3. (a) Cartoon representation of 
the five helices comprising each SAM domain, and the location of the complementary 
head (H) to tail (T) surfaces. The head surface is formed by contributions from helices 2, 
3, and 4. The tail surface is formed by contributions mainly from helix 5.                                 
(b) Intermolecular contacts between at the intra- and intermolecular head and tail surfaces 
are labeled. Boxes indicated amino acids selected for mutagenesis. 
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Figure 3. 5 – The linker interface in the Caskin2 SAM tandem dimer. As observed in 
the crystal structure of the domain swapped dimer, SAM1 and SAM2 are restrained by 
intra- and intermolecular hydrophobic interactions between W554 and Y558 (orange) in 
the linker region. This central interface is further defined by an ionic interaction between 
E565 (red) and R618 (blue). 
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Figure 3. 6 — Omit map of the Caskin2 SAM domain tandem linker region. A 
composite 2mFo-DFc omit map covering the linker (549-561) was calculated with Phenix 
1.10.1 (iterative removal of phase bias simulated annealing for low resolution structures). 
The map shown was contoured at 1.0σ. The SAM domains and the linker are colored 
separately for reference. Selected aromatic amino acids are labeled for reference. 
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3.3.4.  Structural Features of the G537D/K540E Double Mutant 
Since the G537D/K540E mutant was very soluble, a uniformly 15N/13C labeled 
sample was produced and studied by NMR methods. We had confidence that the SAM 
domain interactions were preserved because the 1H-15N HSQC spectra of the double 
mutant (at 0.8 mM) and wild type protein (at 0.01 mM) were superimposable (Figure 
3.7). From a set of conventional heteronuclear experiments acquired at 950 MHz, some 
backbone (HN, CA, CB, C) chemical shift assignments could not be made likely due to 
hydrogen exchange occurring at 37 ºC and pH 7.8 (Figure 3.8). Six of the thirteen 
backbone amide resonances in the linker region between the SAM domains could not be 
assigned suggesting it could be experiencing motions in the intermediate (µs-ms) 
timescale exacerbated by hydrogen exchange. Thus the data in solution appear to suggest 
that the linker in the G537D/K540E mutant is more flexible in contrast to the single 
conformation that observed in the wild type SAM tandem crystal structure. 
In the crystal structure, the C-terminal segment of helix 5 in SAM2 extends to 
G658 and makes contacts with a similar segment in another dimer. From the solution 
NMR studies of the G537D/K540E double mutant that suppresses oligomerization, helix 
5 is shorter, ending instead at L652 as evidenced by the absence of strong sequential 
backbone HN(i,i+1) NOEs from this position onwards. Building upon the G537D/K540E 
framework, a ∆620 C-terminal deletion mutant was expressed and 15N uniformly labeled.   
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Figure 3.7 — Comparison of wild type and double mutant SAM tandem proteins by 
NMR spectroscopy. Overlay of 1H-15N HSQC spectra acquired at 298 K of the wild type 
protein (green; 10 µM, 20 mM sodium phosphate pH 7.8, 300 mM NaCl) and 
G537D/K540E double mutant (red; 800 µM, 20 mM sodium phosphate pH 7.8, 150 mM 
NaCl). 
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Figure 3. 8 – Secondary structure of the Caskin2 SAM tandem by NMR and X-ray 
methods. Closed and open rectangles denote the five helices in each SAM domain. 
Triangles denote two surface exposed amino acids (G537, K540) whose substitution 
suppressed oligomerization. Black squares denote amino acids that could not be assigned 
in 950 MHz NMR spectra of a Caskin2 G537D/K540E double mutant. Ub denotes a 
ubiquitin site observed from a global proteomics survey of Caskin1 (Wagner et al., 2012). 
Δ653 identifies the site of a C-terminal truncation of the G537D/K540E double mutant to 
delimit the boundary of helix 5 in solution. In the sequence comparison with Caskin2, 
black boxes denote sequence similarity. Two red boxes denote differences between 
Caskin2 and Caskin1 that are predicted to reduce hydrophobic and ionic contacts at, and 
in the vicinity of, the linker region. 
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The 1H-15N HSQC of this deletion mutant was virtually indistinguishable from the 
parent G537D/K540E confirming that helix 5 is not only shorter in the oligomerization-
suppressed double mutant, and that the region from residue 653 onwards does not make 
any significant contributions to the SAM1-SAM2 fold. 
A series of 15N T1 and T2 relaxation rate measurements were made on a 13C,15N 
labeled sample of the G537D/K540E double mutant at high concentration (0.8 mM) at          
25 ºC. From the spectra, 49 non-overlapping resonances corresponding to structured 
regions of protein were selected for further analysis with an average 15N T1 and T2 rates 
of 1.55 ± 0.15 s and 0.064 ± 0.002 s, respectively. From the T1/T2 ratios of each 
observation, an average correlation time of 13.2 ± 1.1 ns was determined. In terms of 
molecular weight, this correlation time corresponds to an isotropically tumbling protein 
of 29 ± 2 kDa. To put this observation in context, the monomeric molecular weight of the 
6xHis tagged SAM1-SAM2 tandem is 20.4 kDa, and if the unstructured amino- and 
carboxy termini are ignored, the remaining 140 aa. contribute 15.7 kDa. Thus, the 
correlation time suggests that the SAM tandem in solution has characteristics of a protein 
assembly larger than a monomer, upwards to a dimer. 
3.3.5.  Monomer-Dimer Equilibria of the Wild Type SAM Tandem and an 
Oligomerization Suppressed Double Mutant 
The oligomerization state of the wild type Caskin2 SAM tandem is affected by 
temperature, protein concentration and ionic strength. In our early NMR studies, a 
transition to the oligomer occurred at concentrations near the practical limit of the 
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technique (~50 µM) leading us to pursue a structure-directed G537D/K540E double 
mutant that was resistant to oligomerization. However, we observed differences in the 
linker and helix 5 of SAM2 leading us to consider the possibility that the mutations 
affected the equilibrium between the monomeric and dimeric states. A solution of the 
G537D/K540E double mutant structure was not pursued because the observed correlation 
time suggested that there could be two indistinguishable states — a compact monomer 
similar to Caskin1 crystal structure (Stafford et al., 2011) and a dimer similar to the 
Caskin2 crystal structure presented in this study. 
To complement and extend these initial observations at high concentrations, a 
series of analytical ultracentrifugation / sedimentation velocity (AUC-SV) experiments 
were performed at two low concentrations (10 µM and 34 µM) and two ionic strengths 
(150 and 300 mM NaCl). AUC-SV is particularly well suited for studying mass action 
driven reversible associations and detecting subtle changes in thermodynamic behavior. 
Representative diffusion corrected sedimentation profiles shown in Figure 3.9 
clearly demonstrate that the wild type Caskin2 SAM tandem responds to mass action, 
while the G537D/K540E double mutant does not. In other words, as the concentration 
increases, oligomerization of the wild type SAM tandem increases and the diffusion 
corrected sedimentation distributions shift towards higher values. As we initially observed 
during crystallization trials, salt concentration was also observed to promote 
oligomerization in the analytical ultracentrifuge, with the highest protein and salt 
concentrations producing an additive effect. Quantitative Kd values and anisotropy 
information were obtained by fitting AUC-SV experiments from the 34 µM experiments 
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to reversibly self-associating monomer-dimer equilibrium models using a genetic 
algorithm (Demeler et al., 2010). Only the higher concentration experiments were fitted, 
since these experiments cover a larger concentration range and therefore contain more 
signal, covering both monomer and dimer species with higher confidence. Since AUC-
SV experiments produce a moving boundary which extends from zero concentration to 
the loading concentration (34 µM, in this case), reversibly self-associating systems will 
display a reaction boundary where the ratio of monomer to oligomer changes from 100% 
monomer near zero concentration towards increasing amounts of the oligomeric species 
at the higher loading concentration. Fitting the entire reacting boundary shape with finite 
element solutions of the Lamm equation for reacting systems (Cao and Demeler, 2008) 
then permits an accurate determination of the equilibrium constant. All AUC-SV 
experiments produced excellent fits with RMSD values comparable to the more 
degenerate 2DSA fits. The Kd values for all four measurements are summarized in Table 
3.2. These results clearly show that the Kd determined for the double mutant far exceeded 
the loading concentration, suggesting essentially monomeric composition. The Kd of the 
double mutant at 300mM NaCl concentration is approximately three-fold higher than the 
loading concentration, indicating that even under high salt conditions there is only 
negligible self-association. Thus, the AUC-SV study provides convincing evidence that 
the oligomerization deficient mutant G537D/K540E at a 34 µM concentration and below 
is a compact monomer.  
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Figure 3. 9 – Van Holde - Weischet integral G(s) sedimentation coefficient 
distributions for Caskin2 at 10 µM (wild type, blue; G537D/K540E double mutant, 
cyan) and 34 µM (wild type, green; G537D/K540E double mutant, red) loading 
concentrations. Panels (a) and (b) were measured at 150 mM NaCl, while panels (c) and 
(d) were measured at 300 mM NaCl. A shift in sedimentation coefficient for higher 
concentrations indicates reversible mass action. This effect is only seen for the wild type, 
not for the double mutant. Furthermore, the effect is enhanced at higher ionic strength, 
indicative of a decrease in K d for the wild type. These results indicate that the double 
mutant only exists in a monomeric form at low concentration, while the wild type SAM 
tandem dimerizes and is more sensitive to changes in ionic strength.  
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Table 3. 2 – Monomer-dimer equilibrium constants for wild type Caskin2 SAM1-
SAM2 and an oligomerization-inhibited double (G537D/K540E) at two NaCl 
concentrations. 
 
Values in parentheses represent the 95 % confidence intervals obtained from a genetic-algorithm Monte 
Carlo analysis. φ represents the anisotropy of the molecule, with a value close to 1.0 indicating a more 
compact and globular structure, while increasingly larger values reflect more extended shapes. Since the 
dimer concentration of the G537D/K540E mutant is negligible, the anisotropy of the dimer was not 
calculated. A Kd for the G537D/K540E mutant at 150 mM NaCl could not be detected (n.d.) because the 
sample was essential monomeric. 
 
 
 
A comparison of the anisotropy values from the AUC-SV analysis indicate that 
the monomeric and dimeric forms of the wild type SAM tandem are similarly compact 
(Table 3.2). The anisotropy values also indicated that G537D/K540E double mutant 
monomer is slightly more compact than the wild type SAM tandem reinforcing the 
observations from the NMR investigation that the double mutant and wild type SAM 
tandems have structural differences. 
 
 
   150 mM NaCl 300 mM NaCl 
Wild type    
 Kd (µM) 52.9 (49.3, 56.5) 27.6 (26.8, 28.3) 
 φ (monomer) 1.25 1.27 
 φ (dimer) 1.28 1.25 
G537D/K540E    
 Kd (µM) n.d. 99.8 (98.9,100.7) 
 φ (monomer) 1.14 1.02 
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3.3.6.  Expression of the Caskin1 and Caskin2 SAM Domain Tandems in Neuro2a 
Cells 
To begin understanding how oligomerization may affect cellular processes, we transfected 
EGFP fusions of wild type Caskin2 SAM tandem (EGFP-WT) and the non-oligomerizing 
G537D/K540E mutant (EGFP-G537D/K540E) into Neuro2a cells. We chose to express 
only the SAM tandems to visualize their effect independently from the other protein 
interaction domains (ankyrin and SH3) in the amino terminal region and other unknown 
interaction motifs in the carboxy terminal region of Caskin2. From a series of micrographs 
analyzed, one representative set is shown in Figure 3.10a. Both EGFP-WT and EGFP-
G537D/K540E were observed throughout the cell, including the nucleus. Nuclear 
localization by diffusion is possible since the molecular weight of the EGFP-Caskin2 
SAM tandem is ~50 kDa. While the fluorescence distribution was relatively uniform for 
the G537D/K540E mutant, fluorescence was concentrated in dense punctae for the wild 
type protein. The same expression assay under similar conditions was performed with the 
EGFP-tagged Caskin1 SAM tandem and an analogous double mutant G520D/K523E to 
the Caskin2 G537D/K540E double mutant features in this study (Figure 3.10b). While 
we did not perform an in vitro study to confirm that the Caskin1 mutant was 
oligomerization-suppressed, it is worth noting that a Caskin1 G520E single mutant 
described in (Stafford et al., 2011) was sufficient on its own. 
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Figure 3. 10 – Caskin2 and Caskin1 SAM domain expression in Neuro2a cells. Images 
were made 48 h after transient transfection with (a) Caskin2-EGFP (wild type) and mutant 
Caskin2 (G537D/K540E)-EGFP (b) Caskin1-EGFP (wild type) and mutant Caskin1 
(G520D/K523E)-EGFP plasmids. The green fluorescence demonstrates distinct protein 
distributions for the wild type and mutant proteins. Counterstaining with DAPI (blue) 
reveals that the subcellular distribution of wild type and mutant proteins in the cytoplasm 
and nucleus is indistinguishable. Scale bar: 5 µm. Western blots of cell lysates 
demonstrating expression of EGFP-Caskin2 and EGFP-Caskin1 proteins probed with 
monoclonal anti-EGFP antibodies presented on the left side of the panels. The blots were 
re-probed with monoclonal anti-β-actin antibodies as a loading control.  
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Consistent with our observations for the Caskin2 SAM tandem, the Caskin1 SAM 
tandem double mutant was distributed throughout the cytoplasm and nucleus, and the wild 
type Caskin1 SAM tandem formed punctae. The punctae, however, were distinct from the 
Caskin2 SAM tandem, appearing not as condensed speckles, but rod-like structures 
throughout the cell. In summary, this in vivo expression study is consistent with our 
observations from crystallography — the Caskin2 and Caskin1 SAM domains self-
associate differently and consequently present a different oligomeric architecture. The 
differences in the morphology of the aggregates cannot be explained by variances in 
concentration since both SAM tandems were expressed at approximately the same levels 
as an actin control. 
3.4.   Discussion 
We have presented data from a set of complimentary sources (X-ray 
crystallography, NMR spectroscopy, analytical ultracentrifugation, and in vivo 
expression) demonstrating that the Caskin2 SAM tandem experiences concentration and 
salt dependent oligomerization. While the Caskin2 SAM domain crystal structure presents 
a series of head-to-tail contacts that are typical for most self-associating SAM domains, 
the manner in which the oligomer is organized as a repeating set dimers is new and distinct 
from Caskin1. 
Analysis of the AUC-SV data suggests that the wild type Caskin2 SAM tandem is 
in a reversible monomer-dimer equilibrium at low concentrations (10-34 µM). In contrast, 
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the oligomerization suppressed G537D/K540E double mutant is essentially monomeric 
with the dimeric form only beginning to become apparent at high (>500 µM) 
concentrations. This difference between the wild type and double mutant proteins is 
qualitatively apparent in the magnitude of the shifts and shapes in sedimentation 
distributions. From these data and prior knowledge of the system, a quantitative approach 
using discrete reversible monomer-dimer equilibrium models were justified to determine 
a Kd of the wild type SAM tandem from the SV data directly at two ionic strengths. 
Consistent with the crystallization conditions, ionic strength enhanced dimerization for 
the wild type SAM tandem and to a much lesser extent for the G537D/K540E double 
mutant. 
The Kd of the Caskin2 SAM tandem is well suited to the anticipated levels of the 
protein at synaptic sites and is within the realm of other signaling domains such as SH3 
and WW domain that must rapidly sample ligands to fulfill their biological functions. At 
low concentrations, Caskin2 in its monomeric or dimeric form could serve as a classical 
adaptor bringing protein partners together (Figure 3.11). Furthermore, dimeric Caskin2 
may help activate associated proteins that depend upon dimerization. At higher 
concentrations, oligomeric Caskin2 could provide the increased avidity to concentrate and 
amplify low affinity protein partnerships that would otherwise be suppressed. 
Along with concentration, ionic strength can contribute to oligomerization, 
although it is unclear if cation fluxes associated with neuronal signaling are sufficient to 
serve a regulatory role. Pursuing this idea, we did observe a series of hydrophobic contacts 
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in the central portion of the linker region supported by ionic contacts from the nearby 
SAM domains. In an analogous interaction mode to Caskin2 domain-swapped dimer, 
hydrophobic interactions dominate in Byr2-SAM / Ste4-SAM (Ramachander et al., 2002; 
Ramachander and Bowie, 2004) and Ste11 / Ste50 (Kwan et al., 2006) heterodimer 
interface with peripheral support from charged / polar residues. Likewise, Ph (Kim et al., 
2002), TEL (Kim et al., 2001) and Yan (Qiao et al., 2004) homo-oligomers and Ph / Scm 
(Kim and Kim, 2005) hetero-oligomers assemble around a central hydrophobic cluster in 
the central head-tail interface supported by number of peripheral electrostatic interactions. 
An examination of the Caskin2 and Caskin1 sequences suggests that these contacts would 
not be preserved thereby providing a possible explanation for why the minimal repeating 
unit of Caskin1 is a compact monomer while the minimal repeating unit of Caskin2 is a 
dimer. Furthermore, since ionic contacts are involved, salt concentration and pH may also 
serve a role at mediating Caskin2 dimerization and oligomerization. Indeed, as salt 
concentration increases, the Kd describing the monomer-dimer equilibrium increases. The 
precise effects of salt concentration could be complex as charges are screened and 
hydrophobic effects begin to predominate. 
The high concentration of sodium formate used to promote crystallization 
represents the extreme effect where the protein is essentially salted out of solution. While 
our investigation was limited to only two NaCl concentrations (0.15 and 0.3 M) and one 
pH, we refer the reader to a survey of the EphA2 / SHIP2 SAM domain heterodimer for a 
comprehensive perspective of ionic interactions using NMR methods and molecular 
modeling (Lee et al., 2012).  
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Figure 3. 11 – Signaling consequences of dimerization and oligomerization by the 
tandem SAM domains of Caskin2. In its oligomeric form, Caskin2 would provide a vast 
array of interaction sites with enhanced avidity for many proteins through its available 
intrinsically unstructured regions and ankyrin repeats. In its dimeric form, Caskin2 could 
fulfill a classic adaptor role bringing together protein partners that potentially depend on 
dimerization themselves for coupling and activation. 
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EGFP-tagged Caskin2 SAM1-SAM2 protein was observed as punctae when 
expressed in Neuro2a cells. This distinctive pattern is very similar to what has been 
reported for the oligomeric form of the Dishevelled DIX domain (Fiedler et al., 2011; 
Schwarz-Romond et al., 2007). Although they were less apparent, punctae were also 
observed in micrographs of GFP-tagged diacylglyercol kinase d1 (DGKδ1), facilitated by 
the Zn(II) dependent oligomerization of its single SAM domain (Harada et al., 2008; 
Knight et al., 2010). Mutations in the DGKδ1SAM domain that either abolished Zn(II) 
binding or inhibited oligomerization resulted in disappearance of punctae and 
translocation of DGKδ1 to the plasma membrane. Supplementing the structural study of 
the Caskin1 SAM tandem, transfections of GFP-tagged full length Caskin1 were 
performed in HEK293 cells with the majority of fluorescence observed in the cytoplasm 
along with some higher intensity speckles near the nucleus (Stafford et al., 2011). To 
enable a consistent comparison with the results presented in this study, the Caskin1 SAM 
domain tandem and oligomerization inhibited double mutant were expressed in Neuro2a 
cells under similar conditions (vector, fluorescent reporter, protein levels) as the Caskin2 
SAM tandem. As shown in the micrographs, there was a striking difference in the 
morphology of the aggregates. Taken together with the crystal structures, the Caskin2 and 
Caskin1 SAM domains appear to oligomerize differently in vitro and in vivo. The 
biological consequences of this difference may reflect the divergent roles that each protein 
plays in the neuron.  
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If Caskin2 oligomerization is an essential aspect of its neuronal signaling function, 
it stands to reason that there should be ways to regulate oligomerization that supersede 
solution conditions such as protein concentration, pH, and divalent ion concentration 
(Gundelfinger et al., 2006; Knight et al., 2010). Post-translational modifications and 
protein partner binding (Qiao et al., 2004) offer targeted opportunities to affect the 
oligomerization process, by repressing the formation of oligomers or by facilitating the 
disassembly of oligomers. While no biological process that regulates Caskin2 has been 
identified to date, a global mass spectrometry survey identified a ubiquitinated lysine 
(K536) in Caskin1 at the same oligomerization surface as the G537D/K540E mutants 
described in this study (Wagner et al., 2012). Ubiquitination may possibly block the 
formation of oligomers in an analogous manner that has been reported for the Dishevelled 
DIX domain (Madrzak et al., 2015) and incorporate this neuronal signaling scaffolding 
protein into other signaling and translation pathways in the neuron.  
In conclusion, sterile alpha motif (SAM) domains are versatile protein-protein 
interaction modules. Using the Caskin2 scaffolding protein as a focus of this investigation, 
we have demonstrated that its SAM domain tandem is able to sample monomeric, dimeric, 
and oligomeric states. Given the structural distinctiveness of these states, Caskin2 has the 
potential to support many different functions in neuronal signaling circuits.  
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_______________________________________________________________________ 
4.  CHAPTER 4: 
CASKIN2 PARTNERSHIP WITH THE LEUKOCYTE 
COMMON ANTIGEN RELATED PROTEIN TYROSINE 
PHOSPHATASE RECEPTOR (LAR)  
_______________________________________________________________________ 
 
4.1.   Introduction 
 Neurons generate new synapses through complex neuronal adhesion events 
that involve the assembly of receptors, channels, pre- and postsynaptic signaling scaffolds. 
Stabilization and maturation of newly created synaptic sites greatly rely on the cell 
adhesion molecules (Um & Ko, 2013). In addition to serving as a platform for neuronal 
connections, synaptic adhesion molecules are key participants in the development of long-
term potentiation and synaptic plasticity (Um & Ko, 2013). Two studies functionally link 
the LAR receptor tyrosine phosphatase protein family to neuronal system development in 
both vertebrates and invertebrates (Chagnon, Uetani, & Tremblay, 2004; Xu & Fisher, 
2012). Most recently, their role as major synaptic adhesion molecules has been proposed 
(Han, Jeon, Um, & Ko, 2016; Um & Ko, 2013). Identification and characterization of 
intra- and extracellular ligands of LAR PTPs is crucial for understanding the outcomes of 
distinct signaling pathways and the connections between them.  
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The LAR PTP family includes three vertebrate (LAR, PTPδ and PTPσ) and two 
fly homologs (Dlar and DPTP69D). Weng et al. (2011) reported that Drosophila Csk 
directly interacts with Dlar via an N-terminal SAM domain and connected this partnership 
to a motor axon pathfinding. The same group had demonstrated via a yeast two-hybrid 
assay that both the tandem SAM domain of mouse Caskin ortholog as well as the full-
length protein preferentially interacts with two murine LAR receptor family members, 
LAR and PTPσ, but not with PTPδ.  Other multidomain proteins of Liprin family have 
been reported to interact with the D2 domain of LAR through their triple-SAM domain 
module (Astigarraga et al., 2010; Serra-Pagès et al., 1995; Serra-Pagès, Medley, Tang, 
Hart, & Streuli, 1998; Spangler & Hoogenraad, 2007; Stryker & Johnson, 2007). 
Liprin/LAR complexes have been functionally linked to presynaptic active zone 
organization and synaptic maturation in C. elegans and Drosophila (Dai et al., 2006; Patel 
et al., 2006; Spangler & Hoogenraad, 2007; Taru & Jin, 2011). The fact that Liprin-α and 
Ckn cannot simultaneously bind LAR (Weng et al., 2011a) suggests that they might target 
a common or overlapping binding site on LAR. The competitive nature of 
Caskin/Liprin:LAR interactions suggests the possibility of very distinct signaling 
outcomes of these complexes. 
The research presented here demonstrates the evidence that the interaction is 
preserved between human orthologs of LAR and Caskin2. Experimental evidence (Spot 
blot analysis, in vitro co-immunoprecipitation) suggests that it takes place at the second, 
catalytically inactive, domain of LAR and the SAM2 domain of Caskin2. The interaction 
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between wild type Caskin2 SAM1 SAM2 and LARD1D2 was further characterized by 
fluorescence anisotropy methods establishing a stoichiometric ratio (1:1) with a 
dissociation constant of 1.1 ± 0.4 µM (n = 4). Following in vitro studies, proteins were 
co-expressed in neuroblastoma cells (Neuro2a) and visualized by confocal microscopy 
demonstrated strong co-localization between EGFP-Caskin2 SAM1 SAM2 and dsRED-
LARD1D2/D2 fluorescent fusion constructs. 
4.2.   Materials and Experimental Procedures 
4.2.1.  Peptide array synthesis and experimental procedures 
An array of 12-mer peptides was synthesized and anchored on the cellulose membrane as 
previously described in the SPOT method (Frank, 2002) with an Intavis MultiPep 
synthesizer. As a synthesis quality control check of synthesis, a crude estimate of the 
peptide content in each spot was made by staining with Fast Green FCF dye. The peptide 
array membrane was washed three times in phosphate-buffered saline with Tween-20 
buffer (PBS/T buffer composition: 3.2 mM Na2HPO4, 0.5 mM KH2PO4, 1.3 mM KCl, 
135 mM NaCl, and 0.1% Tween 20, pH 7.4) prior to blocking with Blocking Buffer (5% 
milk, 2.5% BSA in PBS/T) at 4 ˚C overnight. The membrane was probed with 1µM of 
protein of interest in PBS (1 hr incubation at RT on the orbital shaker) and followed by 
removal of unbound protein by three PBS/T washing steps and pre-blocking with 
Blocking Buffer before the final 1 hour incubation with horseradish peroxidase (HRP)-
conjugated antibody diluted to 1:5000 in Blocking Buffer. The membrane was washed 
five times in PBS/T before the development with ECL chemiluminescence reagents (ECL 
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Western blotting analysis system, Amersham) and imaging on the X-ray film. In cases 
where membrane was re-probed, it was regenerated with 6M guanidinium hydrochloride: 
0.5M imidazole solution. 
4.2.2.  Co-IP and immunoblotting  
Immunoprecipitation experiments with FLAG-H6-LARD1D2 and His6-Caskin SAM1 
SAM2 and GST-tagged single SAM domain constructs were performed in two modes 
using GST sepharose beads (Clontech) and anti-FLAG-Ab-conjugated magnetic beads 
(Sigma-Aldrich). The batch binding technique was generally used for both types of pull-
downs with the difference that the centrifugation was used in the case of GST beads and 
a magnetic separator for anti-FLAG beads for separation steps. Twenty microliters of 
packed gel volume of anti-FLAG M2 (equivalent to ~40µL of 50% bead suspension) and 
250μL of GST bead suspension per reaction according to manufacturer's recommended 
protocols were used. Prior to the protein binding step, the resin was washed three times 
with 10x packed gel volumes of TBS (50 mM Tris-HCl, 150 mM NaCl, pH 7.4) buffer. 
After removing the buffer, the appropriate protein was added to the beads and allowed to 
bind by inverting for 20 minutes at room temperature. Beads were separated from 
supernatants (gentle centrifugation at 3000 rpm or in magnetic separator) following by 
three washes with TBS buffer. The appropriate presumptive interacting protein was added 
to the beads (either purified or freshly made pre-cleared protein lysate) and allowed to 
bind by inverting for 1hr at RT. The supernatants were removed and the beads were 
washed with TBS buffer at least three times. After removing the buffer, protein complexes 
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were eluted using 150-200μl of glutathione buffer (pH 7.8) or 2xSDS loading dye from 
GST and anti-FLAG resin respectively. Samples were separated on a 4-20% SDS-PAGE 
gel (BioRad) and transferred to PVDF or nitrocellulose membrane using the Trans-Blot 
Turbo transfer system (BioRad) and the Trans-Blot Turbo mini transfer packs (BioRad) 
for immunodetection. The membrane was pre-blocked overnight at 4 ºC in Blocking 
Buffer (5% milk, 2.5% BSA in PBS/T) to minimize the nonspecific signal background. 
Primary antibodies, Anti-H6-rabbit (Santa Cruz) and anti-GST-mouse (Sigma-Aldrich), 
were used at the 1:4000 dilution, followed by probing with secondary antibodies for 
detection; goat-anti-mouse IRDye800CW and donkey-anti-rabbit IRDye680LT (LI-COR 
Biosciences) at 1:20000 dilutions. Signals for IRDyes were detected using the Odyssey 
Infrared Imaging System (LI-COR Biosciences).  
4.2.3.  Fluorescence anisotropy titrations 
Labeling method: A maleimide dye conjugation reaction was performed in accordance 
with the Invitrogen recommended protocol “Thiol-Reactive Probes” in PBS buffer (pH 
7.5) The stock solution of the maleimide dye BODIPY® FL (N-(2-Aminoethyl 
Maleimide, B10250) (Thermo Fisher Scientific) was freshly prepared before labeling at a 
concentration of 0.5mg/µL in anhydrous DMSO. Purified Caskin SAM2/SAM1-SAM2 
protein was prepared in phosphate buffered saline (PBS) buffer: 20 mM sodium 
phosphate, pH 7.5, 0.15 M NaCl. At pH 7.5 the cysteine free thiol (sulfhydryl) group 
readily reacts with the maleimide dye forming a stable thioether bond.  
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Labeling chemistry reaction:  
 
The dye was added to the protein at 20-fold molar excess and incubated for at least 2 hours 
at RT protected from light. The reaction was quenched with an excess of glutathione and 
protein was dialyzed overnight at 4 ºC into the assay buffer (PBS, pH 7.8) to eliminate the 
excess of unbound dye and glutathione. The protein conjugate was stored at 4 ºC protected 
from light.  
Fluorescence titration procedure: Labeled 6xHis-Caskin SAM SAM and SAM2 (at 0.5 
µM) and unlabeled 6xHis-LARD1D2 at a concentration range of 38 nM to 19 µM were 
used for fluorescence anisotropy binding studies at 25 ºC using an Agilent Eclipse 
spectrophotometer equipped with a manual polarizer accessory. Excitation/emission 
signals were measured at 496/516 nm wavelengths with an averaging time of 0.25 sec 
with three reading replicates for each sample. Anisotropy was calculated from the 
relationship (Iparallel–GIperp)/(Iparallel/2GIperp) and normalized with the blank experiment and 
to the maximum fluorescence change (F/Fmax). The final plot was generated using the 
Prism 7 graphing program (GraphPad Software Inc.).  The equilibrium dissociation 
constant (Kd) was calculated by fitting the averaged data set (n=4) directly using nonlinear 
least squares analysis plugin within the Prism 7 program. 
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4.2.4.  Cloning and site-directed mutagenesis, protein expression and purification 
EGFP and dsRed constructs were sub-cloned from Caskin2 SAM1-SAM2 tandem in 
pET28 (483-634; Uniprot Q8WXE0) (Novagen) and LARD1D2 in pD441-NF (DNA 2.0).  
The fusion proteins were prepared by inserting a suitable PCR product into the XhoI/KpnI 
restriction sites of the pEGFP-N1 and pDsRed-monomer (Clontech) expression vectors. 
Followed by the transformation into DH5α cells, amplification and DNA extraction was 
performed for further use in mammalian cells. The C-terminal deletion 
ΔCSS[G70D/K73E] in pET28b plasmid was generated by site-directed mutagenesis from 
the Caskin2 SAM1-SAM2 G537D/K540E (pET28b) clone using the Quikchange 
Lightning kit (Agilent Technologies). All plasmid constructs were sequence verified 
(TCAG DNA Sequencing Facility, Hospital for Sick Children, Toronto). pET28b 
plasmids were transformed into E. coli BL21:DE3 for 6xHis-tagged protein expression. 
Transformed E. coli BL21:DE3 were grown at 37 ºC in LB (or M9 minimal media for 
NMR samples) until the exponential phase (OD600 of 0.7-0.8). Protein expression was 
induced with the addition of 1 mM IPTG and further incubation for another 3 hours at 37 
ºC. In the case of His6-FLAG-LARD1D2, the highest levels of expression were achieved 
in Arctic express DE3 cells with an overnight induction at 13 ºC. Cell pellets were 
dissolved in T300 buffer (20 mM Tris-HCl, 300 mM NaCl, 0.05 % NaN3) and lysed by 
French press. Highly purified protein was obtained from a two-step purification involving 
Nickel-NTA affinity chromatography (Qiagen), followed by gel filtration 
chromatography (Sephacryl-100, HiLoad 16/60; GE Life Sciences). GST-tagged proteins 
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were purified using a glutathione sepharose column (Sigma-Aldrich) with elution buffer 
containing 10mM glutathione, pH 7.8 in T300 buffer. All bacterial expression constructs 
included a thrombin protease cleavage sequence located N-terminally of the protein 
sequence. Proteins were liberated from the GST tag when required depending on the 
experiment, reverse purified and dialyzed into the final buffer. Protein purity was assessed 
by SDS-PAGE chromatography.  The final buffer for NMR analyses was phosphate 
buffered saline (PBS): 20 mM sodium phosphate, pH 7.8, 0.15 M NaCl, 0.05 % (w/v) 
NaN3.   
4.2.5.  Cell culture, transient transfection, coexpression and immunoblotting   
Neuroblastoma 2a (Neuro2a) cells (Olmsted et al., 1970) were maintained using standard 
growth conditions and used for expression and localization studies as described in 
(Prochnow, Hoffmann, Dermietzel, & Zoidl, 2009). Cells were seeded in 24-well plates 
or glass-bottom dishes (MatTek Corporation, Ashland, MA, USA) and transfected with 
200 ng (single transfection) or 400ng (double transfection) endotoxin-free plasmid DNA, 
using the Effectene transfection protocol (Qiagen Inc., Valencia, CA, USA). Whole cell 
protein lysates from transfected Neuro2a cells collected 48 h post-transfection were 
separated by 10 % SDS-PAGE and transferred to 0.2 μm Hybond-ECL nitrocellulose 
membrane (GE Life Sciences) for immunodetection. Primary antibodies were diluted 
1:1000 (rabbit anti-GFP; Santa Cruz) and 1:20000 (mouse anti-β-actin; Sigma-Aldrich). 
Secondary antibodies (LI-COR Biosciences) were diluted 1:20000 (donkey anti-rabbit 
IRDye680LT) or 1:20000 (goat anti- mouse IRDye800CW). Signals were detected using 
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the Odyssey Infrared Imaging System (LI-COR Biosciences).  
4.2.6.  Confocal microscopy  
Transfected cells were fixed with 4% paraformaldehyde for 20 min at room temperature, 
washed with PBS, counterstained with DAPI and mounted for imaging. Samples were 
visualized using a Zeiss LSM 700 confocal microscope with a Plan-Apochromat 63x/1.4 
Oil DIC M27 objective and the ZEN 2010 program to control all hardware parameters. 
Images were collected by line averaging (4x) at high resolution (2048x2048 pixel) using 
single planes or z-stacks. Mander’s overlap coefficients were calculated using the built-in 
co-localization analysis tools in the ZEN 2010 program (Manders & Tyberghein, 1993). 
Ten random cells from each co-transfection data set were used for overlap coefficient 
determinations. Images were combined in Adobe Illustrator CC for presentation.  
4.3.   Results 
4.3.1.  A search for putative interaction surfaces on Caskin SAM-SAM and LARD2 
To identify the interaction surfaces a synthetic peptide blotting method (SPOT 
blot) was used. A 12-mer peptide array covering the Caskin2 tandem SAM domain amino 
acid sequence with a three amino acid shift window was probed for interaction with 
LARD2. Two surface exposed regions on the second SAM domain were detected (Figure 
4.1a). The first consensus sequence (103)L-G-L-P-Q-Y-H-K(110) highlighted in green 
(Figure 4.1b, c) covers the end of helix 1 and the portion of helix 2 plus the short loop 
between them, with a basic Lys110 protruding into solution. The second detected 
123 
sequence (150)R-L-A-E-L-R-R-G(157), highlighted in a darker orange shade, comprises 
the core of the helix 5 within SAM2 (Figure 4.1b, c). Note that helix 5 is not involved in 
the dimerization interface and is solvent exposed in either form of Caskin, dimeric or 
monomeric. In addition to cMyc-His6-LARD2 protein, the membrane was also tested with 
GST-LARD2 and GST-LARD1D2 protein constructs revealing the same peptide regions 
(data not shown). The complementary peptide array was produced with two amino acid 
sliding sequence window covering the entire sequence of LAR D2 domain (Figure 4.2), 
based on the Drosophila ortholog sequence (GenBank ID: AAC47002.1).   
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Figure 4. 1 – Peptide SPOT array analysis of the interaction between LARD2 and 
Caskin SAM1 SAM2. (a) The array comprising SAM1-SAM2 domain sequence of 
Caskin2 with three amino acid shift window probed with cMyc-His6-LARD2. The 
resulting positive peptide sequences detected with His6-HRP-conjugated antibody listed 
in (b) panel and consistently highlighted in green and orange color in all panels including 
the spherical molecular representation of SAM tandem structure (c) The eight core amino 
acids identified as consensus sequences are colored in darker shades and six flanking 
residues are colored in lighter shade of green and orange. Four additional, unboxed, spots 
are positive control peptides composed of 6xHis flanked by 3xAla on either side.  
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Figure 4. 2 – Peptide SPOT array of LARD2 sequence tested with Caskin SAM1 SAM2.      
(a) Spherical representation of the LAR D2 domain with regions identified by spot blot experiment 
colored in purple and red consistent with a panel (b) showing the LARD2 peptide array probed 
with His6-Caskin SAM1 SAM2 detected with His6-HRP-conjugated antibody as well as a positive 
control experiment where the array was probed with His6-HRP antibody only. Resulting consensus 
sequences H-C-S-A-G-V-G-R (red) and C-F-Q-Y-W-P-H-E-R-S-V-R (purple) are indicated on 
the blot. (c) Sequence alignment of LAR D2 domains from different organisms. Highlighted 
regions corresponding to fully conserved regions within sequences identified by SPOT blot 
analysis. Additionally, a WPE-loop of D2 domain is highlighted. It corresponds to WPD-loop 
associated with (pY)-peptide binding cleft in the catalytically active D1 domain. An alignment was 
performed using Clustal Omega multiple protein sequence alignment program 
(http://www.ebi.ac.uk/Tools/msa/clustalo/). UniProtKB sequence IDs: P18052 LAR D2 (Mus musculus), 
P10586 LAR D2 (Homo sapiens), P16621 Dlar (Drosophila melanogaster).  
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Likewise, two distinct surfaces of the LARD2 domain demonstrated binding 
affinity for Caskin SAM1 SAM2 wild type. The signal detected for the consensus 
sequence H-C-S-A-G-V-G-R (colored in red) was relatively stronger than for the other: 
C-F-Q-Y-W-P-H-E-R-S-V-R (colored purple) (Figure 4.2a, b). Additional experiments 
with G70A, K73E and G140A mutant versions of the Caskin2 tandem SAM domain 
produced similar results (data not shown).  
The LAR SPOT blot result was followed up with an NMR-based titration of Caskin 
SAM1 SAM2 with an 11 amino acid-long synthetic peptide, REKCFQYWPHERSVR 
(CanPeptide, Montreal QC), corresponding to the “purple” SPOT blot sequence derived 
from Dlar (Drosophila ortholog) protein. The peptide was titrated up to 10-fold molar 
excess into the 15N Caskin2 SAM1-SAM2 protein and monitored by 15N-HSQC spectra 
(data not shown). The experiment demonstrated moderate signal broadening, but no 
significant chemical shift changes were observed, suggesting the absence of the 
interaction or possibility of very weak interaction. 
The plausible binding sequence derived from helix five of Caskin SAM2 domain 
(151)R-L-A-E-L-R-R-G(158) (Figure 4.1c - orange) was tested as a candidate for LAR 
D1D2 interaction site. The rationale for choosing this sequence over the other was its 
location within a surface-exposed finger-like helix. A significant portion of the C-terminal 
end of helix 5 does not contribute to the SAM1-SAM2 intramolecular interface that 
stabilizes the domains, neither is it involved in the intermolecular 
dimerization/oligomerization interface. The C-terminal deletion version was sub-cloned 
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of more soluble and stable Caskin2 SAM1 SAM2 [G70D/K73E] mutant using Side 
directed mutagenesis (SDM) method, with truncation ending at -R-L-A*.  This last portion 
of the α-helix is involved in intense hydrogen bonding network and indispensable for 
SAM2 domain overall structural fold and stability. The new construct was verified by 
sequencing and named C-term ΔCSS[G70D/K73E]. The IP experiments on GST and 
FLAG antibody-conjugated agarose beads (data not shown) revealed that the truncated 
construct ΔCSS[G70D/K73E] was able to recruit the LARD2 protein similarly to the wild 
type. 
In order to further test the hypothesis that D2 domain of LAR is recognized by 
SAM2 domain of Caskin2 in vitro immuno-precipitation (IP) experiments were applied. 
FLAG-H6-LARD1D2 was immobilized on highly specific FLAG beads and tested with 
single and tandem Caskin2 SAM domain constructs.  Selected experiment presented in 
Figure 4.3. The reverse pull-down experiments were performed with immobilized GST-
tagged Caskin2 protein constructs incubated with LARD1D2 and confirmed the SAM2 
domain of Caskin2 as the interaction domain (Figure 4.4). The appropriate negative 
control experiments were performed to demonstrate the absence of nonspecific binding of 
LAR to GST-tag or GST-conjugated resin. Additional co-IPs to test LARD1D2 against 
various mutant versions of Caskin2 with amino acid alternations targeting the 
oligomerization interface: CSSG70A, CSSK73E, CSSG140A and CSS[G70D/K73E] 
were performed. All assessed mutants were shown to co-elute with LARD1D2 (data not 
shown) leading to the conclusion that Caskin2 oligomerization interface is not involved 
in the interaction. 
128 
 
 
 
 
 
 
 
 
 
Figure 4. 3 – FLAG Immunoprecipitation. IP experiments with purified recombinant 
FLAG-H6-LARD1D2 protein immobilized on the anti-FLAG-Ab-conjugated magnetic 
beads (Sigma-Aldrich) incubated with H6-Caskin2 SAM1-SAM2 WT (purified) and GST-
Caskin2 SAM2/SAM1 protein lysates. Experimental, negative control and loading control 
samples were transferred to Western blots. Double primary, Anti-H6-rabbit and anti-GST-
mouse antibodies, followed by IR-800-anti-rabbit and IR-600-anti-mouse secondary 
antibodies respectively were used for the detection and imaging with Odyssey infrared 
imager. H6-Caskin2 SAM1-SAM2 WT and GST-Caskin2 SAM2 co-eluted with 
LARD1D2 protein, whereas GST-Caskin2 SAM1 did not. The low molecular weight band 
present in all experimental samples (left panel) was attributed to in the FLAG antibody 
light chain (IgG) that was nonspecifically detected by the infrared IR-600 antibody. 
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Figure 4. 4 – GST Immunoprecipitation. A complementary reverse IP experiment with 
GST-Caskin2 SAM2/SAM1 proteins immobilized on the anti-GST-Ab-agarose beads 
(Clontech) incubated with FLAG-H6-LARD1D2 protein. Double primary, Anti-H6-rabbit 
and anti-GST-mouse antibodies, followed by IR-800-anti-mouse and IR-600-anti-rabbit 
secondary antibodies were used for the detection and imaging with Odyssey infrared 
imager. LARD1D2 protein co-eluted with GST-Caskin2 SAM2.  
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4.3.2.  Determination of the reaction kinetic parameters by fluorescence anisotropy 
Building on the successful application of the fluorescence polarization 
spectroscopy method for determination of binding affinities of APP peptides to the PTB 
domain of AIDA-1 protein (Smirnova et al., 2013), I used this approach to study the LAR-
Caskin interaction. The smaller protein, Caskin2 SAM1-SAM2 (20 kDa), was used for 
labeling and detection and LAR D1D2/D2 (60-70 kDa) as a titrant. A maleimide 
fluorophore was chosen as a probe because it is selective for and makes covalent bonds 
with exposed, reduced cysteine side chains. The labeling method particularly suitable for 
Caskin2 since there is only one cysteine in its tandem SAM domain. Titrations were 
performed using two methods: (1) microplate sampling method using the Synergy Hybrid 
Reader detection with a sample volume of 10 µL; (2) a Varian Agilent Eclipse 
spectrophotometer equipped with a manual polarizer accessory that requires 500 µL total 
sample volume. The titration set plotted as an average of four independent experiments is 
presented in Figure 4.5. The dissociation constant of 1.1 ± 0.4 µM for wild type Caskin2 
SAM1-SAM2 interaction with LARD1D2 was calculated using nonlinear regression 
analysis. Additional LARD1D2 titrations with the maleimide-labeled Caskin2 SAM2, 
expressed as a single domain, resulted in a similar dissociation constant of 0.8 µM. 
Therefore, the microplate-based titrations with single SAM2 domain delivered Kd values 
comparable to a tandem SAM domain interaction with LARD1D2 derived from Varian 
titration series.  
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Figure 4.5 – Fluorescence anisotropy binding assay. Normalized fluorescence 
anisotropy titration curve of LAR D1D2 with maleimide-labeled Caskin2 SAM SAM WT 
plotted as mean values of four experiments with bars representing SEM errors for each 
data point.  Outer plot: logarithmic scale; inset plot: linear scale. The plot was generated 
using Prism 7 graphing program (by GraphPad Software Inc.) 
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However, due to an extremely small sample volume (10 µL) and the high instrument 
sensitivity, the Synergy Hybrid Reader data sets were suffering from multiple 
experimental artifacts. Therefore, the final reported kinetic parameters were calculated 
from data sets obtained from Varian spectrophotometer-based experiments.  
4.3.3.   Assessment of subcellular distribution and colocalization between LAR and 
Caskin2 in neuroblastoma cells 
An attempt to assess colocalization of Caskin and LAR in vivo and possibly determine 
their subcellular distribution was made by using fluorescent fusions of proteins in the 
mammalian expression vectors. Single and co-transfections were performed in Neuro2a 
cells using EGFP wild type Caskin2 SAM tandem (EGFP-CSSwt), the non-oligomerizing 
mutant EGFP-CSS[G537D/ K540E], dsRED-LARD2 and D1D2 fusion constructs (refer 
to Figure 4.6 and 4.7). Not unexpectedly, the single transfections with Caskin EGFP 
constructs demonstrated both cytoplasmic and nuclear distribution, whereas dsRED-
LARD2/D1D2 were diffusely distributed in the cytoplasm, often with noticeable 
accumulation in the cell membrane. Since fluorescent fusion proteins were overexpressed 
as separate protein domains rather than full-length proteins, the EGFP-CSSwt (47 kDa) 
protein was small enough to diffuse through the nuclear pore (Wang & Brattain, 2007). 
The degree of co-localization of EGFP-CSSwt and dsRED-LAR single D2 and double 
D1D2 domain constructs were assessed by calculating Manders overlap coefficients 
(Manders et al., 1993) (Figure 4.6c). Average overlap coefficients of 0.83 and 0.80 for 
EGFP-CSSwt with dsRED-LARD2/D1D2 respectively demonstrated substantial 
colocalization in both cases. 
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Figure 4.6 –Caskin2 SAM1 SAM2 and LARD1D2/D2 co-expression in Neuro2a cells. 
Neuro2a cells were transiently transfected with (a) pEGFP-N1-CSS w.t. and dsRED-mono-
LARD1D2 and (b) dsRED-mono-LARD2; blue (DAPI) nucleus staining, green channel – pEGFP, 
red channel – dsRED-mono; images acquired at the 40x magnification with confocal microscope 
LSM 700. Scale bar: 10 µm. (c) Western blot analyses of whole cell N2A lysates were performed 
to assess relative expressions of pEGFPN1-Caskin2 and dsRED-mono-LARD1D2/D2 fusion 
proteins with b-actin as a loading control. Monoclonal anti-EGFP, anti-LAR and anti-b-actin 
primary and IR-860/800 secondary antibodies were used for detection.  (d) Overlap coefficients 
(1.0≥y≥0) generated by the ZEN 2010 program for Caskin2 SAM1 SAM2 WT and LARD1D2/D2 
plotted as mean values with SEM error bars using Prism7 program, where n=54 for LARD1D2 
and n=58 for LARD2. 
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Figure 4.7 – Selected images of the double mutant Caskin2 (EGFP-G537D/ K540E) and 
LARD1D2/D2 co-expression experiments. Images were acquired at the 40x magnification 
using a Zeiss LSM 700 confocal microscope. Scale bar: 10µm.  
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4.4.   Discussion  
Apart from their direct phosphatase functions, the LAR RPTPs protein family only 
recently emerged as prospective synaptic cell adhesion molecules. This notion is 
supported by their high evolutionary conservation, the receptor-like structures and 
multiple extracellular and intracellular protein partnerships, including a set of synaptic 
membrane proteins linked to the synaptic development and synaptic adhesion pathways 
(Han et al., 2016; Um & Ko, 2013). A growing number of LAR PTPase family 
intracellular protein partners have been reported to interact with their membrane distal 
domains (D2), including Caskin, Liprin-α, Trio, diaphanous-related formins (DRFs), b-
catenin, and Abelson tyrosine kinase (Abl)–Enabled (Ena)/vasodilator-stimulated 
phosphoprotein (VASP) proteins, missing in metastasis protein (MIM-B) (reviewed by 
Um & Ko, 2013). The proposed LAR-RPTPs-based synaptogenesis model is illustrated 
in Figure 4.8.  where LAR-RPTPs have been suggested to act in conjunction with 
transmembrane receptors and intracellular signaling protein scaffolds, recruiting synaptic 
vesicles and active zone proteins; shaping the presynaptic differentiation; supporting the 
synaptic adhesion between dendrites and axons; and eventually transducing various 
postsynaptic signals.  
Studies demonstrate that Caskin1, but not Caskin2 is able to participate in the 
CASK signaling scaffold (Stafford et al., 2011a). In addition, our group had recently 
shown in vitro and in vivo that Caskin2 tandem SAM domain oligomerizes differently 
(Smirnova et al., 2016) from Caskin1 (Stafford et al., 2011b). Drosophila Caskin and both 
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mammalian and Drosophila alpha-liprin proteins have been reported to directly interact 
with the D2 domains of LAR RPTPs via their SAM domain modules in a competitive 
fashion (Wei et al., 2011; Serra-Pagès et al., 1995; 1998; Stryker & Johnson, 2007). Both 
partnerships emerge as essential determinants of axon guidance in Drosophila (Spangler 
& Hoogenraad, 2007; Wei et al., 2011). In addition, Liprin-α-LAR complexes recruit a 
number of known active zone modulators, such as RIM1-α, ERC2 and GIT1 (Ko et al., 
2003; Schoch et al., 2002; Stryker & Johnson, 2007) required for synaptic organization 
and maturation. Although the biological consequences of LAR/Caskin2-specific signaling 
scaffold, distinct from Liprin-α and CASK/Velis/Caskin1/Mint has yet to be identified, 
the existence of two closely related, yet different, human Caskin homologs suggest their 
different roles in the neuron.  
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Figure 4. 8 – Leukocyte common antigen-related receptor protein tyrosine 
phosphatases (LAR-RPTPs) regulated synaptogenesis. (a) Schematic illustration of 
excitatory and inhibitory synapses. LAR-RPTPs associations with extracellular and 
intracellular synaptic protein complexes regulate excitatory synapse development. (b) 
Intracellular domains of LAR-RPTPs interact with diverse intracellular proteins, 
including liprin-α, Trio, β-catenin and Caskins, as part of synaptic retrograde 
neurotransmission. At the postsynaptic sites, LAR-RPTPs mediate anterograde 
neurotransmission through partnerships with postsynaptic proteins, such as protein 
PSD95/SAPAP/Shank complex. The intracellular interactions include proteins that bind 
receptor tyrosine kinase TrkC and Slitrks. (c) As an exception, PTPσ forms a complex 
with Slit- and Slitrk3 at inhibitory synapses. The possibility that specific coreceptors 
regulate LAR-RPTPs activity colocalizing with LAR-RPTPs at different subsets of 
synapses remains to be investigated (Han et al., 2016). Illustration revised from (Um & 
Ko, 2013) prepared by Lesia Szyca, (2016).  
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Figure Abbreviations: ELKS, glutamine, leucine, lysine, and serine-rich protein; Slitrk1/2/3/4/5, Slit- and 
Trk-like family protein (1-5); GIT1, G-protein-coupled receptor kinase-interacting protein 1; Shank, SH3 
and multiple ankyrin repeat domains protein; PSD-95, postsynaptic density protein 95; SAPAP, PSD-95-
associated protein; TrkC, neurotrophin receptor tyrosine kinase C; MALS/Veli, mammalian LIN-
7/vertebrate homolog of LIN-7; Mint, Munc-18-interacting protein; NGL-3, netrin-G ligand-3; RIMs, Rab3-
interacting molecules; MIM-B, missing in metastasis protein B.  
 
I used the peptide SPOT blot method to identify the putative interaction surface on 
Caskin tandem SAM and LAR D2 domains.  The first identified array-derived sequence 
C-F-Q-Y-W-P-H-E-R-S (Drosophila) is partially conserved across species (refer to 
Figure 4.2c), with a core sequence QYWP conserved in both D1 and D2 domains; the 
second peptide array sequence H-C-S-A-G-V-G-R corresponds to the PTPase active site 
which is fully conserved in both D1 and D2 domains. In the catalytically active LAR 
PTPase D1 domain the (p)Tyr-binding site is formed by three regions: a catalytic site 
(I/V)H-C-X-A-G-X-G-R(S/T)G with thiol residue is directly involved in nucleophilic 
attack on the  pTyr and two additional loops contributing to acid-base catalysis and 
substrate recognition namely WPD-loop and pTyr-recognition loop. The tertiary 
structures of both intracellular domains of LAR are very similar and demonstrate 
remarkable sequence conservation, including preservation of the Cys-centered active site 
(Nam et al., 1999). However, two amino acid differences in the D2 domain, Leu1644 
(Tyr1644 in D1) and Glu-1779 (Asp1779 in D1), located in the pTyr recognition loop and 
WPD-loop respectively, induce a conformational difference and steric hindrance thereby 
preventing pTyr peptide from binding to D2 domain. Moreover, the reverse mutation of 
these residues (Leu1644Tyr; Glu1779) fully restored the robust PTPase catalytic activity 
of the D2 domain in vitro (Nam et al., 1999). As mentioned earlier, in addition to Caskin, 
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several protein partners interact specifically with membrane distal domain (D2) although 
the precise recognition sites mostly remain unknown at the structural level. Taking 
together the spot blot observations and the fact that catalytic sites of both domains are 
ligand-accessible, it could be hypothesized that a “pseudo catalytic site” of the D2 domain 
may serve as a recognition site recruiting non-phosphorylated protein partners of LAR. 
Most likely, similarly to D1 domain recognition, D2 domain binding requires several non-
consecutive surfaces. The SPOT blot method is applicable in a case of continuous surface-
exposed binding epitopes, but could result in false positives or fail to identify the contact 
surface in which secondary structure defines the specificity, as well as if it is formed by 
non-consecutive residues. NMR titrations of Caskin with LAR-derived peptide 
(REKCFQYWPHERSVR) did not result in observation of substantial conformational 
changes in Caskin2 SAM1 SAM2 that would be considered indicative of binding. The 
other reason could be that to match the SPOT blot result the Drosophila sequence-based 
LAR peptide was tested against human Caskin SAM1-SAM2 protein. However, 
surveying the sequence alignment, it is apparent that this peptide is only partially 
conserved between human/mouse and fly orthologs (Figure 4.2c). An additional 
mutagenesis study would be required to confirm the interaction surface on LARD2.  
Alanine scanning mutagenesis or small truncations targeting the H-C-S-A-G-V-G-R 
pseudo-catalytic site (PTP-loop) and Q-Y-W-P-loop sequence could be tested. The human 
LAR sequence-derived peptides R-E-K-C-H-Q-Y-W-P-A-E-R and H-C-S-A-G-V-G-R 
could be tested for interaction with Caskin2 SAM1 SAM2 by NMR and/or ITC titrations. 
Another possibility is elucidating and characterizing the D2 binding site via structural 
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study of LARD2/D1D2 bound to Caskin or Liprin-α, or ligand-derived peptide (by X-ray 
crystallography). 
Like Caskin2, Liprin-α is another SAM domain-containing protein known to 
interact with the LARD2 domain. Although the Liprin-LAR interaction has yet to be 
characterized at the structural level, it has been reported to take place at the triple-SAM-
domain module of Liprin-α which is highly conserved in entire liprin family, and also 
called liprin homology domain (LHD) (Serra-Pagès et al., 1995; 1998; Serra-Pagès, 
Streuli, & Medley, 2005). Furthermore, the intrinsic autophosphorylation ability had been 
suggested to regulate the liprin family protein partnerships (Serra-Pagès et al., 2005). 
Another similarity between Caskins and Liprins is their predisposition to oligomerization, 
although Caskins oligomerize via SAM domains and liprins had been suggested to 
dimerize via their coiled-coil domains (Serra-Pagès et al., 1998). In addition to homo-
oligomerization, Drosophila liprins β and 𝛾 were shown to hetero-oligomerize with liprin 
α (Astigarraga et al., 2010). As mentioned earlier, the triple SAM domain module is 
remarkably conserved among liprin family members. Surveying a sequence alignment of 
all Liprin-α human homologs with tandem SAM domains of human Caskins (Figure 4.9b) 
two sequence areas drive an attention as they demonstrate an exceptionally high degree of 
conservation, though overall conservation is rather low. For the purpose of this discussion, 
I designated these sequences as the “conservation region 1 and 2” (labeled accordingly in 
the figure Figure 4.9b). Conservation region 2, colored in green on Caskin structure 
(Figure 4.9a), corresponds to the sequence (100)L-C-A-L-G-L-P-Q-Y-H-K(110) within 
Caskin2 SAM2 domain as identified by SPOT blot analysis. It is a solvent exposed 
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continuous sequence region with the exception of a downstream leucine residue (L152) 
located in fifth α-helix, likewise fully conserved in all assessed protein sequences. 
Interestingly, glutamate (E98) and proline (P106) residues are conserved in all liprins and 
Caskin2, but not Caskin 1 (denoted with red boxes in the Figure 4.9b). From Caskin2 
domain-swapped homodimer structure we learned that salt bridges between E98 and R151 
reinforce the dimerization interface (Smirnova et al., 2016); hence glutamate 98 is one of 
the residues defining the distinct mode of Caskin2 dimerization, not observed in Caskin1.  
Another consensus sequence I-G-I/V-S/T-x-P-L/G-H-R denoted as conservation 
region 1 is located within the first SAM domain of Caskin (Figure 4.9a). Surveying this 
region in the Caskin SAM1-SAM2 structure, it is evident that residues G70, H71, K73, 
K,74, plus two conserved residues upstream, L36 and Y39, contribute to the solvent-
exposed conserved cluster. Therefore, in contrast to conservation region 2, the conserved 
surface 1 is non-continuous, hence methods such as peptide array would fail to identify it 
as an interaction site. However, in light that amino acids G70, K73 and K74 are located at 
the Head-to-Tail oligomerization interface of Caskin2 the high degree of conservation is 
not surprising since these surfaces are highly preserved in most SAM domains.  According 
to our in vitro immunoprecipitation studies single/double mutants G70D, K73E, and 
[G70D/K73E] do not perturb interaction with LAR. Likewise, the 929LHR931 (triple A 
mutant) Liprin-α1 assessed in (Serra-Pagès et al., 2005) study remained LAR-active. At 
the same time, the D990(A) mutation in SAM2 domain, assessed in the same study, resulted 
in reduced LAR binding as well as perturbed liprin auto-phosphorylation both in vivo and 
in vitro (Serra-Pagès et al., 2005). Orange boxes denote all mutants examined by Serra 
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Pages et al. (2005) in Figure 4.9b. Furthermore, the most recent study by Astigarraga et 
al. (2011) confirmed that liprin-α and a new isoform that they named liprin-𝛾, but not 
liprin-β, interact with the D2 domain of Lar via LHD (triple-SAM domain). The LAR-
liprin(s) partnership was once more shown to be necessary for normal synapse 
development in Drosophila in both R7 photoreceptors and motor neurons, with liprin-𝛾 
possibly serving as a functional antagonist counteracting and/or regulating the two other 
liprins functions (Astigarraga et al., 2010). 
Another mutagenesis coupled with yeast two-hybrid study by Weng et al. (2011) 
(in Drosophila), however, described Csk SAM1(R305Q) and Csk SAM1Δ324-331 
mutant constructs as Lar-inactive. Initially, these regions were selected for mutagenesis 
as they were earlier connected to the loss-of-function phenotypes (LOFs) causing various 
degrees of motor axon pathfinding disruption. However, an examination of these 
mutations from a structural perspective suggests that the R305Q mutation and large Δ324-
331 truncation would have the serious structural consequences: by disrupting the SAM1 
domain structure they would consequently also perturb the SAM1-SAM2 intra-molecular 
interface, thus SAM1-SAM2 module integrity. Moreover, the perturbation at SAM1 
domain would likely manifest in the loss of Caskin2 oligomerization, which is a known 
requirement for proper function of many scaffolding proteins. Therefore, the observed 
loss of function was rather anticipated in case of SAM1 domain mutants; at the same time, 
Weng et al. (2011) study inarguably confirmed, by a number of methods, the intact 
SAM1-SAM2 module of Csk as an interaction site for Lar PTP (Weng et al., 2011b).  
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Figure 4. 9 – Sequence conservation of SAM1-SAM2 domains of human Liprin family 
members and human Caskins. (a) Caskin2 SAM tandem with highly conserved “region one” in 
SAM1 (orange) and “region two” (green) in SAM2 domains; other fully conserved residues 
colored in yellow. (b) Black regions denote the identity regions, grey – substitutable amino acids. 
Two red boxes denote differences between Caskin2 and Caskin1 in the “conservation region two”. 
Orange boxes indicate liprin mutants 874PF875(AA), D990(A), D1001(A), 929LHR931(3A) 
evaluated in (Serra-Pagès, Streuli, & Medley, 2005) study.  
An alignment was performed using Clustal Omega multiple protein sequence alignment program 
(www.ebi.ac.uk/Tools/msa/clustalo) and color-coded using Color Align Conservation program 
(www.bioinformatics.org/sms2/color_align_cons.html) UniProtKB sequence IDs: human liprin-α2 
(AF034799), human liprin-α4 (AF034801), human liprin-α1 (U22815), human liprin-α3 (AF034800), 
Caskin2 (Q8WXE0), Caskin1(Q8WXE9). The SAM3 domain of liprin was excluded from the alignment.  
a
b
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Within the structural context of this discussion it is worth describing the Liprin-α2 
interaction with C-lobe of CASK CaMK domain which is currently the only Liprin-based 
complex reported at atomic resolution.  The liprin-α2/CASK complex crystal structure, 
solved by Wei at al. (2011), revealed that the intramolecular interface is formed by four 
salt bridges and an intense hydrogen bonding network from both SAM1 and SAM2 
domains of Liprin, as well as short insertion helix between them 978-GNVWVTHE-985 
(namely αL helix).  The Trp981 serves as a hydrophobic anchor intercalated deeply into 
CaMK-binding cleft (Wei et al., 2011).  Interestingly enough, αL helix only exists in the 
α2, α3, and α4 isoforms of mammalian liprins and absent in C-elegans and Drosophila as 
well as in the mammalian liprin-α1 isoform, prompting liprin-α 2/CASK signaling 
complex as vertebrate-specific (Wei et al., 2011). In the case of Caskin tandem SAM 
structure similar epitope is present three times: first in SAM1 domain (-NWL-), then in 
the conservation region SAM2 (-EWL-); in both cases, the tryptophans are buried in the 
molecular surface and incorporated in the α-helical motifs. However, the third sequence 
is located in the flexible linker between first and second SAM domain and conserved -
E/D-W-L- in both Caskin2/1 homologs. In the crystal structure of the domain-swapped 
Caskin2 dimer the linker region provides the hydrophobic homo-dimerization interface. 
In contrast, in solution, the mix of monomeric/dimeric states is observed and the linker 
appears to be flexible (by NMR) (Smirnova et al., 2016). Therefore, it could be speculated 
that linker W554 could potentially serve as a hydrophobic anchoring point similarly to (-
VWV-) motif of Liprin-α2 insertion helix αL. This hypothesis could be tested by the 
computational molecular docking methods and mutagenesis.  
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The extensive in-vitro immunoprecipitation series confirmed the interaction 
between mammalian LARD2 and Caskin SAM1-SAM2 homologs, as well as the 
requirement of SAM2 domain for the interaction. The single SAM1 domain expressed as 
GST-fusion did not co-elute with LARD1D2. However, from the structural studies, we 
have learned that SAM1 domain is highly unstable without SAM2 domain, therefore, the 
possibility of a SAM1-SAM2 interface or the linker region in between providing an 
additional specificity to the interaction could not be entirely eliminated.  Additionally, the 
fluorescent anisotropy titrations were performed to characterize the interaction further. 
The low micromolar affinity was determined for LAR-D1D2 interaction with Caskin2 
SAM1-SAM2, which is common for scaffolding/signaling assemblies at the synaptic sites 
where proteins must rapidly sample multiple ligands and relatively fast 
association/dissociation is required for efficient signal transduction (Burack & Shaw, 
2000; Pan, Sudol, Sheetz, & Low, 2012; Pawson, Scott, & Scott, 1997).  For comparison, 
liprin-a2_LH binds to CASK_CaMK with a Kd of ~0.6 µM (Wei et al., 2011). Finally, 
co-transfections in Neuro-2a cells revealed a high degree of colocalization between 
LARD2/D1D2 and wild type and double mutant Caskin2 SAM1-SAM2 fluorescent 
constructs.  The overexpression of LARD2/D1D2 (single transfections) demonstrated 
membrane accumulation in selected cells, although only cytosolic domains were 
expressed. That could be an indication of physical interactions with transmembrane 
proteins such as N-cadherin (Siu, Fladd, & Rotin, 2007) or other co-receptors (Han et al., 
2016) yet to be identified. 
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To summarize, the experimental evidence supports the interaction between 
mammalian orthologs of LAR and Caskin2. Although additional investigations are 
required to confirm the minimal binding epitopes, two regions were identified as plausible 
binding sites. Both are highly evolutionary conserved across evolution not only in human 
Caskin and Liprin homologs, but liprin-β1/2 and Drosophila liprin, C. elegans liprin-α 
and Drosophila Ckn. Conservation region 2 appears to be the most plausible binding 
recognition epitope, since it remains ligand-accessible in Caskin2 monomeric or 
dimeric/oligomeric forms, whereas conservation region 1 overlaps with the Caskin2 
oligomerization interface (Smirnova et al., 2016). Additional mutagenesis studies, peptide 
titrations, and SPOT blot array of Caskin SAM tandem sequence with consecutive residue 
substitutions can be conducted to further elucidate the binding requirements and provide 
a framework for a more detailed NMR/X-ray structural investigation of the LAR-Caskin 
complex. 
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_______________________________________________________________________ 
5.  CHAPTER 5: 
CONCLUDING REMARKS AND  
FUTURE DIRECTIONS  
_______________________________________________________________________ 
 
5.1.   Summary of Research  
Neuronal protein AIDA-1 links synaptic signaling events with global changes in 
gene expression. Among other neuronal “shuffling” proteins AIDA-1 was suggested to 
serve in NMDAR-regulated neuronal signaling and protein trafficking, essentially linked 
to a long-term memory formation and synaptic plasticity (Dudek, 2007; Jordan & Kreutz, 
2009).  In addition, AIDA-1 has been implicated in APP processing; Cajal body 
regulation, including nucleolar formation and stability; PSD structural remodeling (Xu & 
Hebert, 2005; Dosemeci et al., 2015, Jordan et al., 2009, Tindi et al., 2015). Loss of 
AIDA-1 functions have serious consequences for human health: a number of genetic 
studies have linked the AIDA-1 gene ANKS1B to schizophrenia (Purcell et al., 2014; 
Snyder & Gao, 2013) and autism spectrum disorders (ASDs) (Pinto et al., 2014; M. Uddin 
et al., 2014).  
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In this study, we reported the NMR structure of the carboxy-terminally located 
PTB domain, preserved to all AIDA-1 splice variants, that could be viewed as the business 
end of the molecule capable of supporting multiple protein partnerships including amyloid 
protein precursor (APP), a Cajal body protein coilin, and Ephrin A8 receptor tyrosine 
kinase. Using a comprehensive survey of peptides, the consensus sequence 
YxNxΦYxΨFE around an NxxY motif of APP was identified. Employing a peptide 
docking simulation, we characterized the AIDA-1 PTB binding cleft specificity to AβPP-
AICD derived minimal peptide. In addition, the binding affinity of ∼10 µM for the PTB-
APP interaction was determined using fluorescence anisotropy method. We have 
established that the AIDA-1 PTB domain recognizes unphosphorylated-tyrosine NxxY 
motif-containing ligands, a binding mode typical for the Dab-like class protein family, 
although the consensus sequence NxxY is less stringent than NPxY required for other Dab 
family proteins. A comparison of the binding clefts of the AIDA-1 PTB with X11 and 
Fe65 revealed a binding mode analogous to the X11/Mint PTB-APP interaction.  The 
moderate affinity and slightly different minimal ligand recognition epitope could be 
advantageous for AIDA-1-regulated signaling, alternative to X11, as well as in non-APP 
signaling contexts. 
Two mammalian homologs, Caskin 1 and Caskin 2, are neuronal scaffolding 
proteins highly enriched in neuronal synapses (Tabuchi et al., 2002) as well as retinal 
synapses (Anjum et al., 2014). Caskin1, but not Caskin2 contributes to CASK 
(calcium/calmodulin-dependent serine kinase) regulated signaling pathways. Despite an 
overall high level of homology, the apparent differences in their oligomerization modes 
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suggest the possibility of distinct functional outcomes in neuronal signaling circuits. The 
reported crystal structure of the Caskin2 SAM domain tandem revealed an oligomeric 
form different from Caskin1, with the minimal repeating unit being a domain-swapped 
dimer, rather than a monomer. Examination of the dimer interface suggested that residues 
critical for homo-dimerization in Caskin2 were not preserved in Caskin1, providing a 
possible explanation why Caskin2 and Caskin1 oligomerize differently in vitro and in 
vivo. Such structural diversity could be advantageous in a concentration-dependent 
mechanism regulating low-affinity protein interactions, common for signaling pathways. 
This study contributes to understanding how neuronal SAM domain-containing proteins 
facilitate the assembly of large macromolecular complexes in order to concentrate and 
amplify synaptic responses. 
Growing evidence of the mammalian LAR receptor tyrosine phosphatase 
regulatory functions in complex processes such as axonogenesis, synaptic assembly, 
neuronal plasticity, and its implications for human health, including neuronal 
regeneration, autism spectrum and other neurodegenerative disorders, demands a detailed 
elucidation of mammalian LAR PTP signaling pathways. The experimental evidence 
supports the interaction between mammalian orthologs of LAR and Caskin2 as presented 
in this dissertation. A combination of biochemical and biophysical techniques was used 
to characterize the interaction between the membrane distal domain D2 of LAR and the 
tandem SAM domain of Caskin2. Although additional experiments would be required to 
characterize the interaction surface and binding specificity, accumulated experimental 
data suggests the minimal requirement of SAM2 domain of Caskin2.  
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5.2.   Future Directions 
5.2.1.   AIDA-1 
Considering that the abundance of AIDA-1 in the PSD is comparable to GKAP 
guanylate kinase-associated proteins and PSD-95 fractions (Lowenthal, Markey & 
Dosemeci, 2015), our current understanding of its physiological functions is very modest. 
Several outstanding questions remain to be addressed: What regulatory mechanisms are 
encoded by AIDA-1 via alternative splicing? Are the subcellular locations of AIDA-1 
isoforms a reflection of their distinct functions? Moreover, the mechanism of AIDA1 
NMDA receptor specific functions has yet to be fully elucidated. The AIDA-1 nuclear 
translocation mechanism and the gene expression consequences are also not entirely 
understood.  
NMDAR activation triggers the proteolytic cleavage and subsequent translocation 
of the AIDA-1d fragment to the nucleus where it associates with Cajal bodies and 
stabilizes its interaction with nucleoli (Jordan et al., 2007). Silencing AIDA-1 through 
siRNA knockdown resulted in disruption of Cajal bodies and increased cell death rate (Xu 
& Hebert, 2005). The basis of AIDA-1 interaction with Cajal bodies protein Coilin has 
not been elucidated at the structural level. Preliminary investigations, performed by our 
laboratory members, suggested the interaction is between the Coilin Tudor domain and 
PTB domain of AIDA-1. Additional mutagenesis and structural studies would be required 
to verify this hypothesis.  
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Bryen A. Jordan’s group suggested that AIDA-1 acts as a subunit-specific 
NMDAR transport facilitator. AIDA1 mediation of NMDAR function by fluctuations of 
GluN2B subunit levels has been proposed (Tindi et al., 2015). The structural basis for 
preferential binding of AIDA-1 to GluN2B versus GluN2A is currently unknown. This 
research avenue is necessary for understanding of AIDA-1 protein contributions to 
pathogenesis of neuropsychiatric disorders such as autism and schizophrenia, which are 
strongly associated with NMDA receptor synaptic dysfunctions. 
The observations that the short AIDA-1a isoform demonstrates preferential 
binding to AβPP-AICD while isoform b is AβPP-inactive (Ghersi et al., 2004a) suggested 
the possibility of a self-inhibitory mechanism in which the sequence region encoded by 
exon14 is precluding AIDA-1 from association with AβPP by direct interaction with PTB 
domain. Similar self-inhibitory mechanisms have been described for PTB domains of X11 
(Matos et al. 2012) and Talin (Goksoy et al. 2008) proteins. Although our investigations 
of the AIDA-1 self-inhibition, conducted up to date, delivered controversial results, if this 
segment of the study is pursued the possible contributions of exon14 flanking sequences 
and/or phosphorylation events should be considered. Phosphorylation-induced 
conformational change displaces Fe65, but does not prevent X11s from binding to the 
GYENPTY motif of the AβPP cytoplasmic domain (Suzuki & Nakaya, 2008).  
The PTB domains of AIDA-1, X11 and Fe65 target the same overlapping binding 
site on AICD, and the competitive nature of their interaction with AICD has been 
previously reported. It would be instrumental to determine if a subset of AIDA-1-positive 
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synapses overlaps with X11 in order to address a key question of whether they have 
complementary or distinct roles in APP processing. Further structural and biochemical 
studies of AIDA-1 would lead towards better understanding of neuronal signaling 
pathways. 
5.2.2.  Caskin2 and Lar Tyrosine Phosphatase 
Since the minimal binding requirement has not been determined for any of the 
currently known LAR intracellular ligands, pursuing the structural studies could provide 
insight into the ligand binding specificity of the D2 domain of LAR PTPase. An additional 
mutagenesis study would be required to confirm the interaction surface on LARD2. If the 
minimal binding epitope within LAR originates from consensus peptide sequence, further 
NMR-based structural investigations would be possible. Another option is elucidating and 
characterizing the D2 binding site via a structural study of LARD2/D1D2 bound to 
Caskin, Liprin-α, or ligand-derived peptide by X-ray crystallography. A competition 
between Liprin-α and Caskin2 for LAR could be tested by applying a fluorescent 
polarization spectroscopy method. Complementary ITC titrations could be used to 
confirm the binding affinity of LARD1D2 and Caskin SAM1-SAM2 determined by the 
fluorescence anisotropy method.  
With respect to the synaptic functions of LAR PTP family proteins synaptic 
functions, many outstanding questions remain to be addressed: (1) whether or not LAR-
PTPase activity regulates LAR interactions with intracellular ligands; (2) ligand 
selectivity and specificity that allows individual LAR family members (LAR, PTPσ and 
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PTP𝛾) to target a distinct set of protein partners; and (3) what functional consequences 
and regulatory mechanisms are regulated by specific synaptic localization and alternative 
splicing of mammalian LAR family members. Although a comprehensive functional 
investigation is beyond the scope of this dissertation and our laboratory specialization, 
additional behavioral, neurological and electrophysiological studies would be necessary 
to investigate if dysfunctions of LAR RPTPs postsynaptic ligands are directly associated 
with disruptions of LAR functions. The detailed characterization of LAR-regulated 
synaptic adhesion architecture would contribute to a fundamental knowledge of synaptic 
development and synaptic plasticity.  
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5.3.   Concluding remarks 
The modular nature of signal transduction proteins endorses them as the ideal 
modulators of cellular signaling circuits through the ability to interact with a diverse array 
of ligands. The structure-directed studies, described in this dissertation, expand our 
knowledge about domain organization and oligomerization properties of neuronal proteins 
AIDA-1 and Caskin2.  
Structure-functional characterization of AIDA-1 PTB domain as the interaction 
hub, together with its SAM tandem structure, described earlier by our group, could provide 
a framework for future functional studies ultimately revealing the functional details of      
AIDA-1 functions at the synapse with important consequences for human health. 
The reported distinct structural attributes of Caskin2 and its partnership with LAR 
RPTP is one step towards understanding their cellular functions. With much hope these 
studies would contribute to future investigations improving our understanding of LAR-
RPTPs signaling outcomes in the development of various neurological conditions.  
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Appendix A 
Protein NMR Spectroscopy 
In the post-genomic era, protein structure has become an essential component for 
understanding complex biological processes. Structure focused studies also benefit 
therapeutic discovery, drug development, and biotechnology. For decades, NMR 
spectroscopy and X-ray crystallography were the only techniques permitting protein 
structure determination at atomic resolution; however, cryo-EM techniques are now 
gaining favour in the structural biology community. In contrast to X-ray diffraction 
methodology that requires protein crystallization, NMR allows studying proteins in their 
natural solution state. In addition to three-dimensional structure, NMR spectroscopy can 
provide information about molecular dynamics, conformational equilibria, and ligand-
binding kinetics. In the context of this thesis, I will briefly discuss the fundamental 
principles of NMR to set the foundation for the following section which will focus on the 
aspects of NMR protein structure determination.   
NMR basic theory 
Nuclear magnetic resonance (NMR) spectroscopy technique is based on 
observation of the quantum-mechanical property of atomic nuclei, termed nuclear spin. 
The nuclei with an even mass and odd charge have an unpaired electron and have spin 
angular momentum of ½. This means that nuclei exist as an equilibrium of two distinct 
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energy levels - one of which (ground state) is lower than the other.  This electromagnetic 
property of the nuclei is exploited in NMR experiments. In the presence of an external 
magnetic field, nuclei absorb, resonate and emit radio frequency energy as 
electromagnetic radiation. In the absence of an external magnetic field, the nuclear spins 
orientations are random. Once the magnetic field is applied the spins reorient in such way 
that one fraction aligns with the field and the other against the field. When nuclei are 
irradiated with electromagnetic waves of certain radio frequency (RF) the lower energy 
nuclei spin flips to the higher state, in other words, resonate with the RF.  The range of 
the frequencies used in NMR range from 50 to 1000 MHz.  
The perturbation of equilibrium states by short RF pulse or a series of the pulses 
followed by the return of the system to the equilibrium state is accompanied by a release 
of energy. The process of a system returning to its thermodynamic equilibrium is called 
relaxation. The resulting oscillating magnetic field producing an NMR signal is termed 
Free Induction Decay (FID). FID represents the series of electromagnetic waves measured 
as a function of time. The Fourier transformed FID signal gives the typical NMR spectrum 
as a collection of absorption peaks at various resonance frequencies. Different nuclei have 
distinct resonance frequencies which match the energy difference between the spin 
populations of this particular nucleus: protons (1H) resonate at ten times higher 
frequencies than 15N and four times higher than 13C nuclei. Furthermore, when coupled 
with different atoms into chemical groups the nuclei of the same type will have different 
resonance frequencies. For instance, amide protons resonate at ≈ 8 ppm, Hα protons at ≈ 
4 ppm and methyl protons at ≈ 1 ppm (Wider, 2000). This phenomenon, termed chemical 
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shift, primarily arises from the influence of elections from surrounding atoms (atom 
electronegativity) on the local magnetic field around the resonating atom of interest 
(Cavanagh et al., 2010). The electrons create their own small magnetic field which slightly 
shields the nuclei from the external field.  The chemical shift (δ) value is expressed in ppm 
(parts per million) and defined as:   
 
δ= ((wsignal - wreference) / wreference) * 106  
 
Instead of Hz the universal ppm units are used as independent of the magnetic field 
strength B0. The reference signal of the methyl groups of tetramethylsilane (TMS) or 2,2-
dimethyl-2-silapentane-5-sulfonic acid (DSS) is used as a reference frequency for the ppm 
scale and defined as the chemical shift of 0 ppm). 
Nuclear spins influence each other in two ways: through chemical bonds (scalar 
coupling) and through space (dipolar coupling). The latter is especially important for 
protein structure determination. Dipolar interactions manifest themselves as a change of 
NMR signal intensity of nuclear spin which thermodynamic equilibrium is being 
perturbed as well as the neighboring spin systems that are situated close enough to have 
dipolar interactions with it. This phenomenon is called nuclear the Overhauser effect 
(NOE). NOE arises as a result of cross relaxation and magnetization transfer between the 
magnetic dipoles of neighboring atoms. It provides valuable spatial information about 
inter-atomic distances in the macromolecule.  J-coupling experiments give correlation 
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information through one, two or three bonds (1J, 2J, 3J). Amide group heteronuclear 
coupling (1J 15N-1H) is an example of one bond coupling, whereas CαH-CβH proton 
coupling is a two bond coupling. Three-bond coupling, such as amide hydrogen to alpha 
hydrogen, gives information about dihedral angles essential for structure determinations 
(Almeida, Moraes, & Gomes-Neto, 2013). 
The 1-dimensional (1D) NMR spectra of large macromolecules such as proteins 
are very complex with many overlapping peaks. Therefore, protein NMR spectroscopy 
exploits the information from a number of NMR experiments in order to assign the 
collection of resonance signals to the particular amino acid. The same amino acid type in 
the folded protein structure will have a different chemical shift profile depending on its 
spatial position in the globular structure. NMR dimensionality, correlation experiments 
and their interpretation resulting in 3D NMR structures will be discussed in subsequent 
sections.  
Sample requirements 
The success of high resolution NMR data acquisition suitable for structure 
determination relies on the protein sample purity, stability and requires high 
concentration. Since the natural abundance of NMR-detectable nuclei 15N and 13C is only 
0.37% and 1.1% respectively (Wider, 2000) biochemical isotopic enrichment is required 
(McIntosh & Dahlquist, 1990).  Bacterial protein expression systems are the most 
commonly used for protein labeling. The so-called minimal medium contains salts and 
trace mineral required for bacterial growth and proliferation and supplemented with 
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supplemented with 15NH4Cl and unlabeled or 13C-glucose as a sole source of nitrogen and 
carbon. An addition of 10% D2O is required for required for control and stabilization of 
magnetic field strength. For proteins bigger than 30 kDa, a 15N,13C,2H triple labelling 
technique is used, achieved by substituting H2O with D2O in addition to 15N/13C isotopic 
labeling. The fact that larger molecules tumble slower in solution affects their relaxation 
rate and causes NMR signal broadening. By eliminating the bulk of proton signal the 
spectral resolution is greatly improved. Other methodologies such as methyl-specific 
labeling (Otten et al., 2010) or amino acid specific labeling (Krishna & Berliner, 1999; 
McIntosh & Dahlquist, 1990) is also used for large proteins.  
Signal correlations and NMR dimensionality 
As noted earlier, NMR structural determinations require incorporation of both 
through-bond and through-space correlation experiments (Cavanagh et al., 2010; Wider, 
2000). 2D experiments employing J-coupling (scalar coupling) for direct through-bond 
correlation of different nuclei are called correlation spectroscopy or COSY.  For instance, 
HSQC (Heteronuclear Single Quantum Correlation/Coherence) reflects all amide group 
N-H correlations, most of which are backbone originated. In the HSQC experiment, the 
magnetization is transferred from 1H to 15N then after chemical shift evolution it is 
transferred back to proton and recorded at the 1H channel. The 3D experiments are 
practically based on 2D experiments propagated to the third dimension, where x and y are 
1H and 15N and z is 13C dimension. The correlation of all three signals as a result of a 
combination of HSQC and HNCO data will gain a single cross-referenced peak for each 
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amide group and adjacent carbonyl (C’O-N-NH) (Kay et al., 2011) (refer to Figure A1). 
Through-space correlation experiments that employ nuclear Overhauser effect are 
observed when two or more spins are not more than a few angstroms apart and become 
coupled with each other through the dipolar coupling (Almeida et al., 2013).  The 
experiments that derive the distance constraints between protons called NOE and also 
referred as NOESY (Almeida et al., 2013; Wider, 2000). They allow the correlations 
between residues that could be far apart in the primary sequence, but nearby in space in 
folded protein structure. The NOE intensity depends on cross-relaxation and reduced with 
the power of six proportionally to the distance between two interacting spins (r-6). 
Therefore it allows the measurement of dipolar coupling within 6 Å only (Almeida et al., 
2013; Wider, 2000). 
Backbone assignment strategies and generation of 3D structure 
High-resolution data acquisition necessary for successful structural calculations is 
achieved by use of the higher field magnets (750 MHz and up).  Several multidimensional 
NMR strategies are used for tailoring an experimental information into the final globular 
structure. The most straightforward backbone assignment method requires triple 
resonance experiments such as CBCANNH and CBCA(CO)NNH that are based on the 
observation of all three nuclei: 1H, 15N and 13C (illustrated in Figure A.1).  These 
experiments allow the sequential assignment of molecular backbone, in other words, the 
protein primary sequence. The TROSY (transverse relaxation optimized spectroscopy) 
techniques could simplify the backbone assignments for larger proteins where signal 
overlap is an issue (Xu & Matthews, 2013).  
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Figure A1 – The schematic presentation of 2D and 3D NMR spectrum. (a) The 
crosspeaks correlating [1H, 15N] resonances in 2D (HSQC) spectrum are translated into 
the third 13C-dimension (b, c). The 1H dimension is generally left in the x-dimension and 
in most cases the 13C dimension is viewed along the y-axis, leaving 15N to form the z-axis. 
Essentially the 3D spectrum can be visualized as a stack of a 1H-13C 2D spectra lined up 
along the 15N dimension (d and e). The figure is reprinted from the online resource: 
Protein NMR. A practical Guide: (www.protein-nmr.org.uk) by Dr. Victoria A. Higman 
with author’s permission. 
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The side chain assignments follow the back-bone assignments. For example, the 
most commonly used combination is HCCH-TOCSY together with HCCH-COSY. 
Complex analysis of the two links the side chain resonances with previously assigned 
backbone resonances.  NOE experiments contribute the missing geometric and distance 
information based on dihedral angles and dipolar coupling.  NMR structure calculations 
generate the solutions that optimally satisfy the atomic distance and angular restraints. 
Therefore, instead of a single structure the final NMR structure represents an average of 
the population of best structures. The degree of consistent distance constraints used for 
structural calculations directly affects the quality of 3D structure (Cavanagh et al., 2010; 
Kay et al., 2011). 
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Figure A2 – A schematic diagram of sequential backbone assignment using triple resonance 
correlation experiments: CBCANNH and CBCA(CO)NNH. (a) Logistics of sequential 
correlation of Cα/Cβs and NH resonances in the peptide chain. CBCANNH strongly correlates 
each NH group with the Cα and Cβ chemical shifts of its own residue and more weakly with Cα-
Cβ of the preceding residue. The CBCA(CO)NNH correlates the NH group to the preceding Cα 
and Cβ chemical shifts. (b) Two superimposed experiments converted into a strip view, with Cαs 
are shown in dark blue, Cβs in light blue, and dashed lines showing the correlations between the 
experiments. The figure is reproduced from the online resource: Protein NMR. A Practical Guide: 
(www.protein-nmr.org.uk) by Dr. Victoria A. Higman with author’s permission.  
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Appendix B 
Additional Research Accomplishments 
 
A combined ITC and NMR spectroscopy study, to characterize a gap junction protein 
Connexin 36 (Cx36) and its interaction with calmodulin (CaM) has been included as an 
additional research accomplishment. This work was completed as part of a collaboration 
with the laboratory of Dr. G. Zoidl and published in: 
Siu R.C.F., Smirnova E., Brown C.A., Zoidl C., Spray D.C., Donaldson L.W., 
Zoidl G. (2016) “Structural and functional consequences of Connexin 36 (Cx36) 
interaction with Calmodulin”. Frontiers in Molecular Neuroscience. 9:120.  
 
I include here the manuscript abstract and outline the experiments performed by myself. 
 
 
Summary 
Functional plasticity of neuronal gap junctions involves the interaction of the 
neuronal connexin36 with calcium/calmodulin-dependent kinase II (CaMKII). The 
important relationship between Cx36 and CaMKII must also be considered in the context 
of another protein partner, Ca2+ loaded calmodulin, binding an overlapping site in the 
carboxy-terminus of Cx36. We demonstrate that CaM and CaMKII binding to Cx36 is 
calcium-dependent, with Cx36 able to engage with CaM outside of the gap junction 
plaque. Furthermore, Ca2+ loaded calmodulin activates Cx36 channels, which is different 
to other connexins. The NMR solution structure demonstrates that CaM binds Cx36 in its 
characteristic compact state with major hydrophobic contributions arising from W277 at 
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anchor position 1 and V284 at position 8 of Cx36. Our results establish Cx36 as a hub 
binding Ca2+ loaded CaM and they identify this interaction as a critical step with 
implications for functions preceding the initiation of CaMKII mediated plasticity at 
electrical synapses. 
Isothermal Titration Calorimetry (ITC) 
Isothermal titration calorimetry (ITC) measurements were performed on MicroCal 
VP-ITC calorimeter (MicroCal Inc., Northampton, MA, USA). The recombinant H6-CaM 
(affinity purified as described above) was titrated with Cx36 derived peptides reflecting 
the wild type (GSGWRKIKLAVRGAQAKRKSVYEIR; CanPeptide Inc., Montréal, QC, 
Canada) or the W227A mutant (GSGARKIKLAVRGAQAKRKSVY; BioBasic, 
Markham, ON, Canada). An optimal titration was achieved with 25 µM CaM in the 
reaction cell and 250 µM Cx36 peptide in the syringe, each in a buffer containing 50 mM 
NaCl, 5 mM BisTris pH 7.0, 5 mM CaCl2. After an initial injection of 2 µL, the bulk of 
the titration consisted of 34 successive 8 µL injections with an equilibration delay of 300 
s. Heats of dilution were determined by titrating the same peptide solutions into buffer 
alone. Titration profiles corrected for the heat of dilution were fitted into one-binding-site 
model using MicroCal Origin vv5.0. All values reported were calculated based on three 
individual experiments. 
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Figure B1 – Isothermal titration calorimetry (ITC) of Cx36 peptides and CaM. 
Calorimetric traces and integrated isotherms acquired at 30 ºC for (A) Calcium saturated 
CaM titrated with a Cx36 derived peptide, and (B) Calcium saturated CaM titrated with 
the same peptide bearing a W277A substitution. No binding was detected between CaM 
and W277A mutant peptide. Abbreviations: Kd, dissociation constant; n.d., not detected. 
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The ITC experiments were performed to determine the affinity of CaM for a 25 
amino acid long peptide derived from the Cx36 cytoplasmic tail (Figure B1). As predicted 
from the NMR structure, the Cx36 peptide bound Ca2+-CaM stoichiometrically with a Kd 
of 0.53 ± 0.05 µM (n = 3). Highlighting the role of the amino acid W277 at the position 1 
of the 1–8–(14) motif, no binding was observed for the peptide bearing a W277A 
substitution (n = 3). Consistent with the structure and biological assays described 
throughout the study, peptide binding was only observed with Ca2+ saturated CaM. In 
addition, two other Cx36 flanking residue mutants G276A and G276A were tested, as well 
as Ca2+-free CaM was titrated with the wild type Cx36 peptide. Results are summarized 
in the Table B1. 
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Table B1: The Dissociation Constants and Thermodynamic Characteristics of CaM 
Interactions with WT and Mutant Cx36 Peptides Used in This Study. 
 
 
Data acquired in 50mM NaCl, 5mM BisTris pH7.0, 5mM CaCl2 (no CaCl2 for apoCaM experiment). 
The kinetic and thermodynamic parameters reported were calculated as averages of 2-4 individual 
experiments for each peptide, with error range expressed as a standard deviation. All experiments used for 
analysis were corrected for the heat of dilution. Ndb = no binding detected. of the titrant.  
*A double binding site fitting algorithm produced the best results for R278A peptide, parameters produced 
by the single binding site fitting provided for the comparison. 
 
Data Ka (M-1) remove later 
Fitting 
mode Kd (µM) 
ΔH  
(kcal mol-
1) 
-TΔS 
(kcal mol-
1) 
Ca2+CaM titrated 
with Cx36 WT 
peptide 
 
1.9075x106 Single site binding  0.528 ± 46 
– 5.00 ± 
0.93 
– 3.71 ± 
0.97 
CaM (Ca2+ free) 
titrated with Cx 36 
WT peptide 
 
nbd na nbd nbd nbd 
Ca2+CaM titrated 
with Cx36 G276A 
peptide 
 
3.42x105 
 
Single site 
binding 2.92 ± 1.7 
-5.09 ± 
0.72 
-2.57 ± 
0.79 
Ca2+CaM titrated 
with Cx36 R278A 
peptide 
 
  
6.28x104 
 Double site 
binding 
15.9 ± 2.9 -4.45 ± 1.3 
-3.33 ± 
0.19 
5.77x107 0.017 ± 0.0011 
-5.33 ± 
0.17 
-5.41 ± 
0.27 
 
 
1.64x105 
 
Single site 
binding*   6.1 ± 0.02 
-6.10 ± 
0.02 
-1.602 ± 
0.02 
Ca2+CaM titrated 
with Cx36 W277A 
peptide 
 
nbd na nbd nbd nbd 
